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ABSTRACT 
In recent times, drugs loaded into nanocomposite fibre mats have gained significant 
attention due to their good structural stability, reduced toxic side-effects, enhancement 
of healing effectiveness and higher efficiency of drug encapsulation compared to other 
drug delivery carriers. This study created novel electrospun hybrid nanocomposite fibre 
mats from a variety of materials: poly(lactic acid) (PLA) with poly(ε-caprolactone) 
(PCL); PLA and PCL embedded with halloysite nanotubes (HNTs); and PLA and PCL 
embedded with magnetic nanoparticles (MPs), with the aim of finding a material 
combination that could maintain the steady release of a hydrophilic drug from this 
hydrophobic polymer system. The main purpose of this work is to holistically 
understand the influences of the solvent system, solution electrical conductivity, solution 
viscosity, polymer blend ratio, PCL concentration and PCL molecular weight on the 
nanofibre diameters, porosity and degree of crystallinity, which are considered as 
important parameters in the control of drug release. The research mainly concentrated on 
studying the impact of adding pure MPs, impure MPs, unmodified HNT and HNT 
modified with 3-aminopropyltriethoxysilane (ASP) on the morphology, structure, 
crystallinity, thermal properties, connecting bonds and drug release kinetics of 
nanocomposite fibre mats. This study also took into account the effect of the interaction 
between the drugs (tetracycline hydrochloride TCH and Indomethacin IMC) and the 
PLA: PCL polymer blend on the drug release rate. Additionally, the mechanism of drug 
release was investigated by fitting five mathematical models, including zero order, first 
order, Higuchi, Ritger-Peppas and Zeng models, to the experimental drug release data. 
 
Increasing the molecular weight and PCL concentration enhanced the solution viscosity 
and created bead-free nanofibrous structures, especially at a blending ratio of 1:1 for 
PLA: PCL. The nanofibres produced from a chloroform: methanol solvent were larger in 
diameter and better aligned in their fibrous structure compared with counterparts from a 
DCM: DMF solvent. The crystallinity (Xc) increased when the concentration of high 
molecular weight PCL increased, especially at a blend ratio of 1:1; whereas, using low 
molecular weight PCL led to a sharp decline in Xc and melting temperature (Tm) of PCL, 
and a noticeable increase in the crystallisation temperature (Tc) of PLA within the blend 
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compared with high molecular weight PCL. Furthermore, the rapid evaporation of 
methanol solvent led to a reasonable decrease in Xc and Tc when compared to DMF 
solvent. There was better miscibility between PLA and PCL within their blends, 
particularly in the case of using PLA: 15% PCL at a blend ratio of 1:1 and dissolved in 
the chloroform: methanol system. 
 
Adding HNT to PLA: low molecular weight PCL blend hindered the homogeneous 
dispersion of HNT in the solution. The nanofibre diameters did not noticeably change 
when increasing the amount of HNTs from 1 to 2 wt%/v owing to the low solution 
viscosity, which is opposite to what was obtained from embedding HNT into PLA: high 
molecular weight PCL. Moreover, PLA: high molecular weight PCL composites 
embedded with modified HNT-ASP showed moderately enhanced HNT dispersion, 
leading to less agglomeration and decreased average fibre diameters compared to 
unmodified HNTs. Adding HNT-ASP to the blends led to a reasonable decline in Xc and 
there were also slight decreases in the glass transition temperature (Tg) of PCL, and the 
Tc and Tm of PLA within the composites. Furthermore, the infrared spectra confirmed a 
reduction in HNT agglomeration when embedding HNT-ASP into PLA: PCL 
nanofibres. 
 
The embedding of pure MPs raised the solution viscosity and supported better MP 
dispersion compared to adding impure MPs, which led to a significant decline in the 
average fibre diameter as a result of a significant viscosity reduction. Embedding impure 
MPs generated unique cell structures that were observed for the first time in this study. 
Pure MPs led to decreases in the Xc and Tg of PCL, as well as the Tc of PLA; whereas, 
impure MPs caused overall increases in the above-mentioned thermal parameters, except 
for the undetected Tm of PLA. The infrared spectra showed that impure MPs 
considerably affected chemical bonds and confirmed the effective embedding of MPs 
into the composites. 
 
The addition of the drug indomethacin (IMC) did not alter nanofibre diameters as 
opposed to what resulted from adding another model drug, tetracycline hydrochloride 
iv 
 
(TCH). Thermal properties, such as Tg and Tm of PCL within the blends, and Xc were 
reduced when loading both TCH and IMC. The biodegradation rate was accelerated by 
decreasing the PCL concentration and also by embedding MPs into the composites. 
Loading TCH into HNT-ASP and then adding this mixture into PLA: PCL solution 
produced a nanocomposite system that reduced the drug release rate and overcame the 
weakness of the interaction between the polymer and drug, which was in contrast to the 
behaviour of PLA: PCL blend solution embedded with pure MPs. There was good 
agreement between the acquired experimental data on drug release kinetics and the 
Ritger-Peppas and Zeng models in description of the mechanisms of drug release. 
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Chapter 1 
Introduction 
1.1. Background 
Nanotechnology is a cutting-edge interdisciplinary area that combines the study, control, 
management and assembly of diverse nanoscaled elements into materials, methods and 
apparatuses of enormous interest and creative potential. This promising field has 
possible applications in various areas of the worldwide application system, including 
power, transportation, health, manufactured consumer goods and agriculture (Kumbar et 
al., 2008). Nanotechnology deals with synthetic and natural formations on the 
nanoscaled level, specifically in the range of 1 nm to1µm (Qi et al., 2010). Fibres 
fabricated from polymers are employed for a variety of purposes from fabrics to 
composite reinforcements (Deitzel et al., 2001). Diverse approaches have been 
developed in recent years to produce nanoscaled level structures for many applications. 
Several fabrication techniques are used, such as phase separation, self-assembly and 
electrospinning (Kontogiannopoulos et al., 2011). Among these methods, 
electrospinning is a flexible polymer processing method to produce nanofibres in which 
a flow of a polymer melt or solution is charged in a high voltage electric field, leading to 
the formation of polymer jets. These jets are driven out from the droplet surface and 
drawn in the direction of a collecting plate (Ji et al., 2006a). Recently, electrospinning 
has been developed for various uses in a number of diverse research areas such as 
biomaterials, energy, filtration media (Bosworth and Downes, 2012), nanosensors, 
cosmetics, protecting clothes, separation, and fuel cells (Li et al., 2012). Furthermore, 
the electrospun non-woven mats with nano/microfibres can be also applied in the 
biomedical field, for example as drug delivery carriers (Yan et al., 2012), materials for 
wound dressing, tissue repair replacements and tissue engineering scaffolds due to their 
biodegradability, fibre physical properties, biocompatibility and high fibre surface area 
to volume ratio (Jiang et al., 2005). Among these applications, electrospun mats 
demonstrate the great potential as drug carriers in that they facilitate drug delivery to the 
target area in the human body for wound therapy and cancer treatment (Song et al., 
2012). Polymers may possess certain properties that can cater specific criteria for the 
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design of appropriate drug delivery systems (Bermudez and Grau, 2011). In drug 
delivery from polymer nanofibres mats, it is believed that the dissolution speed of the 
drug macromolecules is increased by raising the surface area to volume ratio of the 
drug-loaded nanofibres mats and the drug. Moreover, drugs can be easily loaded into the 
polymeric carriers by employing the electrospinning method, which differs from 
universal encapsulations, which involve a number of preparation difficulties (Cui et al., 
2006). Nanofibres have been effectively electrospun from diverse polymer systems like 
polymer blends, co-polymers like poly(lactic-co-glycolic acid), high performance 
polymers, biopolymers and organic polymers such as ribonucleic acid and starch. The 
electrospinning method can facilitate and shape different morphologies such as 
continuously aligned and randomly distributed nanofibres (Chowdhury and Stylios, 
2011). Nanofibres are ultrafine solid fibres which are promising nanomaterials due to 
their huge surface areas per unit volume, flexibility, absorbency (Cai et al., 2011) and 
tiny porous areas (Subbiah et al., 2005). Continuous nanofibres can be achieved by 
adjusting the polymer solution and electrospinning parameters, which in turn control the 
formation of polymer fibres on a collector (Evcin and Kaya, 2010; Thompson et al., 
2007). Consequently, the consideration of the processing conditions, structure, 
morphology and solution properties are important for engineering polymer nanofibres to 
achieve end-user requirements for different applications (Inai et al., 2005). 
 
Nanoparticles are able to be incorporated into biomolecules during various synthesis 
methods, such as complementary recognition, covalent coupling, electrostatic binding, 
and physical adsorption. They can be tailored to accomplish particular intracellular 
objectives in particular areas (Goldberg et al., 2007). Nanocarriers of different 
geometries and compositions including liposomes, polymeric nanoparticles, solid lipid 
particles, micelles, nanofibres, and core-shell nanofibres have been used as carriers for 
drug delivery (Zeng et al., 2011). 
 
Nanocomposite fibres have gained a significant attention owing to their continuously 
improving optical, electronic, electrical and chemical characteristics. The applications of 
these materials are not limited to defence and safety areas, but also include filtration 
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membranes, microelectronics appliances, structural strengthening, energy production, 
and biomedical engineering (Zhang et al., 2009). In recent years, using a polymer as a 
carrier and controller for drug delivery systems has become very popular due to the 
enhancement of healing effectiveness and decrease in toxic side-effects (Xie and 
Buschle Diller, 2010). Drug release has been an essential subject in the area of drug 
delivery for a long time. Novel materials with increasing complication and more 
functions have been fabricated for the improvement of drug delivery apparatus with 
progressive work in materials science and engineering. In the area of controlling drug 
release, both natural and synthetic polymers have been employed broadly to increase 
bioeffectiveness and assist medical applicability. Drug release is the method in which 
drug molecules travel from the primary location in the polymeric system to the 
environment (Fu and Kao, 2010). In order to obtain controlled drug release, different 
dosages have been manufactured by employing biodegradable polymers such as 
nanoparticles, microspheres, millirods and films (Tiwari et al., 2010). In addition, the 
interaction between drug and carrier is important to manage a sustained drug release 
(Zeng et al., 2011). Many benefits from using electrospun polymer nanofibres have been 
identified compared with other dosage forms. Therapeutic composites can be simply 
loaded into the carrier polymers by means of the electrospinning technique. The drug 
release system can be adapted by adjusting the material composition and morphology of 
the nanofibrous mats (Huang et al., 2006). 
 
1.2 Research motivation  
1.2.1 Knowledge gap in electrospinning and drug delivery 
Poly(lactic acid) (PLA) and poly(ε-caprolactone) (PCL) have been used widely in the 
biomedical engineering area due to their excellent properties of biodegradability and 
biocompatibility, and also their soft texture, suitable morphology and light weight. In 
general, to fabricate biopolymers into nanofibres during electrospinning is usually not 
easy because of the mixed effects between the electrospinning parameters, which makes 
investigating the effect of these parameters on the nanofibres really challenging (Biber et 
al., 2010). Furthermore, the key factors that hinder the electrospinning solution are often 
the solution viscosity, molecular weight, and solution concentration, as well as the 
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insufficient evaporation of solvents leading to fusing of the electrospun nanofibres on 
the collector. 
 
Development of a new composite nanofibre system for the effective loading and 
sustained release of drugs is still faced with great challenges (Qi et al., 2010). The 
control of electrospinning parameters to obtain fibres with the desired morphology, 
crystallinity and molecular structure has yet to be achieved (Ribeiro et al., 2011). The 
drug dosing decreases significantly over a short time owing to burst drug release at the 
beginning of release  (Im et al., 2010a). Since PCL with high crystallinity easily restricts 
the mobility of drug molecules, they tend to stay on the fibre surfaces. In addition, PCL 
has apparently slower degradation than other aliphatic polyesters owing to its 
hydrophobic nature and high crystallinity. Besides, the addition of PLA with low 
crystallinity can accelerate fibre degradation. Loading a hydrophilic drug (tetracycline 
hydrochloride, TCH) into hydrophobic polymers (PLA and PCL) will lead to drug 
deposition outside of the nanofibres and will subsequently cause a burst release due to 
the weak interaction between them. Furthermore, the chemical interaction between the 
polymer and drug is able to hinder the crystallisation process of the drug in the 
nanofibres, which may generate a sustained drug release in the crystalline state. 
 
1.2.2 Significance of the current study  
The current study aims to develop new electrospun hybrid nanocomposite systems, 
including PLA: PCL, PLA: PCL/ halloysite nanotubes - 3-aminopropyltriethoxysilane 
(HNT-ASP) and PLA: PCL/ magnetic nanoparticles (MPs), to benefit the sustained 
release of hydrophilic drugs with hydrophobic polymers. Such a PLA: PCL based 
composite system could help to achieve balanced crystallinity with the possible benefit 
of steady drug release. The specific objective of this study is to understand the effects of 
the solvent system, solution electrical conductivity, solution viscosity, PCL 
concentration and PCL molecular weight on the nanofibre diameters, porosity and 
degree of crystallinity, which are regarded as important factors in the control of drug 
release. Moreover, due to its low pH value, the PLA degradation components can 
damage tissues. Blending PCL with PLA can decrease that effect as PCL is gradually 
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degraded and does not form the same acidic environment as PLA. The addition of HNTs 
can reduce that effect due to the hydroxide groups in the HNT structure (Touny et al., 
2010). The current work has particularly focused on studying the effect of the embedded 
MPs and HNTs on morphology, structure, crystallinity, thermal properties, connecting 
bonds and drug release of hybrid nanocomposites. The blend viscosity is an important 
factor for HNT and MP dispersion within the polymer blend in the electrospinning 
process. The current work has promoted nanofibre quality without any bead defects or 
non-fibrous structures by controlling the crystallinity level of the PLA: PCL blend. 
Furthermore, HNT agglomeration may be reduced by using the ASP modifier, having 
benefits for future drug release applications. The study also examined the drug release 
kinetics by fitting the release data to five mathematical models including zero order, first 
order, Higuchi, Ritger-Peppas and the newly developed Zeng model to help understand 
the mechanism of drug release. 
 
1.3 Research contributions 
This thesis makes significant contributions to understanding PLA: PCL nanocomposites 
and drug release phenomena as follows: 
• Fabricating a variety of nanofibres with diameters ranging from one micron 
down to a few nanometers with a particularly large surface area to volume ratio 
was achieved. Such extremely small nanofibres were suitable for tailoring 
different biomedical application requirements. The small nanofibre diameter 
allowed the drug release to be achieved more quickly, which is beneficial for 
some wound healing applications. Alternatively, the nanofibre mat is able to 
offer the protection to certain bioactive substances, like growth genes, which 
need to be sheltered for some time to accelerate wound healing in the early 
stages. 
 
• It took into consideration understanding the effect of three co-solvents 
(dichloromethane (DCM): N,N, dimethylformamide (DMF), chloroform: 
methanol and chloroform: acetone), PLA: PCL solution viscosity, electrical 
conductivity of the solution, blend ratio of PLA to PCL, molecular weight of 
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PCL and PCL concentration as vital parameters for the successful production of 
uniform nanofibre mats. Additionally, a clear explanation was given for their 
influences on the nanofibre diameters. For some of them, a clear overview was 
presented for their impacts on the morphological structures, thermal properties 
and the degree of crystallinity of the fabricated composites. 
 
• The investigations of PLA: PCL/ HNT nanocomposites resulted in a new drug 
delivery system with sustained release for a range of applications. Both 
unmodified HNTs and HNTs modified with 3-aminopropyltriethoxysilane were 
utilised to improve the HNT dispersion in the solution. The infrared spectra of 
nanocomposites provided insight for identifying the successful embedding of 
HNT-ASP into nanofibres relative to unmodified HNTs due to the pre-
modification leading to reduced agglomeration behaviour. 
 
• A new study investigating the effects of the purity of synthesised magnetic 
nanoparticles (Fe3O4) on the structure, morphology, crystallinity, thermal 
properties and the interaction between MPs and PLA: PCL polymer blend was 
performed. TCH release was accelerated by adding MPs to the blend. One of the 
application possibilities is the direct delivery of a drug to the target area of the 
body by using an external magnetic field. 
 
• Electrospun nanofibre mats can be cut to any dimension and be applied typically 
for skin and wound therapeutic purposes or for other types of drug release. The 
goals for the development of nanofibre composite/drug systems are that they 
dramatically improve patient compliance and therapeutic activity, minimize the 
toxic side-effects of drugs through extended dosing, with the ability to avoid 
being rapidly taken up by the reticuloendothelial system, and target the drug to 
specific sites. 
 
• Electrospun nanofibrous hybrid composite structures were successfully created 
for carrying a therapeutic compound, like TCH and indomethacin (IMC), with 
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the potential use for medical applications. The material system provided useful 
information on how constituents of hybrid composites influenced the surface 
morphology that controlled drug release. Loading a hydrophilic drug (TCH) into 
HNT-ASP and hydrophobic polymers (PLA and PCL) was observed to enhance 
drug release and to overcome the weak interaction between the polymer and the 
drug. 
 
• Release kinetics data have been successfully fit to five mathematical models, 
which are categorized as zero order, first order, Higuchi, Ritger-Peppas and Zeng 
models. Typical characteristics were clearly revealed and excellent agreement 
was obtained between the experimental data and the Ritger-Peppas and Zeng 
models for the drug release kinetics. 
 
1.4 Thesis outline  
The thesis is structured into eight chapters as summarised below and in Figure 1-1: 
Chapter 1 presents an introduction about the project consisting of background 
information about the research growth in electrospinning, nanofibres, nanocomposites 
and drug delivery. Moreover this chapter demonstrates a current knowledge gap, and 
presents the significance of the current study and its research contributions. 
 
Chapter 2 covers an extensive literature review on progress, existing findings and 
knowledge gaps in electrospinning, biopolymers, blending polymers, nanofibres, 
nanocomposites and drug delivery areas. 
 
Chapter 3 reports on the material selections for PLA, PCL, HNT, synthesised MP, TCH, 
IMC, solvents and modifiers. It explains the research methodology, which includes the 
electrospinning setup, blending of PLA: PCL, nanofibre fabrication, embedding of HNT 
and MPs, drug incorporation and release, and drug release kinetics, and finally the 
analytical characterization techniques. These include scanning electron microscopy 
(SEM), transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier 
transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), UV-
7 
 
vis spectrophotometer (UV), gel permeation chromatography (GPC), energy dispersive 
spectroscopy (EDS), viscometry and electrical conductivity testing. 
 
Chapter 4 presents the initial investigation, which is pertinent to determining the 
appropriate polymer concentration, blending ratio, molecular weight, viscosity and co-
solvents to obtain uniform electrospun nanofibres, controlling the crystallinity level, and 
adjusting blend solution viscosity prior to embedding HNTs and MPs. 
 
Chapter 5 employed the obtained results from Chapter 4 by embedding two different 
concentrations of unmodified HNTs and HNTs modified with 3-
aminopropyltriethoxysilane (ASP) into two different concentrations of the PLA: PCL 
blend (namely 9% and 15% wt%/v of PCL). The effect of modified and unmodified 
HNTs on nanocomposite morphology, solution viscosity, thermal properties, degree of 
crystallinity and interaction level between HNTs, ASP and the biopolymers was 
investigated. 
 
Chapter 6 utilised the findings obtained from Chapter 4 by embedding three different 
concentrations of synthesised pure and impure MPs into the PLA: 15% PCL mixture 
(which was proven by Chapter 5 to give better nanoparticle dispersion than PLA: 9% 
PCL). The effect of pure and impure MPs on nanocomposite morphology, solution 
viscosity, electrical conductivity, thermal properties, degree of crystallinity and 
interaction level between HNTs and the biopolymers was investigated. 
 
Chapter 7 reports an application and test of drug release and nanofibre biodegradation, 
which uses results obtained through Chapters 4, 5 and 6. The effect of drug type (TCH 
and IMC) and drug (TCH) concentration on the nanofibre mat morphology, solution 
electrical conductivity, thermal properties, degree of crystallinity, drug release, 
biodegradation, and release kinetic models was examined. 
 
Chapter 8 summarise the main conclusions and presents a number of recommendations 
for future work respectively.  
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Chapter 2    
Literature Review 
2.1 Electrospinning 
Nanofibres can be created by diverse techniques such as wet spinning, drawing, template 
synthesis, electrospinning (Ribeiro et al., 2010), phase separation and self-assembly (Ma 
et al., 2005). However, the majority of these methods cannot well control the orientation 
and the diameter of the fibres for certain polymers. Electrospinning has been established 
to be a brilliant technique for the production of small diameter fibres down to the 
nanoscale level for a broad range of polymeric materials (Jiang et al., 2006; Jian et al., 
2008). Electrospinning is a combination of two processing methods, namely 
electrospraying and spinning (Agarwal et al., 2008). This technique has a number of 
attractive qualities, such as comparatively high fabrication rate, being reasonably 
inexpensive, the ability to produce fibres with large surface area to volume ratios (Singh 
et al., 2009; Zhang et al., 2007b), and applicability to several varieties of polymers. 
Polymer micro/nanofibres have been electrospun from different types of polymers, such 
as textile fibre polymers, proteins, conventional polymers, biodegradable and 
biocompatible polymers, and peptides (Jiang et al., 2004). Micro/nanofibres have 
widespread applications due to their good properties (Karim and Yeum, 2010), for 
example fibre-strengthened plastics, light and solar sails, plant pesticides, biomedical 
needs, mirrors in space, protective clothing for chemical and biological safety, catalyst 
supports (Kim et al., 2010), filtration (Charernsriwilaiwat et al., 2010), membranes for 
gas separation, water treatment, protein refinement (Meng et al., 2012) and military 
defensive clothing (Jiang et al., 2004). Electrospinning is an efficient, convenient and 
versatile method for creating reliable ultrafine fibres from polymer solutions, and it has 
been the subject of growing interest during recent years. It offers a promising technique 
to manufacture continuous fibres with diameters ranging from nanometres to microns 
(Han et al., 2009; Hadjiargyrou and Chiu, 2008). Fibre length could reach thousands of 
kilometres in a short period of time (Chowdhury and Stylios, 2011). 
The initial patent for the electrospinning method was published as early as 1934, and in 
1964 (Zong et al., 2002a). However, the manufacturing of polymeric nanofibres by this 
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method has not been well performed until recent times (Jian et al., 2008; Frenot and 
Chronakis, 2003). The method is comparatively simple, flexible, speedy, and efficient, 
resulting in adjustable surface morphologies and superior mechanical properties of the 
fibres produced (Kontogiannopoulos et al., 2011; Dong et al., 2013). Electrospun fibrous 
structures have potential biomedical applications such as sutures, cardiac grafts, wound 
dressings, artificial blood vessels (Sonseca et al., 2012), nerve guidance conduits, bone 
regeneration materials, vascular grafts (Liu et al., 2012), tissue engineering scaffolds, 
implants and systems for drug delivery control (Ribeiro et al., 2011). Electrospun 
polymer fibres are of particular importance to the field of tissue engineering and drug 
delivery because they have a number of benefits such as achieving high drug loadings, 
comparatively simple drug entrapment through the fabrication method, stability and 
protection of drug, drug burst control, high surface area to volume ratio, which improves 
drug release, and special morphologies that can be managed during fabrication (He et 
al., 2006; Natu et al., 2010). Additionally, the benefits from this technique are to 
decrease the drug’s side effects and to improve the drug’s bioavailability. This 
fabrication technique is extremely interesting in biomedical applications, especially for 
drug-delivery systems, because nanofibres can allow site-specific drug delivery in the 
body, and maybe one or more drugs can be encapsulated straight into the fibres as well 
(Wei et al., 2010). 
 
The setup of an electrospinning system typically consists of four main components as 
shown in Figure 2-1. These include a grounded collecting plate, a pump, a spinneret and 
a high-voltage power supply (Qian et al., 2010; Dong et al., 2014b). When a charged 
polymer solution is ejected from the spinneret, a Taylor cone is created with the aid of 
an external electric field. At that time, the surface tension of solution droplets is 
balanced with the electric field (Bosworth and Downes, 2012; Sung et al., 2012; Demir 
et al., 2002). A little jet is driven out from the droplet surface and drawn in the direction 
of the collecting plate, towards the electrode of opposite polarity, across an air gap when 
the affected electric field is high enough to overcome the surface tension, (Sung et al., 
2012; Chew et al., 2006). In addition, the jet is stable and does not break up into droplets 
of beads as expected for a solution conical thread. This is attributed to the polymer 
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solution’s viscosity and the presence of polymer chain entanglements (Duzyer et al., 
2011). Moreover, the solvent in the jet stream steadily evaporates as the jet spreads in 
the direction of the collecting plate, and the resulting product is a non-woven 
micro/nanofibre mat (Zhang et al., 2012). The morphology, fibre diameter and mat 
thickness can be manipulated by various solution parameters, such as solution 
concentration, viscosity, electrical conductivity and surface tension, or process 
parameters, including electric field strength and distance between the spinneret and the 
collecting plate (Liang et al., 2007; Cui et al., 2010; Yu et al., 2012). 
 
 
Figure 2-1: A typical electrospinning apparatus (Bhardwaj and Kundu, 2010). 
 
2.2 Natural and synthetic polymers  
In the last decade, various studies have demonstrated the use of biodegradable polymers 
as helpful vehicles for drug delivery (Kim et al., 2004). Polymers offer of different fields 
and wide range of using in scope of biological and drug-delivery systems (Goldberg et 
al., 2007). A diversity of biocompatible non-biodegradable or biodegradable polymeric 
materials is employed for drug delivery. The selection of the polymer is dictated by the 
necessities of the particular application (Kenawy et al., 2002). Biodegradable polymers 
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are excellent candidates for some applications in the biotherapeutic field due to their 
degradation without side-effects, their biocompatibility, and good mechanical properties 
(Wei et al., 2010). The US Food and Drug Administration (FDA) has approved 
biocompatible nanofibres for medical applications and for specific purposes. For 
example, those applications consist of wound healing devices, tissue repair and materials 
appropriate for controlled drug release. For those structures, the morphology is a 
significant characteristic, because of adsorption processes that take place at the boundary 
of the biofibres and the physiological surroundings (Buschle-Diller et al., 2007). 
Naturally produced biodegradable polymers have been fabricated into micro/nanofibres, 
such as hyaluronic acid, dextran, collagen, silk protein, elastin, chitosan and their blends. 
The poor mechanical properties of these natural materials and theirstructure loss in 
aqueous sources (Tiwari et al., 2010) are significant factors that limited and prevented 
them from being applied in drug delivery systems and tissue engineering (Cui et al., 
2010). A limited number of natural biopolymers has been effectively electrospun 
compared with synthetic polymers owing to their poor processability (Li et al., 2006). 
Biodegradable hydrophobic polymers normally have excellent mechanical strength 
relative to natural biopolymers (Jiang et al., 2004). Aliphatic polyesters, including of 
poly(lactic acid) (PLA), poly(lactide-co-glycolide) (PLGA), poly(glycolic acid) (PGA), 
poly-DL-lactide-poly(ethylene glycol) (PELA) and poly(ε-caprolactone) (PCL) are 
biodegradable polymers that have been employed in biomedical industries (Lee et al., 
2003b). This is mostly due to their biocompatibility and the flexibility present in terms 
of degradation ability and mechanical properties, which allow investigators to modify 
these polymers for particular applications (Cui et al., 2006). Suitable drug release 
kinetics can be achieved by manipulating the selected polymer and polymer matrix 
properties, such as enhancing the degradation speed and swelling ratio of the polymer 
matrix (Cao et al., 2010). Table 2-1 summarizes the various types of biopolymers that 
have been electrospun by different researchers and their applications. These 
biocompatible materials may find use in many applications such as wound dressing, 
tissue scaffolds or drug delivery vehicles (Wang et al., 2012). 
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Table 2-1: Different polymers used in electrospinning and their applications. 
Polymer Solvent Fibre 
diameter 
(nm) 
Application Reference 
PEG-PLA Chloroform 600-730 Wounds (Xu et al., 
2010) 
PEO Water 200 Drug delivery (Im et al., 
2010) 
PLGA-PVA HFIP 400-700 Tissue engineering (Samani et al., 
2010) 
PVA-alginate Doubly 
distilled water 
50-500 _ (Islam, 2010) 
(PLGA) -
collagen 
HFIP 150-650 Wound dressing (Liu et al., 
2010a) 
(PLGA) DMF 260-360 Drug delivery  (Kim et al., 
2004) 
PDLLA Methanol: 
Chloroform 
220-830 Drug delivery (Xie and 
Buschle Diller, 
2010) 
HA-Collagen FA: HFIP 50-400 Tissue engineering (Hsu et al., 
2010) 
PELA-HPCD DCM :DMSO 700-780 Drug delivery (Xie et al., 
2010) 
Eudragit® L 
100-55 
Ethanol:DMAc 360-1950 Drug delivery (Shen et al., 
2011) 
 
2.2.1 Poly(lactic acid) (PLA) 
PLA is a biodegradable polymer produced from sustainable materials (Fowlks and 
Narayan, 2010), mostly from starch, sugarcanes, wheat and sugar beets (Chow et al., 
2012; Dong et al., 2014a). It is a promising biodegradable material source to decrease 
the solid waste disposal problems (Wang et al., 2006b). PLA is a biodegradable 
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polyester derived from α-hydroxy acids with good mechanical properties and several 
possible applications (Wang et al., 2012; Picciani et al., 2010), such as a dialysis 
medium, matrix for tissue engineering, biodegradable sutures, agricultural products, 
drug-delivery systems, food packaging and consumer products (Lim et al., 2008). 
Depending on the relative ratio of PLA backbone chains produced during chemical 
syntheses, PLA can be either semicrystalline or amorphous. PLA can be obtained by 
lactic acid condensation or through ring opening polymerization of a cyclic lactide dimer 
(Jandas et al., 2011). Figure 2-2 shows the chemical structure of PLA (Wang et al., 
2010b).  
 
PLA has attractive properties, including easy processability, ability to be dissolved in 
common solvents (Deng et al., 2007), sustainability, good biocompatibility, reasonably 
good optical properties (Lim et al., 2008), moderate thermal plasticity and suitable 
mechanical properties relative to petroleum-based polymers (Kim et al., 2003; Li et al., 
2012). Additionally, it has been generally used as a system for drug release control. 
There are several reasons for PLA to be well recognized. First, PLA is biocompatible 
and degrades to form nontoxic monomers for biomedical application (Haroosh et al., 
2012). It undergoes scission to monomeric units of lactic acid in the body, which is 
naturally in the carbohydrate metabolism (Lv et al., 2008; Kim et al., 2010).  However, 
using PLA in this way is not effective because it produces an initial burst release of drug 
at the commencement of healing (Kim et al., 2010), as well as having brittleness and 
slow crystallization (Chow et al., 2012; Bhatia et al., 2007). In addition, PLA 
degradation is harmful to local tissues (Touny et al., 2010) due to its low pH value (Xu 
et al., 2010). The second reason is that when used in oral drugs, the polymer matrix 
protects drugs and proteins from the negative environmental conditions (Romero-Cano 
and Vincent, 2002). There are some advanced ways to enhance PLA usage, which 
consist of loading fillers or using blending method (Chow et al., 2012). 
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Figure 2-2: Chemical structure of poly (lactic acid) (Wang et al., 2010b). 
 
2.2.2 Poly(ε-caprolactone) (PCL) 
Poly(ε-caprolactone) (PCL) is a hydrophobic and  semi-crystalline polymer (Kenawy et 
al., 2009), so it  usually is employed for enhancing elasticity (Lee et al., 2003b). It is 
well-known for its acceptable drug permeability and good biocompatibility (Huang et 
al., 2006). A local acidic environment is not generated when PCL degrades. This 
advantage, along with its moderately low cost, places PCL as a good candidate for 
biomedical applications (Kenawy et al., 2009; Luong-Van et al., 2006). Among a variety 
of polymers, PCL has a molecular structure of five nonpolar methylene groups and one 
comparatively polar ester group as shown in Figure 2-3. It can be used in several 
biomedical applications such as scaffolds and bone renewal (Qin and Wu, 2012). The 
presence of the aliphatic ester bond that can undergo hydrolysis makes the polymer 
degrade in the body (Kweon et al., 2003) and the resulting materials can be both 
metabolized through the tricarboxylic acid cycle and removed straight via renal secretion 
(Sun and Downes, 2009). Furthermore, PCL is a slowly degraded biopolymer compared 
with many other counterparts such as PLA because of its semi-crystalline nature (Huang 
et al., 2006). Moreover, it is not harmful to local tissues such as poly(lactide-co-
glycolide) (PLGA) or PLA.  The chains of PCL polymer degrade to low molecular 
weight nontoxic products when they accompany by simultaneous drug release 
(Hamoudeh and Fessi, 2006). However, some disadvantages have been identified from 
using PCL in biomedical applications. For instance, the hydrophobicity and semi-
crystalline nature of PCL polymer restricted its practical application (Fu and Kao, 2010; 
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Li et al., 2008). Furthermore, the insufficient mechanical properties of PCL and its poor 
porosity restrict its applications in hard tissue engineering and drug delivery, 
respectively. PCL based composites were generally investigated to overcome these 
shortcomings; these included PCL/ collagen and PCL/ gelatin electrospun nanofibre 
composites (Meng et al., 2010). Moreover, Kenawy et al. (2009) demonstrated drug 
release from PCL fibres and also the period of fibre degradation. The process of 
degradation primarily takes place by the diffusion of water into the fibres, and then by 
random hydrolysis fragmentation of the fibres, and lastly by broader hydrolysis 
accompanied by diffusion, metabolism, and phagocytosis. Hydrolysis is influenced by 
the hydrophilicity of the polymer, the pH value of the release environment and the 
crystallinity of the polymer (Kenawy et al., 2009). Furthermore, Natu et al. (2010) 
showed that PCL fibres absorbed water steadily, which was attributed to the semi-
crystalline and hydrophobic fibres hindering water penetration within the fibre. For 
example, the fibres that created from high molecular weight PCL did not demonstrate 
approximately any mass loss (0.45%) whereas, mass loss of PCL was obvious just after 
the molecular weight reaches 10,000 g/mol (Natu et al., 2010). 
 
 
Figure 2-3: Chemical structure of polycaprolactone (PCL) (Han et al., 2010). 
 
2.3 Polymer blending 
Polymer blending is usually employed to build up novel materials because of the 
property variation that can be gained by suitable blending of individual components 
(Kenawy et al., 2002; Dhandayuthapani et al., 2010). The matrix properties, such as 
swelling, hydrophobicity and mechanical strength, can be modified just by adjusting the 
composition (Jiang et al., 2004). Polymer blending represents an extremely helpful 
technique for the development or adjustment of the physicochemical properties of 
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polymeric materials (Picciani et al., 2009). A number of polymer blends can be created 
that are extremely different from the individual polymers, showing unusual properties. 
The miscibility of elements is a significant property of a polymer blend because it 
influences the mechanical properties, the degradation, morphology, and the 
permeability. The blends are physical combinations of structurally diverse polymers that 
network using secondary forces, such as charge transfer complexes for single polymer 
combinations, hydrogen bonding and dipole–dipole forces, without covalent bonding 
(Islam, 2010). The efficiency of blending process can be reorganized in terms of 
enhanced elasticity of the polymeric solution, which is frequently traced to enhanced 
entanglement density (Wang et al., 2010d). Biodegradable hydrophobic polymers 
normally have good mechanical strength but with weak cell affinity; whereas 
hydrophilic polymers have good cell affinity but little mechanical strength, especially in 
the swollen and degradation conditions. Blending biodegradable hydrophilic and 
hydrophobic polymers will avoid the limitations of the pure materials. However, 
hydrophobic polymers and hydrophilic polymers have greatly different intrinsic 
properties, and blending them to form a uniform structure is not easy to achieve (Cui et 
al., 2009). Moreover, about 24 h after blending, separation of the polymer phases occurs. 
Therefore, to minimize this phase separation problem, the blend solutions need to be 
electrospun immediately after their blending (Srikar et al., 2008). 
 
Various studies have been conducted into the electrospinning of blended polymers, 
especially those composed of biocompatible and biodegradable materials. Zhang et al. 
(2005) showed that the approach of blending synthetic polymers, and occasionally bio-
artificial polymeric materials, with gelatine has been commonly studied by investigators. 
They have shown that blending is a feasible approach that provides a compromise 
solution for overcoming the shortcomings of synthetic and natural polymers. 
Additionally, it reduces the potential problem of cytotoxin, due to employing a chemical 
cross-linking reagent. This technique creates a novel biomaterial with suitable 
biocompatibility and enhanced the chemical and mechanical properties of the 
biopolymeric matrix. The incorporating of the hydrophobic polymer PCL with the 
hydrophilic polymer gelatin offers a reliable way to release gelatin protein molecules 
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from the blending matrix (Zhang et al., 2005). In addition, Han et al. (2009) found that 
blending poly(trimethylene carbonate) PTMC with PCL at a blending ratio of 5:5 
resulted in dissolved and swollen fibres in the solution. This was because amorphous 
PTMC is more hydrophilic than the semi-crystallised PCL, which increased the porosity 
on the film surface. Therefore, high PTMC content in the fibres results in raising water 
absorption, leading to fibres dissolving quickly in the release solution. They also found a 
higher PCL ratio prevented the blend fibres from swelling to some extent (Han et al., 
2009). Another study demonstrated that increasing the ratio of PTMC to PCL led to 
decreased fibre diameter with acceptable fibre morphology (Han et al., 2010). According 
to Zhang et al. (2006), when blending the water-soluble polymer poly(ethylene glycol) 
(PEG) with PCL and protein, fluorescein isothiocyanate-conjugated bovine serum 
albumin (fitcBSA) to produce nanofibres by a normal electrospinning technique, they 
have shown evidence of beaded fibre morphologies even though they used established 
processing conditions. The determined fibre diameters of core-shell-structured PCL-r-
fitcBSA/PEG were slightly bigger than those of PCL/ PEG / fitcBSA blends (Zhang et 
al., 2006). 
 
The blending of poly(L-lactic acid) (PLA) with other polymers has received significant 
attention recently and is deemed one of the most innovative materials built up from 
renewable resources (Picciani et al., 2010). According to Kim et al. (2003), PLA-based 
multi-component blends containing lactide (a hydrolytic catalyst) and two connecting 
materials (triblock copolymer PLA-b-PEG-b-PLA and low molecular weight random 
copolymer PLGA) were combined and employed in electrospinning. The data revealed 
that the biodegradation speed of the electrospun scaffolds was adjusted with different 
material compositions, which displayed steady mechanical properties in aqueous 
conditions. Those matrixes were appropriate for some biomedical applications, such as 
prevention of post-operative adhesions and scaffolds for tissue engineering (Kim et al., 
2003). In another study, fibres of different blending ratios of PEG in poly (DL-lactide) 
PDLLA were fabricated by the electrospinning method. The degradation patterns of the 
PEG/ PDLLA matrix changed from bulk degradation to surface erosion with the 
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decrease of the PEG content in the composites. During the creation of crystal sections of 
PEG in the fibre matrix, the dimensional shrinkage was lowered (Cui et al., 2010). 
 
The mechanical properties of electrospun fibrous mats are influenced by the properties 
of fibre structure and each polymer in the blend (Yao et al., 2007). Studies on blends of 
hyaluronic acid HA and gelatin GE have indicated that GE can provide HA with protein 
properties to enhance the cell attachment, and blends of HA-GE have a potential 
application in tissue mending. The reason for incorporating GE was to enhance the 
electrospinning processability and to provide the fibrous mats with protein 
characteristics (Li et al., 2006). In addition, it was found that the decrease in surface 
tension of the spinning solutions was achieved when GE was added to HA to improve 
the processability (Xu et al., 2009). Furthermore, blending chitosan and alginate 
produced a hydrogel because of complications of the polyelectrolytes. Several 
parameters of the polysaccharides and their solutions were significant factors in the 
formation of polyelectrolyte complexes. Those parameters were molecular weight, pH 
value and the ratio of chitosan to alginate. The nanofibres including alginate and 
chitosan were less swelling in an aqueous environment compared to those composed 
only of water-soluble alginate because the chitosan was not water-soluble. The swelling 
ratio increased as the quantity of chitosan decreased (Jeong et al., 2010). Moreover, the 
addition of poly(D,L-lactide-co-glycolide) PLGA materials to the collagen enhanced the 
mechanical strength of electrospun nanofibres (Liu et al., 2010a). A differential scanning 
calorimeter (DSC) was used to evaluate the miscibility between dextran and PLGA in 
the electrospun composite membranes. The composite fabric membranes were in a two-
phase system because the glass transition temperature (Tg) of dextran did not change by 
blending with PLGA (Jiang et al., 2004). 
 
Many other studies have been conducted into electrospun blended polymers. For 
instance, electrospun fibres imitating the extracellular matrix for tissue engineering were 
prepared from blending collagen with chitosan and from blending PLA with chitosan. A 
vehicle for drug controlled release was developed from electrospun nanofibres by 
blending gelatin with PVA, and more recently, a potential application for wound 
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dressings was investigated using electrospun fibre mats from mixing gelatin with PLLA. 
Moreover, the incorporating of PLCL into collagen fibres improved proliferation and 
cell adhesion (Samani et al., 2010). The cell attachment, proliferation and extracellular 
mat secretion were enhanced by blending PLGA with collagen, which were indicated to 
be related to the ratio of collagen in the composite scaffold (Cui et al., 2010). In another 
study, the synthetic polymer PVA was blended with alginate to overcome the poor 
electrospinnability of alginate solutions. Furthermore, the nanofibres of polymer blends 
showed improvement in the mechanical properties with the addition of alginate 
compared to electrospun PVA alone (Islam, 2010). 
 
2.4 Nanoparticles and nanocomposites 
Polymer nanocomposites incorporating nanoparticles have attracted great attention due 
to their tailored properties (Fowlks and Narayan, 2010; Noor Azman et al., 2013) and 
unique structures, which might not be accomplished in conventional composites (Du et 
al., 2008). This material system has been studied for many applications because of their 
inexpensive manufacturing, simple processability, remarkable electrical, thermal (Lee et 
al., 2003a), optical, (Sonseca et al., 2012) and magnetic properties, and antibacterial 
activities, as well as excellent substrate adhesion (Zhang et al., 2009). It is hypothesised 
that the interfacial interactions between the polymer and embedded inorganic particles 
are significant factors in the final performance of nanocomposites. The interfacial 
interactions between inorganic particles and the matrix of the polymer generally consist 
of covalent bonds, vander Waals force, ionic bonds and hydrogen bonds. To improve the 
interfacial interactions of such nanocomposites, various approaches were developed to 
modify the matrix properties. Up to now, novel effective approaches to enhance the 
interfacial interactions in nanocomposites are still and important research area (Du et al., 
2008). Moreover, the final properties of the composites are determined by several 
critical factors including the dispersion of nanoparticles in the matrix and the interfacial 
bonding between the matrix and inorganic particles (Liu et al., 2009c; Schmidt, 2005). 
 
Composite inorganic – organic materials with polymers are produced when two or more 
different materials are blended on a nanoscale level to achieve unique characteristics 
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resulting from a synergy between the two chemical components. Furthermore, 
interactions between organic materials and inorganic layered materials (such as Zn-Al 
layered double hydroxide) are attractive, particularly in the examination of guest-host 
interactions and their potential in a variety of technical and manufacturing applications. 
Moreover, syntheses of these hybrids are achieved by direct intercalation of inorganic 
components into polymers or by pre-intercalation of their monomers. This will establish 
a novel method to construct new polymer-inorganic nanoscale assemblies (Lappas et al., 
2005) with high porosity (Meng et al., 2012). Nanofillers such as nanosilica, carbon 
nanotubes, calcium carbonate nanoparticles and layered silicates have been widely 
examined. Usually, polymer-inorganic nanocomposites with good properties are 
characterized by strong interfacial interactions and good dispersion at the nanoscale 
level (Jia et al., 2009). Zhang et al. (2008) showed that the encapsulation of inorganic 
nanomaterials with polyaniline resulted in many interesting nanocomposites. So far, 
several methods have been explained to produce nanocomposites by using coated 
inorganic nanomaterials with polyaniline such as nanobelts and silicate clays in in-situ 
oxidative polymerization, as well as nanoparticles and nanotubes in gamma radiation-
induced chemical polymerization or electropolymerization. Some of the chemical and 
physical properties of these materials differ from those of the pure polymers, and they 
also differ from each other in many properties such as permeability and toughness 
(Zhang et al., 2008). 
 
Increasing both shear viscosity and extensional viscosity is very effectively achieved by 
means of dispersions of nanoparticles such as clay silicates into the polymer, which are 
generally due to the interactions between the nanoparticles and between the polymers 
and the nanoparticles (Wang et al., 2010d). There are diverse feasible techniques for 
fabricating hybrid inorganic-organic fibres, such as electrospinning, coating, and 
blending (Liu et al., 2008c). Electrospinning of dispersed nanoparticles in the polymer is 
an efficient approach to create a fibre with diameters at the nano to micro level from 
polymeric solutions at low concentrations (Wang et al., 2010d; McCullen et al., 2007). 
However, hard nanoparticles hinder polymer chain interactions by increasing their 
distance (Tsioptsias et al., 2010). The electrospinning method has been used for 
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fabricating fibre mats based on biodegradable polymers and inorganic-polymer 
nanocomposite materials (Tsioptsias et al., 2010). Particles embedded in the 
nanocomposite sustain an additional homogeneous charge density in the whipping 
instability generated via electrospinning (McCullen et al., 2007). In addition, 
nanocomposite fibres electrospun after dispersing nanoparticles into the polymer 
demonstrated improved mechanical properties. For instance, electrospun polymeric 
PMMA nanocomposite fibres displayed an improved thermal stability compared with 
fibres produced just from PMMA (Wang et al., 2010d). Furthermore, 
poly(hydroxybutyrate) (PHB), poly(butylene succinate) (PBS) and PLA are generally 
employed as biodegradable polymers and their thermal and mechanical parameters can 
be significantly enhanced by incorporating different inorganic or organic particles 
(Matusik et al., 2011). 
 
2.4.1 Halloysite nanotubes (HNTs) 
 The interaction between clay minerals and organic polymers to produce novel hybrid 
materials has attracted more interest in the past decade. The varied characteristics of 
nanocomposites, such as thermal properties, electrical properties, electrochemical 
properties and mechanical properties, can be efficiently tailored by a suitable selection 
of synthesis conditions and initial materials. The properties of prepared nanocomposites 
are basically different from the properties of pure polymer or nanoclay components. This 
is because of the diverse types of polymer and clay interactions that occur at a molecular 
level (Matusik et al., 2011). Halloysite nanotubes (HNT) as nanoparticles for polymer 
reinforcement purposes have been a focus of research recently. HNT belong to the 
kaolin group of clay minerals, with a composition of Al2Si2O5(OH)4.nH2O, which 
naturally has the structure of multilayer inorganic nanotubes (Qi et al., 2010). 
Dehydrated halloysite (interlayer spacing d001=7 Å) corresponds to n = 0, while hydrated 
mineral halloysite (d001=10 Å) forms when n = 2. HNTs show a hollow tubular 
formation as the main morphology (Carli et al., 2011). Wrapping clay layers around onto 
themselves to form hollow tubes over suitable geological conditions will result in highly 
this unusual meso/macroscopic superstructure (Yuan et al., 2008). HNTs are 
aluminosilicates with a mainly tubular form at the nanoscale level and the surface of 
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HNTs is composed of siloxane and a few hydroxyl groups (Chew et al., 2006). This 
indicates that HNTs have a high dispersion characteristics compared to other natural 
silicates such as kaolinite and montmorillonite (MMT), and have the ability to create 
hydrogen bonds (Du et al., 2008; Liu et al., 2008b). Additionally, a majority of HNTs 
are rolled multi-wall nanotubes (Rooj et al., 2010). The structure of a HNT is revealed in 
Figure 2-4. 
 
 
Figure 2-4: Schematic diagrams of HNT structure (Yuan et al., 2008). 
 
HNTs from diverse sources differ in size and the usual dimension of halloysiteranges 
from 300 to 1500 nm in length, 15 to100 nm for the inner diameter and 40 to 120 nm for 
the outer diameter (Liu et al., 2009b). HNTs are useful in various applications, such as 
cosmetics, catalyst carriers, ceramics and drug delivery, due to their unusual shape and 
geometry, surface properties and chemical structure (Jia et al., 2009). HNT is 
appropriate for the carrier of a range of materials due to its extremely large halloysite 
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lumen diameter (Yuan et al., 2008). Figure 2-5 is a schematic diagram of the HNT 
crystalline structure. 
 
Figure 2-5:Crystalline structure of HNTs (Rooj et al., 2010). 
 
HNTs work as nanofillers embedded within polymer matrices. It has been found that the 
natural inorganic nanotubes have significant reinforcement and influence on many 
polymers such as polypropylene, linear low density polyethylene epoxy resin, nylon (Jia 
et al., 2009), natural rubber (Carli et al., 2011) and polyvinyl alcohol to enhance the 
thermal and mechanical properties of the composites (Ismail et al., 2008, Guo et al., 
2009a). In addition, Liu et al. (2007) mentioned that nanocomposite films could be 
produced from dispersed HNTs in polyvinyl alcohol PVA solution, which is attributed to 
the hydrogen bonding between the hydroxyl groups of PVA and surface silanols of the 
HNT. They showed that, as a result of the strong hydrogen bonding between the HNT 
particles, HNTs re-aggregated after that and this aggregation influenced the properties 
and structure of the composite film (Liu et al., 2007). Jia et al. (2009) demonstrated that 
HNTs without the surface enhancement offered poorer dispersion and weak interfacial 
combination in rubber due to low compatibility with the rubber macromolecules. They 
mentioned that the surface enhancement of HNTs must be performed to enhance the 
dispersion of HNTs in rubber film and improve the interactions between the rubber film 
and HNTs (Jia et al., 2009). According to Qi et al. (2010), the incorporation of HNTs 
into the poly(lactic-co-glycolic acid) PLGA fibres did not affect significantly the 
morphology of the fibres; whereas the fibre diameters obtained by incorporating HNTs 
in PLGA were slightly larger than those obtained for pure PLGA fibres. They proposed 
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that HNTs are promising drug carriers. They stated that by mixing the drug with HNTs 
using the eletrospinning method, a novel drug delivery system with sustained-release 
properties may be developed for a variety of applications in pharmaceutical areas and 
tissue engineering (Qi et al., 2010). 
 
2.4.2 Magnetic Particles (MPs) 
Among a range of multiple-use composite materials, those with electrical and magnetic 
properties are appropriate candidates for a wide range of applications such as magnetic 
transporters for microwave absorbers, biofuel cell membranes, electromagnetic 
equipment applications and biomedical applications (Bayat et al., 2011; Kyung Sung et 
al., 2011). Moreover, magnetic materials frequently show numerous attractive properties 
such as transparency, solubility and low density, allowing them to be used as 
components of superior electronic devices (Schlueter et al., 2010). Magnetic particles 
are typically manufactured from maghemite, cobalt ferrite (CoFe2O4) and magnetite 
(Fe3O4) (Yang et al., 2006). Magnetite Fe3O4 has been widely investigated and 
employed among the magnetic nanoparticles for bioscience applications due to its 
simplicity of synthesis, good biocompatibility and large saturation magnetization (Lin et 
al., 2009; Haroosh et al., 2013b) . Moreover, Fe3O4 shows very little toxicity, so that it 
can be well accepted in the human body (Yang et al., 2006). Magnetic particles can be 
employed in a variety of medical systems because of their desirable magnetic properties 
that are unavailable in other materials. These magnetic nanoparticles are also potentially 
helpful in various fields such as data storage, sensors, (Sung et al., 2012), purification 
separation, magnetic resonance imaging, enzyme immobilization, immunoassay, drug 
delivery, and hyperthermia treatment (Hamoudeh and Fessi, 2006). Magnetic 
nanoparticles tend to agglomerate to reduce their energies owing to their high surface 
area to volume ratio. Many studies have suggested overcoming this difficulty by using a 
stabilizer, such as steric polymers and electrostatic surfactants (Kyung Sung et al., 
2011). For example, adding oleic acid was able to stabilize magnetite precipitate, as it 
works as a surfactant to prevent magnetic particle agglomeration by producing a 
hydrophilic surface (Timko et al., 2006). 
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Various methods have been implemented to manufacture polymer – magnetic particle 
hybrids, such as solvent evaporation, emulsion polymerization, suspension 
polymerization, micro emulsion polymerization, dispersion polymerization and solvent 
diffusion (Zhang et al., 2007a; Hamoudeh and Fessi, 2006). However, these techniques 
are complex and it is hard to tailor the physical and chemical properties of the polymer 
magnetic composites. So far, the techniques to prepare magnetic polymer composites are 
still under investigation for novel applications (Guo et al., 2009b). In addition, there are 
a variety of feasible techniques for fabricating polymer magnetic particle hybrids, such 
as coating, blending, and electrospinning (Liu et al., 2008c). Direct drug delivery to the 
target region of the body is one of the possible strategies that may be achieved with 
drug-enabled MPs and external magnetic fields (Zavisova et al., 2007) as shown in 
Figure 2-6. 
 
 
Figure 2-6: The mechanism of the drug delivery to a target area with the assistance of 
magnetic nanoparticles (Yang et al., 2006). 
 
Magnetic nanocomposites such as nanowires,  nanotubes, and nanofibres have lately 
gained prominence as they demonstrate a number of unique properties that are not 
shown by their bulk materials, in addition to having high processability, versatility, and 
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cost-effectiveness (Wang et al., 2010a). The aim of manufacturing such nanocomposites 
is to achieve the homogeneous dispersion of magnetic nanoparticles inside the polymeric 
structures by selecting an appropriate method for fabricating the nanofibres (Kyung 
Sung et al., 2011). Manufacturing nanofibres based on magnetic polymer hybrids from a 
variety of polymers with specific mechanical properties is still not easily achieved. In 
addition, the ability to electrospin a range of polymer magnetite nanocomposites has not 
been methodically studied (Wang et al., 2010a). Lin et al. (2009) developed a simple 
method to create Fe3O4 nanoparticles encapsulated in polyvinyl pyrrolidone PVP 
nanofibres by the electrospinning technique, and investigated their magnetic 
characteristics and structures (Lin et al., 2009). The electrostatically driven instability 
rises in magnitude because the electric field force increases in the electrospinning 
process, which causes the jet to undergo more whipping leading to the reduction of fibre 
diameter (Chowdhury and Stylios, 2011). Moreover, the effect of Fe3O4 in increasing 
the electrical conductivity is ascribed to its catalytic influence. Schmidt (2005) 
synthesized a core-shell hybrid, using magnetite (Fe3O4) as the inorganic core because 
of its paramagnetic behaviour and a polymeric shell was provided as a stabilizing 
coating, which gave the preparation a stable particle dispersion. This type of dispersion 
of magnetic particles has been called a ferrofluid: it behaves as a liquid with flow 
performance and physical properties being manipulated by external magnetic fields 
(Schmidt, 2005). Wang et al. showed a combined method of electrospinning with in-situ 
composites of Fe3O4/ PVA nanofibres. They found that the Fe3O4 nanoparticles were 
stabilized by PVA to prevent agglomeration in the electrospun composite nanofibres 
(Liu et al., 2008a). Yang et al. (2007) hypothesized the mechanism for the formation of 
parallel fibres by magnetic electrospinning (MES) as shown in Figure 2-7. The 
mechanism is that fibres with magnetic particles are considered to act as a thread 
charged with magnetic dots and connected through a viscoelastic source. They 
illustrated the main aspects to the effective fabrication of well-aligned fibrous arrays by 
MES including a suitable magnetic field, the magnetized polymeric solution, and 
appropriate gap size between the two magnets. The magnets they used were made of a 
ferromagnetic oxide mineral and were insulators. The results confirmed that the 
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magnetic field is the driving power that induces the fibres to align into parallel 
collections (Yang et al., 2007b).  
 
 
Figure 2-7: (a) clarification of the system for magnetic electrospinning (MES), (b) 
illustration of magnetic field strength between the two magnets (Yang et al., 2007b). 
 
 
In addition, vertical anisotropy is revealed in magnetic chains built up using a high 
magnetic field. Magnetic nanoparticles re-orient themselves to align along their axis 
with the applied field during solvent vaporization (Sharma et al., 2010b). 
 
2.5 Parameter effects 
Electrospinning is a complex process that can be affected by either the processing 
parameters or solution characteristics (Ji et al., 2006; Zhang et al., 2005). The properties 
of nanofibres and their morphology heavily rely on the properties of the solution and the 
electrospinning parameters (Liao et al., 2011). The electrical and mechanical properties 
of electrospun fibre matrixes are related to the resulting fibre diameter. A decrease in the 
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fibre diameter will lead to an increase in the mechanical strength and fibre density while 
the porosity decreases accordingly (Dhakate et al., 2011; Duzyer et al., 2011). Moreover, 
the fibre size and material morphology influence the hydrophobic behaviour of polymers 
(Chen et al., 2009). Solution parameters, such as concentration of the solution, the 
viscosity of the solution, surface tension (Arumugam et al., 2009, Liu et al., 2009a), and 
molecular weight of the polymer, affect the chain entanglement of the polymer (Ribeiro 
et al., 2010). Moreover, solvent properties, such as dielectric properties, solubility, 
boiling point and the solvent volatility, play a significant role in the electrospinning 
process. In addition, processing parameters can also affect fibre manufacturing  these 
parameters include geometry of the needle tip, voltage, distance between collector and 
needle tip, the solution feed rate and fibres collector (Ribeiro et al., 2011). Furthermore, 
environmental parameters, such as the type of atmosphere, humidity, temperature and 
pressure, could have some impact. The examination of polymeric fibres produced by 
electrospinning and the consideration of the connection between molecular structure and 
properties of these electrospun fibres are a challenge (Heydarkhan-Hagvall et al., 2008). 
The investigation of the effect of the parameters on the electrospun fibresis in fact quite 
challenging due to interactions between the parameters (Biber et al., 2010). Among a 
range of electrospinning parameters, the solution concentration (Yao et al., 2007), the 
viscosity, electrical conductivity of solution (Kim et al., 2008), polymer molecular 
weight and use solvents (Buschle-Diller et al., 2007) are the most influential variables 
that control the morphology and fibre diameter. Many studies have been undertaken into 
manipulating all these electrospinning parameters to achieve desired crystallinity, fibre 
diameter, molecular structure, and morphology (Ribeiro et al., 2011, Wang et al., 
2006a). 
 
2.5.1 Polymer viscosity 
The solution viscosity is a significant parameter that affects the fibre morphology since 
it is connected with chain entanglement (Alipour et al., 2009; Lee et al., 2010). The 
number of beads created in the mat and the fibre diameter decrease when the viscosity of 
the solution is reduced (Chen et al., 2010). The viscosity of the polymer solution must be 
within a certain range that permits effectual polymer chain entanglement so as to 
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accomplish the arrangement of uniform fibres (Verreck et al., 2003b). When the solution 
viscosity is low, that can lead to the formation of nanoscale beads instead of long fibres 
because the Coulombic forces have a tendency to stretch the jet and control the 
viscoelastic forces that resist the jet breakup. So, low viscosity assists in a fast breakup 
of the charged polymer jet at smaller distances (Chuangchote et al., 2009). At moderate 
viscosity, the viscoelasticity produced by chain entanglements increases as a result of an 
increased number of polymer chains per unit volume of polymer solution. As a result, 
the charged polymer jet cannot completely break up into beads (Jiang et al., 2004). At 
high solution viscosity, there is a larger number of chain entanglements which are 
required to formation a steady jet in order to compensate for the influence of the surface 
tension which reduces jet sizes (Spasova et al., 2007; Sharma et al., 2010a). During the 
electrospinning process, the equilibrium between the electrostatic repulsion, viscoelastic 
strength, and surface tension is found to be important to control the fibre uniformity. In 
addition, high quality fibres can be achieved by balanced forces which can shape and 
maintain a Taylor cone. Otherwise, considerable bead formation will occur when the jet 
at the spinning tip is unstable (Zhang et al., 2009). 
 
According to Alipour et al. (2009), the shear viscosity of poly(vinyl alcohol) (PVA) and 
N-[(2-hydroxy-3-trimethylammonium)propyl] chitosan chloride (HTCC) blend solutions  
increases with a decrease in the HTCC amount. At a constant applied electrical field, a 
drop off in the average fibre diameter was observed. This finding was attributed to 
solution conductivity and viscosity, which are significant parameters that influence the 
electrospun fibre morphology and spinnability of the solution. Pure HTCC solutions 
with a concentration between 10 and 12 wt%/v were unsuitable, and just beads were 
formed on the target plate collector. This was due to the low viscosity of HTCC solution, 
which prevents the creation of a steady drop at the needle tip (Alipour et al., 2009). Gu 
et al. (2009) mentioned that the transfer from bead structures to elongated fibre 
morphology resulted from a relationship between the solution viscosity and surface 
tension. When the solution concentration decreases, the viscosity of the polymer solution 
can be expected to decrease (Gu et al., 2009). Moreover, Homayoni et al. (2009) showed 
that chitosan solution with a molecular weight of 1095000 g/mol dissolved in glacial 
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acetic acid (AcOH) solvent resulted in an excessive viscosity solution, which prevented 
the solution jet from being elongated in the electrical field during electrospinning. This 
difficulty was not solved even by altering the electrospinning parameters and the 
produced solution arrived on the collector as droplets (Homayoni et al., 2009). 
Arayanarakul et al. (2006) demonstrated that the addition of 0.5 wt%/v Sodium Dodecyl 
Sulfate (SDS) into poly(ethylene glycol) (PEG) solution decreased the solution 
viscosity. The data showed that the viscosity increased from about 338cP at 7 wt%/v 
SDS to about 476 cP at 0.5 wt%/v SDS. In general, the decrease in the viscosity of the 
electrospun solution leads to the decrease of fibre diameters (Arayanarakul et al., 2006). 
Cui et al. (2009) found that the viscosity of the blended poly(ethylene glycol) PEG and 
poly(DL-lactide) PDLLA at the same concentration dropped with the addition of a large 
amount of PEG, resulting in smaller fibre diameters. However, there were no 
electrospun fibres formed when the blend contained 60 wt%/v PEG owing to the low 
solution viscosity resulting from blending a high ratio of low molecular weight PEG 
(Cui et al., 2009). 
 
2.5.2 Material concentration 
The polymer concentration plays one of the most important roles in controlling fibre 
diameter in the electrospinning process (Pham et al., 2006; Xie and Buschle Diller, 
2010) because of the polymer chain entanglements necessary for effective 
electrospinning and the quantity of solvent to be removed during processing (Wang et 
al., 2005). The polymer solution concentration is an important factor in the formation of 
beads, bead-fibre structures and fibre mats (Macossay et al., 2007; Beachley and Wen, 
2009). A high solution concentration with an appropriate viscosity is vital for effective 
fibre formation (Um et al., 2004). However, at extremely high solution concentrations, 
the electric force cannot overcome the surface tension and the large viscosity of the 
solution, leading to the collapse of steady jet flow. Conversely, at low solution 
concentrations, the polymer chains are not adequately entangled to form nanofibers 
(Wang et al., 2005). Additionally, the quick evaporation of the solvent at higher 
concentrations decreases spinningas a smaller amount of solvent needs to be removed in 
the same time, leading to large fibre diameters (Heydarkhan-Hagvall et al., 2008). 
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Thinner fibres can be produced at low concentrations and the solvent needs a longer 
time to be removed from the fibres (Jiang et al., 2004). Thicker fibres can be generated 
at high concentrations and solvent removal is achieved by the time they arrive at the 
target, resulting in the prevention of further fibre elongation (Duzyer et al., 2011). When 
the solution concentrations are excessively high, it could be difficult to produce fibre 
structures due to their high viscosity. The Taylor cone angle of a polymer jet decreases 
with decreasing  the solution concentration (Hsu et al., 2010). The appropriate solution 
concentration is the key factor in the formation of a steady and continuous charged jet, 
which is important to exceed the extensive  molecular entanglements (Qin and Wu, 
2012). When enough chain entanglement is present in the solution, fibres are can be 
steadily produced (Chen et al., 2010; Liao et al., 2011). A collapse from electrospinning 
to electrospraying takes place for solutions with a concentration lower than the 
entanglement concentration, and this produces beads on the collector due to the capillary 
unsteadiness at the end of the jet (Wang et al., 2010b). 
 
 
Figure 2-8: SEM micrographs of electrospun PEG fibres using various PEG 
concentrations: (a) 15%, (b) 20%, (c) 25%, (d) 30%, (e) 35% and (f) 40%. The scale in 
the micrographs is 10 µm (Haroosh et al., 2011). 
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From our previous study, Figures 2-8a and b show that using PEG at concentrations of 
15 and 20%, respectively, led to the formation bead structures. This is because there is a 
lower limit to the polymer concentration and viscosity that must be exceeded for 
successful electrospinning. After all, extensive molecular entanglements are 
prerequisites for the formation of a stable and continuous charged jet. On the other hand, 
Figures 2-8c, d and e demonstrate that increasing the PEG concentration to 25, 30 and 
35%, respectively, leads to the formation of fibrous structures. Figure 2-8f, shows that 
when the PEG concentration reaches 40%, the large fibres have inhomogeneous 
diameters within the mat (Haroosh et al., 2011).  Wang et al. (2005) mentioned that a 
low concentration of hyaluronic acid (HA) of about 2wt%/v cannot facilitate 
electrospinning because of low viscosity, which means fewer polymer chain 
entanglements and a large amount of solvent. As a result of this, they showed it is 
difficult to fabricate tiny fibres just by dropping the polymer concentration (Wang et al., 
2005). Spasova et al. (2007) reported that solutions with three various concentrations (5, 
7 and 9%) by blending PLLA with PEG were electrospun to produce fibres. It was found 
that decreasing the solution concentration led to decreasing the average fibre diameter 
(Spasova et al., 2007). According to Chen et al. (2009), blending of chitosan with 
collagen at a low polymer solution concentration(less than 4%) makes beads even by 
varying the applied voltage and the distance between the tip of the needle and the 
collector. Surface tension influences were dominant with dropping polymer 
concentration and beaded fibres were created (Chen et al., 2009). Puppi et al. (2010) 
observed that by increasing the polymer concentration for PLGA the gap between beads 
on the fibres became bigger and the bead formation moved from round to spindle-
shaped, and when the concentration of PLGA was 20wt%/v homogeneous fibres were 
obtained (Puppi et al., 2010). Dhandayuthapani et al. (2010) demonstrated that at low 
chitosan concentrations of 4 and 5wt%/v, a nonhomogeneous mat with many beads was 
created even when the voltage was changed from 10 to 25 kV. This was due to the low 
viscosity of the polymer solution. Conversely, they mentioned that the flow properties of 
the solution are affected when the polymeric concentration is very high. Therefore it is 
necessary to maintain an optimum concentration for the occurrence of chain 
entanglement (Dhandayuthapani et al., 2010). 
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2.5.3 Molecular weight of polymers 
The selection of a polymer with appropriate molecular weight is essential in 
electrospinning, especially when used for the control of degradation rate and drug 
release from the electrospun fibre mat (Ignatious et al., 2010; Cao et al., 2010). When 
the polymer is dissolved in the solution,  it may degrade if stored for a long time and the 
molecular weight of the polymer will drop quickly in due course (Cantón et al., 2010). 
When a high electrical voltage is applied, small droplet formation occurs for jets of low 
molecular weight solution (Gu et al., 2009; McKee et al., 2004). Blending polymers with 
lower molecular weight decreases the viscosity of the solution without reducing the 
concentration (Um et al., 2004). Duzyer et al. (2011)  evaluated the impact of the 
polymer molecular weight on electrospun poly(ethylene terephthalate) (PET) fibre mats 
and their mechanical properties as a function of the linear velocity of the collecting drum 
They reported that the polymer molecular weight and mechanical properties of the 
electrospun PET fibre mats were associated with the linear velocity of the collecting 
drum (Duzyer et al., 2011). According to Chuangchote (2009), low molecular weight 
poly(vinyl pyrrolidone) PVP at a higher concentration showed slightly smaller fibre 
diameter than higher molecular weight PVP. The electrospinning of low molecular 
weight PVP produced flat and non-uniform fibre mats compared with high molecular 
weight PVP. They attributed this to the charged jet from the high molecular weight PVP 
being elongated through bending instability, which is less than that from the low 
molecular weight PVP (Chuangchote et al., 2009). Liu et al. (2009) electrospun different 
molecular weights of Poly[(lactic acid)-co-(glycolic acid)] PLGA nanofibres  at fixed 
process conditions, such as an applied voltage about 20 kV and flow rate around 1 mL/h. 
For lower molecular weight PLGA (15000 g/mol), bead structures were observed, 
resulting from the low viscosity of the polymer solution. Finer fibres beside many bead 
structures were also observed when the molecular weight was increased to 28000 g/mol. 
Additional increase in the molecular weight of PLGA to 45000 g/mol could produce 
small spindle structures with some fibres. When the molecular weight was 57000 g/mol 
or higher, homogeneous fibrous mats were formed (Liu et al., 2009a). Srikar et al. 
(2008) mentioned that low molecular weight poly(methylmethacrylate) PMMA at 
concentration 15 wt%/v could not be electrospun due to its low viscoelasticity, which 
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affects the spinnability. In addition, the data obviously pointed out the significant 
influence of molecular weight on the drug release speed. The effect of initial polymer 
concentration on drug release speed is considerably weaker than the influence of the 
molecular weight (Srikar et al., 2008). According to Wang et al. (2010), the low 
molecular weight polymer PEG-b-poly(α-hydroxyoctanoic acid) PEG-PHOA with a 
small degree of polymerization is not suitable for electrospinning apparently due to its 
low viscosity. As a result, researchers often use PEG-PHOA as a modifier in the 
electrospinning process by blending it with high molecular weight poly(ethylene 
glycol)-b-poly(L-lactide) PEG-PLLA. In addition, by incorporating a small amount of 
low molecular weight polymer with a high molecular weight polymer, fibre degradation 
and captured drug release from the fibre might be well controlled (Wang et al., 2010c). 
 
2.5.4 Conductivity 
It is well recognized that solution conductivity is one of the most significant factors 
controlling fibre diameter and distribution (Meng et al., 2010; Arumugam et al., 2009). 
The decrease in the solution electrical conductivity influenced the splitting of the 
charged jet in the electrostatic field. Usually, when the electrical conductivity increases, 
the additional electric charges are carried by the electrospinning jet. As a result, higher 
elongation powers are inflicted to the jet over the electrical filed (Liu et al., 2010b). The 
droplet of polymer solution at the needle, which is connected to an electrical pole, 
converts the solution into a Taylor cone (Meng et al., 2010). When the tensile strength 
becomes higher than the droplet surface tension, a solution jet will be ejected from the 
droplet. It  undergoes a stretching process (Chen et al., 2010) and whipping in the 
atmosphere. Finally, after the solvent has evaporated, the jet is converted into a fibre on 
the collector. Hence, a high solution electrical conductivity holds a large charge leading 
to greater tensile force which enhances jet splitting and stretching, leading to small fibre 
diameters (Alipour et al., 2009). However, a broader jet is ejected by large tensile force 
leading to larger fibre diameters at high solution flow rate (Zamani et al., 2010). When 
the fibres are too thin due to high electrical potentials of the solutions, the fibres could 
break down due to their low mechanical strength, which may not sustain the weight of 
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the fibres along the distance between the needle tip and the collector (Yang et al., 
2007b). 
 
The addition of ions can increase the electrical conductivity of the solution and also the 
fibre diameter is affected by the ions’ size. For example, potassium and phosphate ions 
have bigger radii than sodium and chloride ions (Zong et al., 2002b; Zong et al., 2002a). 
A high mobility in response to an external electric source can be achieved when ions 
have smaller atomic radii with a higher charge density. Furthermore, many studies have 
shown that the final fibre diameter is affected by incorporating salts into the polymeric 
solution and that different types of salts have diverse effects (Zong et al., 2002b). The 
incorporation of a small amount of salt increases the charge density in the split jets. The 
use of salt is reported to have strong effects on the morphology of electrospun fibres, 
thus altering the fibres from a bead structure to a uniform structure, and also decreasing 
the nanofibre diameters (Charernsriwilaiwat et al., 2010). For instance, the addition of 
an organic salt such as pyridiniumformate (PF) into the polymer solutions led to a 
decreased amount of bead formation in the fibre mats due to the significantly increased 
conductivity of the solutions (Arayanarakul et al., 2006). The use of salts in polymer 
solutions is a well-recognized technique to enhance solution spinnability. For example, 
the fibre diameter of polyhydroxybuterovalerate (PHBV) was decreased from a range of 
1–4 µm to less than1µm when organosoluble trialkylammonium chlorides were added to 
the polymer solution. In addition, to show electrostatic repulsions, NaCl has been 
dissolved in the polymer solutions of polyelectrolyte (Arumugam et al., 2009). On the 
other hand, there was an increase in fibre uniformity and solution conductivity when  
NaCl and CaCl2were employed in a polymeric solution of poly(2-acrylamido-2-methyl-
1-propanesulfonic acid) (Arumugam et al., 2009). However, Jeong et al. (2010) found 
that a high amount of PEO demonstrated much lower conductivity, which can lead to 
uniform electrospun nanofibres (Jeong et al., 2010). Moreover, Beachley and Wen 
(2009) found that the surface charge density of the solution jet and the conductivity of 
the solution have increased by using additional NaCl salt in the PCL solution. When a 
rotating drum was employed for the collecting device, incorporating salts into the 
polymer solutions decreased bead formation and fibre diameter. The researchers 
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mentioned that a low concentration of NaCl added to the polymer solution did not 
produce any considerable differences in fibre length, uniformity, or diameter (Beachley 
and Wen, 2009). Nevertheless, Arayanarakul et al. (2006) observed that incorporating a 
small quantity of inorganic salts such as NaCl, LiCl, KCl, MgCl2, and CaCl2 into the 
PEO solution gave rise to the formation of non-uniform structures with beaded fibres, 
except for NaCl. Increasing the salt concentration in PEO solution produced films of 
fused fibres with occasional attendance of the salt crystals. Furthermore, the moderately 
low hygroscopicity of NaCl compared with the other salts could be the reason for the 
result with the PEO solution since NaCl is the only salt that produced fibrous structures. 
By incorporating filler molecules, like ionic salts and drugs, the conductivity of the 
spinning solution can be changed and this influences the fibre diameter (Arayanarakul et 
al., 2006). 
 
2.5.5 Solvents 
Appropriate choice of solvent is one of the main factors in producing electrospun 
polymer fibres and for incorporating drugs into the fibres for use as a drug delivery 
system (Shen et al., 2011). The solvent system plays a vital dual role during 
electrospinning. The first role is dissolving the polymer molecules. This is essential for 
the polymer solution being able to form an electrified polymeric jet. The second role is 
carrying the molecules of dissolved polymer into the fibre collector to synthesise fibre 
mats. This allows solvent molecules to quickly vaporize from the polymer fibres. Thus, 
successful electrospinning can also depend upon the selection of a suitable solvent 
system (Hsu et al., 2010; Han et al., 2010). Generally, there are various solvent 
parameters which have a considerable effect on the electrospinning technique such as 
the dielectric constant of the solvent (Saraf et al., 2009) and polymer solubility in the 
solvent (Abdul Rahman et al., 2010). The evaporation is affected by many factors such 
as the initial solution concentration, the solvent boiling point and the charged jet size 
(Cui et al., 2009). The solvent dielectric constant affects the electrospun fibre diameter 
and morphology. The bead size and the fibre diameters decrease for high dielectric 
constant solvents. For example, when the dielectric constant of solvents increased, the 
diameter of PMMA hollow fibres was reduced slightly, but the hollow wall thickness of 
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fibres was considerably reduced from 700 to 180 nm. High dielectric constant leads to 
reduced fibres diameters due to a high repulsive force in a thin jet lead to splitting 
resulting in more thinning of the jet (Lee et al., 2010). Additionally, acids can serve as 
the co-solvent or solvent, and sometimes they are used to enhance the solution 
conductivity. For example, formic and acetic acid were employed as solvents for gelatin 
and chitosan, respectively; whereas camphorsulfonic acid and HCl were used in small 
amounts in the solutions as co-solvents (Arumugam et al., 2009). 
 
 
Figure 2-9: SEM micrographs of electrospun PEG fibres for 35% PEG concentration 
and various ratios of chloroform: methanol: (a) 1:0, (b) 3:1, (c) 1:1 and (d) 1:2. The scale 
in the micrographs is 10 µm (Haroosh et al., 2011). 
 
From our previous study, Figures 2-9a to d show the effect of various ratios of 
chloroform to methanol. When the chloroform to methanol ratio was 1:0 (i.e. pure 
chloroform), a uniform fibre structure with a large average diameter of 870 nm was 
produced. By increasing the amount of methanol to give a chloroform: methanol ratio of 
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3:1, the average large fibre diameter decreased to 703 nm. Further increasing the amount 
of methanol to a 1:1 ratio resulted in broken fibres, and the average fibre diameter also 
decreased to 395 nm. When the ratio of chloroform to methanol was reduced even 
further to 1:2, fibres were produced with some beads, and the average fibre diameter was 
reduced to 301 nm (Haroosh et al., 2011). In Qian et al. (2010) work, they studied the 
dissolving ability of PMMA to create electrospun fibres. The low boiling point solvents 
such as dichloromethane (CH2Cl2) at 40°C and chloroform (CHCl3) at 62°C facilitate 
rapid evaporation following jet splitting, leading to the production of fibres with internal 
pores. In addition, they showed that solidification is considerably influenced by the 
volatilities of the solvents. The relatively low solvent volatility of the electrospun 
PMMA fibres also affected the fibre morphology. The quite high molecular weight of 
the 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) solvent that was used to dissolve the 
PMMA polymer caused incomplete evaporation of the solvent while producing fibres 
(Qian et al., 2010). Jiang et al. (2004) demonstrated partial aggregation of the fibres 
when they reached the collecting plate due to the low volatility of dimethyl sulfoxide 
(DMSO) as a considerable quantity of the solvent stayed on the fibres (Jiang et al., 
2004). Another study revealed that when tetrahydrofuran (THF) was used as a solvent 
for polystyrene (PS), the PS fibres created an unexpected half hollowed spherical 
arrangement. Furthermore, the quantity of beads on the fibre mats were controlled by 
changing the ratio of dimethylformamide (DMF) to THF (Arayanarakul et al., 2006). 
The surface tension and volume fraction dropped with increasing the DMF ratio, but the 
dielectric constant and solution conductivity increased (Lee et al., 2003b, Zamani et al., 
2010). According to Shen et al. (2011), the solution remained for a longer period in a jet 
state due to the lower evaporation of N,N-dimethylacetamide (DMAc). That low 
evaporation led to thin fibres because it permitted the solution to undergo a longer 
drawing period under the electrical voltage in the instability area (Shen et al., 2011). 
However, Kim et al. (2008) demonstrated that the majority of fibres were broadly 
interconnected because of the DMF, which had a slow evaporation rate, and that fibre 
interconnection was reduced by decreasing the DMF ratio. They showed that a stable 
nanofibre mat with an average diameter of 198 ± 45 nm was achieved when the 
hyaluronic acid (HA) concentration was 10 wt% and the NaOH: DMF volume ratio was 
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4:1 (Kim et al., 2008). Furthermore, the incomplete evaporation of solvents from dilute 
polymer solutions is associated with bead formation in electrospinning. For example, it 
is found that low concentrations of DMF solution of a polyurethaneurea created a fibre-
bead morphology and that the created beads were attributed to low polymer solution 
viscosity and solvent evaporation (Verreck et al., 2003b). It is believed that the high 
dielectric constant of water produces ultrafine fibres with an extremely thin diameter, 
but the very high surface tension of water affects the solution jet and in many cases 
hinders the generation of fibres by forming spherical beads. The reduction of surface 
tension can be achieved by mixing water with solvents that have lower surface tension. 
One study reported that uniform fibres could be achieved by raising the ethanol ratio for 
a water-ethanol co-solvent in a poly(ethylene oxide) (PEO) solution, which is attributed 
to the decrease in the surface tension of the solution (Chuangchote et al., 2009). Another 
study mentioned that hyaluronic acid (HA) dissolves in water quickly, but it does not 
dissolve in the majority of organic solvents. Therefore, a water-ethanol co-solvent was 
employed to dissolve HA so as to increase the evaporation rate and to reduce the surface 
tension of the HA solution, which in turn could produce electrospun fibres without beads 
(Li et al., 2006). 
 
2.6 Drug delivery 
The use of biodegradable polymers as carriers for drug had established various 
applications in biomedical areas (Cui et al., 2006). The major benefit of this system is 
that biodegradable polymers in the delivery systems do not need to be removed from the 
body at the end of the healing time because they degrade into physiologically occurring 
compounds that are easily emitted from the body (Im et al., 2010b). In addition, this 
system has some benefits, like non-toxic degradation in the body, and sustained release 
of encapsulated drugs (Yang et al., 2007a; Han et al., 2009), and it does not cause bad 
effects in the surrounding tissue (Liu et al., 2010a). Due to the increased surface area of 
the carrier and drug, the speed of drug uptake by the human body could be enhanced 
with reduction of size of the carrier and drug assembly. Therefore, drug delivery systems 
have been built up by employing polymeric materials in the shape of micelles, 
nano/microparticles and hydrogels. In addition, a broad range of polymers, fabrication 
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systems, and polymer processing methods have been investigated in various geometries 
for loading drug molecules into delivery media (Cui et al., 2006). Recently, the 
incorporation of drugs into electrospun nanofibres has gained attention because this 
system has good structural stability and higher efficiency of drug encapsulation than 
other drug delivery media (Haroosh et al., 2014). Generally, the chemical and physical 
properties of diverse drugs influence the ability for loading them into fibres (Xu et al., 
2010). The drug release from nanofibre mats can be controlled by the modulation of 
fibre morphology, polymer composition, dosage amount, and drug loading method. The 
large surface area to volume associated with electrospun fibre mats permits solvent 
evaporation (Kim et al., 2010), giving the loaded drug a limited period to recrystallise, 
with the preference to form amorphous dispersion (Qi et al., 2010). The nanofibre’s 
porous structure and extremely small diameter also assist efficient drug release 
(Jannesari et al., 2011). 
 
Hence, this system offers site-specific drugs delivery from the scaffold into the body 
(Kenawy et al., 2002) and could be applicable in wound therapeutics and treatments for 
skin (Verreck et al., 2003b). In the wound therapeutic field in cooperation with topical 
delivery systems, biocompatibility with the nature of the drug release is significant for 
successful treatments (Verreck et al., 2003b). In addition, in wound healing, it is used to 
avoid the decomposition of a labile compound in harsh surroundings, and also to carry a 
drug in a sustained method (Zhang et al., 2006). 
 
Loading a drug into the polymer solution influences solution properties such as 
viscosity, surface tension and conductivity. Moreover, the position of the drug inside 
electrospun fibres affects the release characteristics (Buschle-Diller et al., 2007). The 
fundamental requirement for controlled release drug treatment includes the delivery of a 
fixed quantity of drug in a particular time span. The benefit of drug release methods is to 
enhance the efficiency of drug treatment. This enhancement is able to increasing the 
therapeutic activity compared to the intensity of side effects, reducing dosage of drug 
needed through the healing, or eliminating the requirement for the particular drug (Xu et 
al., 2008). Drug release from polymer mats could happen by different mechanisms such 
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as drug diffusion within the polymer, mat erosion and sometimes by both mechanisms. 
This release is influenced by a range of aspects like carrier morphology, drug 
physicochemical properties, crystallinity, molecular weight, drug–nanofibre mat 
interaction and polymer composition (Zamani et al., 2010). It is very difficult to predict 
the mechanism leading to the drug release kinetics from biodegradable polymers due to 
the variations in polymeric properties through degradation, and interfusion between 
permeability and diffusivity of the drug with time (Puppi et al., 2010). Polymer fibres 
are able to offer drug release at fast, immediate or slow speeds, depending on the 
polymer carriers employed and any incorporated stabilizers (He et al., 2006). 
Furthermore, the interaction between carrier (polymer) and drug plays an important role 
in controlled drug release (Zhang et al., 2006). This chemical interaction can block the 
crystallization of the drug in the nanofibres and may establish constant drug release in 
crystalline state (Natu et al., 2010). Hydrophobic drugs including clindamycin, 
ciprofloxacin, and cephalexin can be simply incorporated with hydrophobic polymers. 
However, hydrophilic drugs cannot be embedded into hydrophobic polymers due to 
weak interactions between them, and thus the drug release rate may not be controlled 
(Xu et al., 2010). Table 2-2 outlines some of the previous studies into electrospun 
systems for drug release applications. 
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Table 2-2: Some of the previous studies into electrospun systems for drug-release 
applications. 
Electrospun mat Drug Reference 
PVP Ketoprofen (Yu et al., 2010) 
PLLA Clarithromycin (Wei et al., 2010) 
PEO Rhodamine (Kim et al., 2010) 
PDLLA Tetracycline and  
chlorotetracycline 
(Xie and Buschle Diller, 
2010) 
PLGA Mefoxin (Kim et al., 2004) 
PEG-PLA Doxorubicin hydrochloride (Xu et al., 2008) 
PEG-PLLA Ibuprofen (Wang et al., 2010c, Cantón et 
al., 2010) 
PELA-HPCD Hydroxycamptothecin (Xie et al., 2010) 
Gelatin Centellaasiatica-herbal extract (Sikareepaisan et al., 2008) 
Cellulose acetate Vitamin A and E (Tungprapa et al., 2007) 
 
Natu et al. (2010) noticed that drug dissolution was the predominant mechanism of drug 
release. Fibres with low drug loading presented sustained release in contrast to high drug 
loading which had a burst release. Those drug crystals in the fibre shell and even in the 
fibre core were not completely encapsulated and were immediately released (Natu et al., 
2010). Verreck et al. (2003) have reported the applicability of electrospinning for poorly 
soluble drugs for transdermal and oral delivery. They mentioned that a poorly soluble 
drug, itraconazole, was loaded into hydroxypropylmethylcellulose (HPMC) by using 
dichloromethane with ethanol as co-solvents for the drug and polymer. The amount of 
itraconazole to the polymer played an important role on the drug release from the 
nanofibre mats. In addition, it was found that the drug presented in the amorphous form 
from the thermal analysis data (Verreck et al., 2003a). Cantón et al. (2010) has shown 
achievement of gradual release of Ibuprofen from biodegradable nanofibres of wound 
dressings without affecting wound healing. A biodegradable dressing is extremely 
attractive for the healing of this kind of wound because it does not need to be removed 
after wound healing (Cantón et al., 2010). Liu et al. (2010) mentioned that collagen/ 
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PLGA nanofibre group was obviously quicker than those of the gauze group and the 
commercial dressing group in wound healing and drug delivery areas. The electrospun 
nanofibre mats might begin to rapidly signal the pathway and draw fibroblasts to the 
dermis layer that can excrete vital extracellular mat components such as collagen and 
growth factors to mend injured tissue (Liu et al., 2010a). 
 
2.7 Summary 
In summary, electrospinning has been recognized to be a sophisticated method for 
manufacturing ultrathin micro/nanofibres using a broad range of polymeric materials or 
composites. There has been a significant increase in the study of electrospun fibres in the 
drug delivery field in recent years. Due to their biocompatibility, degradation without 
side effect and good mechanical properties, biodegradable polymers are excellent 
candidates for a number of applications in biomedical fields (Wei et al., 2010). A 
biodegradable polyester polymer PLA has some attractive properties, including easy 
processability, biocompatibility, degradation to form nontoxic monomers and the ability 
to be dissolved in common solvents (Deng et al., 2007). In addition, the monomeric 
units of lactic acid split up in the human body, and are naturally in the carbohydrate 
metabolism (Kim et al., 2010). These properties made PLA very suitable for various 
biomedical purposes.  However, the efficiency of using PLA fibre as a drug carrier is too 
low because it is associated with burst drug release at the commencement of healing 
(Kim et al., 2010) and with its brittleness and slow crystallization (Chow et al., 2012).  
In addition, the degradation of PLA mat is harmful to local tissues (Touny et al., 2010) 
because of its low pH value. On the other hand, PCL degrades slowly compared with 
PLA (Huang et al., 2006). Moreover, it is not harmful to local tissues because it does not 
form an acidic environment like PLA. However, the slow degradation, poor porosity and 
semi-crystalline nature of PCL inevitably limits its usage in drug delivery. PCL with 
high crystallinity easily restricts the mobility of drug molecules so they tend to stay on 
the fibre surfaces. Polymer blends show extremely unusual properties compared with 
individual polymers. Electrospinning is not a straightforward technique because it is 
affected by both the processing parameters and the solution properties (Zhang et al., 
2005). The nanofibre properties and morphology thus effectively depend on the solution 
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properties and the parameters of electrospinning. Investigating the effects of the 
parameters on the electrospun fibres is challenging owing to the interaction between the 
solution and processing parameters (Biber et al., 2010). Among the electrospinning 
parameters, the solution concentration (Yao et al., 2007), viscosity, electrical 
conductivity (Wei et al., 2010), polymer molecular weight and choice of solvent 
(Buschle-Diller et al., 2007) are the most effective variables to control fibre morphology 
and diameter. To manipulate electrospinning parameters, many studies need to be 
carried out in order to achieve the desired crystallinity, fibre diameter, molecular 
structure, and morphology (Ribeiro et al., 2011). 
 
Controlled drug delivery systems have received great attention in the last decades 
(Kenawy et al., 2009). Electrospun nanofibre drug carriers have been highly considered, 
as this system presents good structural stability and a higher efficiency of drug 
embedding than other drug delivery carriers. The drug release from fibre mats can be 
controlled by changing the polymer composition, drug loading method, dosage amount, 
and morphology. Hydrophobic drugs can be efficiently embedded in hydrophobic 
polymers. However, hydrophilic drugs cannot be embedded into hydrophobic polymers 
due to weak interactions between them, and the drug release rate cannot be controlled 
(Xu et al., 2010). Polymer nanocomposites have attracted significant interest due to their 
unique structures and customisable properties, which cannot be achieved by normal 
materials (Liu et al., 2008b). HNTs have a high dispersion characteristics compared to 
other natural silicates, and also have the ability to produce hydrogen bonding (Du et al., 
2008). HNTs are useful in various areas because of their unusual geometric form, 
surface properties and chemical formation (Jia et al., 2009). Magnetic nanoparticles 
Fe3O4 have low toxicity and are acceptable in the human body (Yang et al., 2006). Due 
to their high surface area to volume ratio, Fe3O4 nanoparticles tend to agglomerate with 
each other to reduce their energy. So far magnetic nanoparticles-polymer system are still 
under investigation for novel applications (Guo et al., 2009b). 
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Chapter 3 
Materials, Methodology, and 
Characterisation 
3.1 Materials 
3.1.1 Biopolymers 
Two different types of hydrophobic polymers (PLA and PCL) were selected for the 
purpose of blending them together and using the resulting mixture in electrospinning 
experiments. PLA and PCL are both polyesters where the monomers are related by 
having the same ester functional group. 
 
3.1.1.1 Poly(lactic acid) (PLA) 
Poly(lactic acid) (PLA) is a compostable polymer obtained from sustainable sources, 
mostly from corn, sugar beets, sugarcanes and wheat. PLA belongs to the group of 
aliphatic polyesters obtained from α-hydroxy acids (Lim et al., 2008; Fowlks and 
Narayan, 2010). Despite PLA having limitations of brittleness and low degree of 
crystallinity, it is still widely used due to its biocompatibility, sustainability, ability to be 
formed into a fabric and biodegradability (Chow et al., 2012). PLA 3051D pellets were 
supplied by NatureWorks, USA and used without any purification. The detailed 
specifications are shown in Table 3-1. 
 
Table 3-1: Physical and thermal properties of PLA. 
 
Product  Molecular weight Colour Melting 
temperature Tm 
Glass transition 
temperature Tg 
PLA (3051D) 93,500 g/mol White 145-155°C 55-65°C 
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3.1.1.2 Poly(ε-caprolactone) (PCL) 
PCL is a hydrophobic, semi-crystalline polyester, which makes it degrade slowly and 
have a low porosity. The aliphatic polyester bond undergoes biodegradation in vivo 
without generating a local acidic environment and toxicity. The biodegradation is due to 
the vulnerability of its aliphatic ester bond to hydrolysis (Sun and Downes, 2009; 
Kweon et al., 2003). Low molecular weight PCL (MW = 33,000 g/mol) was purchased 
from Daicel Chemical Industries Ltd, Japan, while high molecular weight PCL (MW = 
80,000 g/mol) was obtained from Sigma-Aldrich. Both were used without any 
purification. The properties are detailed in Table 3-2. 
 
Table 3-2: Physical and thermal properties of PCL. 
 
Product  Molecular weight Colour Melting 
temperature Tm 
Glass transition 
temperature Tg 
PCL  80,000 and 33,000 
g/mol 
White ≈ 60°C ≈  –60°C 
 
3.1.2 Nanoparticles 
Nanocomposite technology is used to tailor material properties to be suitable for specific 
applications by incorporating nanoparticles into polymers (Lee et al., 2003, Fowlks and 
Narayan, 2010). Two different kinds of nanoparticles, Halloysite nanotubes (HNT) and 
Magnetic nanoparticles (MPs), which have different compositions, shapes, sizes and 
properties, have been incorporated into PLA: PCL blends for the purpose of the 
enhancement of their performance capabilities. 
 
3.1.2.1 Halloysite nanotube (HNT) and 3-aminopropyltriethoxysilane 
The halloysite nanotubes (HNTs) belong to the kaolin group of clay minerals, with a 
composition of Al2Si2O5(OH)4.H2O. They disperse well and have the ability to form 
hydrogen bonds. The HNT elemental composition (wt %) is listed as follows: SiO2, 49; 
Al2O3, 34.8; Fe2O3, 0.35; TiO2, 0.12; Na2O, 0.25; MgO, 0.15 (Ismail et al., 2008). The 
dimensions of HNT are about 300–1500 nm in length, 15–100 nm for the inner diameter 
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and 40–120 nm for the outer diameter (Carli et al., 2011). The halloysite nanotubes were 
obtained from Imerys Tableware Limited, New Zeal and 3-aminopropyltriethoxysilane 
(ASP) H2N(CH2)3Si(OCH3)3 was used as modifier for the HNT and was purchased 
from Sigma-Aldrich Ltd. 
 
3.1.2.2 Magnetic nanoparticles (MPs) 
Magnetic nanoparticles (Fe3O4) were employed to synthesize nanocomposites for 
biomedical applications because they have good biocompatibility and low toxicity that 
can be well accepted in the human body (Yang et al., 2006). Additionally, these Fe3O4  
nanoparticles were selected owing to their comparatively higher stability in air than 
metal nanoparticles, as well as because they can carry more charges (Zhang et al., 2009). 
 
Pure MPs and Impure MPs were synthesized in the laboratory by using iron sulphate, 
iron nitrate, sodium hydroxide, and lauric acid. All these materials were purchased from 
Sigma-Aldrich Ltd. 
 
3.1.3 Solvents 
Choosing a suitable solvent system is essential for the success of electrospinning. 
Dichloromethane (DCM), dimethylformamide (DMF), chloroform, acetone and 
methanol were used as solvents. They were purchased from Sigma-Aldrich Ltd and were 
used without any purification. The detailed properties of the solvents are shown in Table 
3-3. Phosphate buffer solution (PBS) acted as a medium of drug release and was also 
purchased from Sigma-Aldrich Ltd. 
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Table 3-3: Properties of solvents used in the electrospinning method (Bhardwaj and 
Kundu, 2010). 
Solvent Dielectric constant Boiling point 
(°C) 
Density 
(g/ml) 
Surface tension 
(mN/m) 
Chloroform 4.8 61.6 1.498 26.5 
Acetone 21 56.1 0.786 25.2 
DCM 9.1 40 1.326 27.2 
DMF 38.3 153 0.994 37.1 
Methanol 33 64.5 0.791 22.3 
 
3.1.4 Drugs 
3.1.4.1 Tetracycline hydrochloride (TCH) 
TCH (C22H24N2O8·HCl, MW=480.9 g/mol) is hydrophilic antibiotic drug and was 
chosen as a model drug. It was purchased from Sigma-Aldrich Ltd and used without any 
purification. The chemical structure is revealed in Figure 3-1. 
 
 
 
Figure 3-1: Chemical structure of model antibiotic drug TCH (tetracycline 
hydrochloride) (Buschle-Diller et al., 2007). 
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3.1.4.2 Indomethacin (IMC) 
IMC (C19H16ClNO4, MW=357.79 g/mol) is hydrophobic non-steroidal anti-
inflammatory drug and was chosen as another model drug. It was purchased from 
Sigma-Aldrich Ltd and used without any purification. The chemical structure is given in 
Figure 3-2. 
 
Figure 3-2: Chemical structure of model drug IMC (Indomethacin) (Chennamaneni et 
al., 2012). 
 
3.2 Research methodology 
3.2.1 Processing techniques 
Solution variables such as viscosity, solution concentration and electrical conductivity 
play very important roles in the electrospinning technique. In addition, they have a great 
impact on fibre diameters and the degree of crystallinity. For this reason, the focus of 
this study was on the solution parameters, while the process parameters remained 
constant for all experiments. 
 
3.2.1.1 Electrospinning rig setup 
The electrospinning rig consists of four main components including a ground collector, a 
Fusion 100 syringe pump (Chemyx Inc., Stafford, TX, USA) to automatically control 
the solution flow, a spinneret and the positive electrode of a ES30P–5Whigh voltage 
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power supply (Gamma High Voltage Research, Ormond Beach, FL, USA), as illustrated 
in Figure 3-3. 
 
During the electrospinning process, the solutions were ejected using a 10 ml syringe 
pump with a 20G metallic needle (0.584 mm in inner diameter). The flow rate of 
polymer solution was set at 2 ml/h, and the applied positive voltage setting was in the 
range of 25–28 kV. The electrospinning process was carried out at 24ºC. The resulting 
fibres were collected on a flat aluminium foil sheet covering a mesh collector. The 
distance between the needle tip and the collector was 13 cm. The thickness of fibre mats 
ranged from 300 to 500 µm. 
 
 
Figure 3-3: Laboratory-scale electrospinning apparatus (a) a wider shot of the voltage 
suppler, pump, needle and collector and (b) a closer shot of the pump, needle and 
collector. 
 
3.2.1.2 Polymer solution preparation and blending 
Electrospinning was carried out using an 8wt%/v solution of PLA mixed with one of 
three PCL solutions: 9 wt%/v high molecular weight (HMW) PCL solution, 15wt%/v 
high molecular weight PCL solution and 15wt%/v low molecular weight (LMW) PCL 
solution. The PLA and PCL solutions were mixed at different blending ratios of 1:0, 3:1, 
1:1, 1:3 and 0:1 v/v with three solvents, namely a DCM: DMF mixture blended at 3:1 
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v/v, a chloroform: methanol mixture blended at 2:1 v/v and a chloroform: acetone 
mixture blended at 2:1 v/v, as summarised in the Table 3-4. The mixing took place at 
room temperature in a bench top orbital shaking incubator for about 3 h. 
 
Table 3-4: The material formulations. 
No. Polymer 
composition(wt%/v) 
PLA to PCL blend 
ratio (v/v) 
Co-solvent type and 
composition (v/v) 
1 8%PLA: 15% HMW 
PCL 
(1:0),(3:1),(1:1),(1:3) 
and (0:1) 
DCM: DMF (3:1) 
2 8%PLA: 15% LMW 
PCL 
(1:0),(3:1),(1:1) and 
(1:3) 
DCM: DMF (3:1) 
3 8%PLA: 15% HMW 
PCL 
(1:0),(3:1),(1:1) and 
(1:3) 
Chloroform:Methanol (2:1) 
4 8%PLA: 15% LMW 
PCL 
(1:0),(3:1),(1:1) and 
(1:3) 
Chloroform:Methanol (2:1) 
5 8%PLA: 15% LMW 
PCL 
(1:0),(3:1),(1:1) and 
(1:3) 
Chloroform:Acetone (2:1) 
6 8%PLA: 9% HMW PCL (1:1) Chloroform:Methanol (2:1) 
 
3.2.1.3 Halloysite nanotube (HNT) solution preparation, modification 
and loading 
In order to modify HNT by using ASP, 2 ml of ASP was initially dissolved in 30 ml of 
chloroform: methanol co-solvent. About 2 g of HNT powder was added to the ASP 
solution and the suspension was sonicated for 1 h at room temperature. The suspension 
was then heated at 120°C for 6 to 8 h by using a magnetic stirrer coupled with a hot-
plate. The deposited HNT-ASP in the resulting mixture was filtered and thoroughly 
washed twice with chloroform: methanol, and then dried for 24 h at 120°C to ensure the 
removal of all solvents. Meanwhile the unmodified HNT were sonicated separately in 
the chloroform: methanol solvent for 1 h and the suspension was then heated and dried 
using the same method as for the modified HNT. Different HNT contents were added at 
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1wt%/v and 2wt%/v to the polymer solution (8 wt%/v of PLA blended with 15 wt%/v 
solution of PCL at a 1:1 volume ratio) and were mixed and sonicated for additional 2 h. 
 
3.2.1.4 Magnetic particles (MPs) synthesis and loading 
Iron sulphate (FeSO4) and iron nitrate (Fe(NO3)3) were dissolved in deionised water to 
make an aqueous solution with molar ratio 2 Fe(III) to 1 Fe(II). Under vigorous stirring 
for 1 hour at 80°C, 1 molar solution of NaOH was added dropwise to achieve a solution 
with pH =12. A black precipitate formed, indicating the presence of magnetite. The 
black precipitate was dried without any purification to get impure MPs. To produce pure 
MPs, 1 ml of lauric acid was added to the solution to coat the MPs then the precipitate 
was centrifuged and washed with deionised water several times. Finally, the powders 
were dried. 
 
The pure and impure MPs were added at 0.01, 0.1 and 1wt%/v to the polymer solution 
(8 wt%/v of PLA blended with 15 wt%/v solution of PCL at a 1:1 volume ratio), mixed 
using ultrasonication for 2 h and then the solutions were used in electrospinning. 
 
3.2.1.5 Drug preparation and loading to electrospun fibrous mats 
For the purpose of the drug release study, TCH was added to the mixture of different 
polymer and nanocomposite solutions. Firstly, 1 and 5wt% of TCH (calculated 
according to the weight of polymer) was dissolved in methanol using an orbital shaking 
incubator and then it was mixed with the blended polymer solution (8 wt%/v of PLA 
mixed with 9 and 15 wt%/v PCL at blending volume ratio of 1:1). 
 
Secondly, 5wt% of TCH was mixed with 0.1and 1 wt%/v of pure MPs for 2 h in 
methanol by using the ultrasonication method and then added to the polymer solution (8 
wt%/v of PLA blended with 15 wt%/v solution of PCL at a 1:1 volume ratio). 
 
Thirdly, 5wt% of TCH was combined with 1 wt%/v of modified HNT for 2 h to make 
HNT adequately dispersed in the TCH by using methanol as a solvent and an incubator 
for the mixing process. After that, the TCH/HNT was blended with the polymer solution 
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(8 wt%/v of PLA blended with 15 wt%/v solution of PCL at a 1:1 volume ratio). Figure 
3-4 shows a variety of mixtures containing TCH used in the electrospinning 
experiments. 
 
 
Figure 3-4: Hybrid composite solutions with TCH drug. 
 
IMC at 5wt% was dissolved in methanol using an orbital shaking incubator and then 
mixed with the blended polymer solution (8 wt%/v of PLA mixed with 15 wt%/v PCL at 
blending volume ratio of 1:1), as summarised in the Table 3-5. 
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Table 3-5: The material formulations with drug. 
No. Polymer 
composition (wt%/v) 
PLA to PCL 
blend ratio 
(v/v) 
Co-solvent type and 
composition (v/v) 
Drug type and 
concentration 
(wt/wt) 
1 8%PLA: 9% HMW 
PCL 
(1:1) Chloroform:Methanol 
(2:1) 
1% TCH 
2 8%PLA: 9% HMW 
PCL 
(1:1) Chloroform:Methanol 
(2:1) 
5% TCH 
3 8%PLA: 15% HMW 
PCL 
(1:1) Chloroform:Methanol 
(2:1) 
5% TCH 
4 8%PLA: 15% LMW 
PCL 
(1:1) Chloroform:Methanol 
(2:1) 
5% IMC 
5 8%PLA: 15% HMW 
PCL/ 0.1% MP 
(1:1) Chloroform:Methanol 
(2:1) 
5% TCH 
6 8%PLA: 15% HMW 
PCL/ 1% MP 
(1:1) Chloroform:Methanol 
(2:1) 
5% TCH 
7 8%PLA: 15% HMW 
PCL/ 1% HNT-ASP 
(1:1) Chloroform:Methanol 
(2:1) 
5% TCH 
 
 3.2.1.6 In vitro drug release study 
A drug-loaded fibre mat sample (2 × 2 cm) was incubated in a rotary shaker at rotor 
speed 100 rpm during the drug release study at 37°C in 20 ml of PBS (pH=7.4). After 
the required incubation time for drug release, the sample was transferred to 20 ml of 
fresh buffer solution and the released TCH and IMC amounts in the buffer solution were 
determined. The amount of drug was measured over 10 day release tests. 
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A standard release curve was obtained by measuring different concentrations of 
TCH/PBS and IMC/PBS solution with the aid of a UV-vis spectrometer at 360 nm and 
319 nm respectively. The slope and intercept of the line provide a relationship between 
absorbance and concentration: 
 
Y = intercept + slope M 
 
where Y is the absorbance and M is the concentration. The unknown concentrations of 
drug in solution (Mu) were determined from the standard absorbance curves, using the 
slope and intercept, for the measured value of the absorbance (Yu). The estimation used 
the following equation: 
 
Mu = (Yu – intercept) / slope  
 
The percentage of the released drug was calculated from the primary weight of the drug 
(TCH and IMC) included in the electrospun mat. The cumulative amount of drug 
released from the nanofibre mat was calculated by the following equation: 
 
Cumulative quantity of drug released (%) = (Mt/M∞) × 100 
 
where Mt is the amount of drugs released up to time t and M∞ is the initial amount of 
drug within the electrospun fibres. Three release tests were conducted for each 
electrospun fibre mat and the average data were recorded. 
 
3.2.1.7 In vitro biodegradation of nanofibre mats 
For in vitro degradation studies, the nanofibre mats with thickness ranging from 300 to 
500 µm were sliced into 2 × 2 cm samples. They were measured to get the initial weight 
(m) and were put into an incubated rotary shaker at rotor speed 100 rpm during the 
biodegradation study at 37°C in 15 ml of PBS (pH=7.4) for the required incubation time. 
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The nanofibre mats were removed at each designated incubation period and washed with 
deionised water. The nanofibre mats dried under vacuum at 37°C until they reached a 
constant weight (m1). The percentage of mass loss was determined by the equation 
below: 
 
Percentage mass loss = ((m – m1)/m) × 100 
 
3.2.1.8 Release kinetics 
The kinetics of TCH and IMC release from the nanofibre mats were determined from the 
curves of % release (Mt/M∞) against time t. The experimental drug release data were 
fitted to five mathematical models for drug release kinetics (Cai et al., 2011), including 
the zero order, first order, Higuchi, and Ritger-Peppas models,and the recently-
developed Zeng model (Zeng et al., 2011). These models are shown below: 
 
1. Zero order model 
 
Mt/M∞= K0t 
 
2. First order model 
 
Mt/M∞= 1 – exp (–K1t) 
 
3. Higuchi model 
 
Mt/M∞= KHt1/2 
 
4. Ritger-Peppas (power law) model 
 
Mt/M∞= KRtn 
 
5. Zeng model 
 
M t/M∞= Koff/(Kon+Koff) × (1 − e−KSt) +Kon/(Kon + Koff) × (1 − e−Koff t) 
 
where K0, K1, KH, and KR are the zero-order, first-order, Higuchi, and Ritger-Peppas 
release constants, respectively, while n is the diffusion exponent in the Ritger-Peppas 
model. In the Zeng model, Kon is the rate constant of association, Koff is the rate constant 
of disassociation, and KS = Ak/V where (A/V) is the surface area-to-volume ratio of the 
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nanofibre mat and k is the rate constant. Here, k = DK/l, where D is the diffusion 
coefficient of the drug, K  is the partition coefficient of the drug between the shell and 
the core, and l is the thickness of the shell. 
 
3.3 Characterisation 
Morphology and structure characterization of nanocomposite fibres is essential to 
understand the effect of nanoparticles and drug within the nanocomposites, as well as to 
understand the drug release mechanism from nanofibre mats, which may help todevelop 
drug delivery systems. Various characterization methods, including scanning electron 
microscopic (SEM),transmission electron microscopy (TEM), X-ray diffraction (XRD), 
differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy 
(FTIR), viscometry, electrical conductivity measurement, gel permeation 
chromatography (GPC) and UV-vis spectrophotometry, were performed on some typical 
mat samples. The specific arrangements and investigation conditions are explained in 
the following subsections. 
 
3.3.1 Scanning electron microscopy (SEM) 
SEM was carried out to investigate the morphological structures of nanofibre mats when 
blending PLA with PCL and incorporating HNTs, MPs and drug (TCH) with the 
blending polymers. SEM employs a focused beam of high energy electrons to produce a 
diversity of signals at the solid specimens’ surface (Bozzola, 1992). The signals that are 
received from the interaction between the nanofibres and electrons are reformatted to 
form microscopic images. 
 
The morphology of electrospun nanofibres was studied via an EVO 40XVP scanning 
electron microscope from Zeiss (Germany) at an accelerating voltage of 5 kV. Before 
SEM observation, the samples were sputter-coated with platinum. Fibre diameter was 
calculated from the SEM images by using an image analysis tool in the Zeiss Smart 
SEM software. For each sample, measurements were made with a minimum of 150 
fibres from multiple scanned SEM images and at a rate 15 fibres per image. 
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3.3.2 Transmission electron microscopy (TEM) 
Transmission electron microscopy was utilized to examine the morphology of HNT and 
MP dispersion within the nanofibres in order to confirm the XRD data. TEM is a 
broadly utilized characterization method for solid materials. In contrast to SEM, the 
beam of TEM electrons is transmitted through a thin sample of the material and assists 
in revealing the detailed structures that are embedded within the material (Williams and 
Carter, 2009).  
 
The nanofibre mat was embedded in Araldite® epoxy resin. The following method was 
used to control the homogeneity and distribution of the fibres in the mat sample: a 
1×1×1 cm3 volume of epoxy was polymerized for 24 h, then the fibre mat was macerated 
in epoxy solution and placed on the solid pre-polymerized epoxy, and subsequently the 
composite was re-polymerized. The composite was sectioned into 100 nm layers using a 
diamond knife with a Leica EM UC6 microtome, and the sections were later mounted 
onto carbon grids. The TEM observations were performed using a JEOL 2011 at an 
accelerating voltage of 200 kV to study the dispersion level of HNT and MP within the 
composite fibre mats. 
 
3.3.3 X-ray diffraction (XRD) 
X-ray diffraction (XRD) allows phase identification of the crystalline material structure, 
including degree of crystallinity, crystallite size, and structural changes.XRD 
measurements of prepared samples were performed in a Bruker Discover 8 X-ray 
diffractometer (Germany) operated at 40 kV and 40 mA using Cu-Kα radiation that was 
monochromatised with graphite sample monochromators in a 2θ range from 5° to 40° 
with a scanning rate of 0.05°/s. The d-spacing (d) corresponding to the silicate XRD 
peak was determined from Bragg’s equation: 
 
nλ=2dsinθ 
 
where θ is the diffraction position, λ is the wavelength, which is 1.54 Å for a Cu target, 
and n is an integer. The crystallite size (L) was calculated from the Scherrer relation: 
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L = Kλ / (Bcosθ) 
 
where B is the complete width at half maxima of the crystalline peak in radians and K is 
the shape factor of the average crystallite. The crystallinity was determined by applying 
the area integration method from diffracted intensity over the range of 2θ data from 8° to 
27° (Ning et al., 2007). 
 
3.3.4 Differential scanning calorimetry (DSC) 
DSC is a common thermo-analytical technique that is used to understand effects of 
heating and cooling on polymer behaviour and also study a polymer’s thermal 
transitions (Menczel et al., 2009). This technique was employed to determine the impact 
of changing the PCL concentration, blending ratio of PLA to PCL, embedding of HNTs, 
embedding of MPs and the addition of drugs on the thermal properties of the 
composites. Thermal analysis was performed using a DSC6000 from PerkinElmer 
(USA) with Cryofill liquid nitrogen cooling system. Approximately 10mg of fibre mat 
was sealed in aluminium pans and its thermal behaviour was analysed during heating 
between 30°C and 200°C with a ramp rate of10°C/min for PLA nanofibres, while 
samples with PCL were heated from –100°C to 200°C. The glass transition temperature 
(Tg), crystallisation temperature (Tc) and melting temperature (Tm) were obtained for 
PLA: PCL nanofibres from analysis of the DSC data. 
 
3.3.5 Fourier transform infrared spectroscopy (FTIR) 
FTIR is a method of materials analysis that produces the ‘fingerprint’ of a material with 
absorption peaks that match the frequencies of vibrations of the material’s atomic bonds. 
It can identification of different compounds because each material is a unique 
combination of atoms (Smith, 2009). FTIR was used to investigate the interaction level 
between biopolymers (PLA: PCL), HNTs, MPs and drugs. It was performed in a 
Spectrum 100 FTIR Spectrometer from PerkinElmer (Japan). Spectra were recorded in 
the range between 4000–550 cm−1 with 4 cm−1 resolution by using an attenuated total 
reflectance (ATR) technique (Chittur, 1998).  
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3.3.6 Viscometry and electrical conductivity measurement 
Solution viscosity, which is a very important variable that influences nanofibre 
diameters, was measured by using a Visco 88 portable viscometer from Malvern 
Instruments (UK). It has a built-in temperature sensor and is supplied with a double gap 
measuring geometry to provide extra sensitivity when measuring low-viscosity fluids. 
All the samples were measured under constant temperature of 23°C. The electrical 
conductivity and pH value of the solution were measured by using a WP-81 Waterproof 
pH and conductivity meter (TPS, Australia). 
 
3.3.7 Gel permeation chromatography (GPC) 
Gel permeation chromatography (GPC) was utilized to find the effect of impurities that 
accompany the MPs on the molecular weight of PLA: PCL blending. GPC analysis was 
performed to measure the molecular weight of polymers at 40°C using a Shodex DS-4 
pump, one Shodex KF-805L and three KF803L columns connected in series, and a UV 
detector.  Tetrahydrofuran (THF) was used as the eluent at a flow rate of 1.0 ml/min. 
 
3.3.8 UV-vis spectrophotometry 
UV-vis spectrophotometry is a method that has been used to identify and measure the 
organic and inorganic materials in many processes. The amount of TCH present in the 
release buffer (PBS) was obtained by means of a UV-vis spectrophotometer (JascoV-67) 
at wavelengths of 360 nm and 319 nm of TCH and IMC respectively.  
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Chapter 4 
Morphological Structures of 
Electrospun Biopolymers 
4.1 PLA: PCL system 
Blending polymers is generally an effective strategy for establishing novel materials 
based on the beneficial properties of each polymer constituent. The mat structure and 
properties of the blends can be tailored by changing the composition to produce blends 
with characteristics quite different from those of the pristine or individual polymers. A 
blended poly(lactic acid) (PLA): poly(ε-caprolactone) (PCL) system may assist in 
achieving well-balanced crystallinity with the potential advantage of well-controlled 
drug release. However, the control of electrospinning parameters to obtain better 
nanofibre quality without any bead defects and also with the desired morphology, 
crystallinity and molecular structures, has yet to be achieved.  
 
This chapter was designed to investigate the effect of polymeric solution variables such 
as solution viscosity, polymer molecular weight, polymer concentration, blend ratio of 
polymers and solvent type. These variables had a substantial and direct impact on fibre 
diameters, morphological structures, thermal properties and the degree of crystallinity, 
as well as potentially on the rate of drug release, which will be investigated in Chapter 7. 
This research work focused on blending high and low molecular weight PCL at 9 wt%/v 
and 15 wt%/v solution with PLA solution (fixed at 8 wt%/v) at five blending ratios. 
Various co-solvents, including chloroform (CHCl3): acetone (C3H6O), chloroform 
(CHCl3): methanol (MeOH) and dichloromethane (DCM): N,N, dimethylformamide 
(DFM) were used for the preparation of PLA: PCL solutions. 
 
4.2 Morphological observations 
4.2.1 Effect of PCL molecular weight  
Molecular weight is an important parameter in the electrospinning process. Figure 4-1(a) 
shows that blending PLA with high molecular weight PCL led to homogenous fibres 
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with an average nanofibre diameter of 814±15 nm. However, by decreasing the 
molecular weight of PCL no fibrous structure was obtained, Figure 4-1(b). This can be 
attributed to lowering the required solution viscosity for effective electrospinning due to 
decreasing the molecular weight. Figure 4-2 shows the viscosity of PLA: 15% PCL 
solutions dissolved in chloroform: methanol (CHCl3: MeOH). It can be seen that a 
decrease in the PCL molecular weight led to a significant decrease of solution viscosity. 
 
 
Figure 4-1: SEM micrographs of electrospun PLA: PCL (1:1) fibres using chloroform: 
methanol as a solvent: (a) high molecular weight 15% PCL and (b) low molecular 
weight 15% PCL. 
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Figure 4-2: Viscosity of 1:1 v/v solutions of PLA with high and low molecular weight 
PCL dissolved in chloroform: methanol co-solvent. 
 
4.2.2 Effect of PCL concentration 
A PLA solution was blended with two different concentrations of high molecular weight 
PCL solution, namely 9 and 15 wt%/v, at a 1:1 blending ratio using chloroform: 
methanol solvent and used for electrospinning. These two systems generated a 
moderately regular fibrous morphology with a number of differences in the fibre 
diameters and morphology. Figure 4-3 demonstrates that when increasing the PCL 
concentration from 9 wt%/v to 15 wt%/v, the corresponding average fibre diameter is 
enlarged from 689±15 nm to 814±15 nm. This finding is ascribed to the increased 
solution viscosity: from 113 cP for 9 wt%/v PCL to 476 cP for 15 wt%/v PCL, Figure 4-
4. It is in good agreement with previous studies that have shown that small fibre 
diameters result from low solution viscosity (Zamani et al., 2010; Arayanarakul et al., 
2006). The increase of solution viscosity is associated with an increase in the number of 
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molecular entanglements per polymer chain and a low amount of solvent due to the 
increased  solution concentration, which is regarded as an important factor for stable jet 
formation in compensation for increased surface tension (Spasova et al., 2007). 
 
 
Figure 4-3: SEM micrographs of electrospun 8 wt%/v PLA solution with high molecular 
weight PCL (a) 9 wt%/v PCL solution, and (b) 15 wt%/v PCL solution. 
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Figure 4-4: Solution viscosity of 1:1 v/v mixtures solutions of PLA with high molecular 
weight 9 and 15 wt%/v PCL dissolved in chloroform: methanol solvent. 
 
4.2.3 Effect of PLA: PCL blending ratio 
Figure 4-5 shows that the use of PLA dissolved in dichloromethane: dimethylformamide 
(DCM: DMF) produced homogenous fibres with average diameter 450±15 nm. In the 
first trial set, the high molecular weight PCL concentration was fixed at 15 wt%/v and it 
was found that for this system the ratio of PLA to PCL of 3:1 facilitated the production 
of good electrospun fibres with average diameter 553±15 nm, Figure 4-6. However, by 
increasing the amount of PCL up to a PLA: PCL ratio of 1:1, the average fibre diameters 
were increased to 610±20 nm, but the fibres produced possessed intermediate quality 
due to the non-uniform morphology. The increasing trend in the fibre diameter 
continued up to 744±15 nm with uniform fibrous structures when the PLA: PCL ratio 
reached 1:3. It was found to be difficult to achieve homogeneous fibres at an even higher 
PLA: PCL ratio of 0:1 due to the significant increase of the solution viscosity preventing 
the solution droplets from being elongated into continuous fibres, Figure 4-6. Solution 
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viscosity plays a significant role in the formation of a greater number of entanglements 
per polymer chain, which is a precursor to generating a stable jet (Spasova et al., 2007). 
 
 
Figure 4-5: SEM micrographs of electrospun PLA: 15% PCL fibres by using DCM: 
DMF as a co-solvent with different PLA: PCL blend ratios: (a) 1:0, (b) 3:1 , (c) 1:1, (d) 
1:3 and (e) 0:1. 
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Figure 4-6: Solution viscosity and nanofibre diameters of PLA: high molecular weight 
15% PCL solutions dissolved in the DCM: DMF with different blend ratios. 
 
Figure 4-7(a) shows that the low molecular weight PCL concentration was fixed at 15 
wt%/v and it was established that for this system a PLA: PCL blend ratio of 3:1 resulted 
in an average fibre diameter of 490±15 nm, Figure 4-8. This implies that the increase in 
blend ratio from 1:0 to 3:1 did not considerably affect the fibre diameters within 
experimental errors. Moreover, increasing the amount of PCL to a blend ratio of 1:1 
caused beads and inhomogeneity in the structures, and decreased the average fibre 
diameter to 250±25 nm, with maximum and minimum diameters of 425 nm and 130 nm, 
respectively. This indicates that by lowering the solution viscosity, as illustrated in 
Figure 4-8, the fibre diameter can be reduced, while inhomogeneity occurs to a great 
extent in the fibre structure. Moreover, the low viscosity leads to quick fragmentation of 
the charged polymer jet at short distances, which may be a plausible reason for the beads 
occurring in the electrospinning process. When the amount of PCL was further 
increased, no visible fibre structures were obtained. 
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Figure 4-7: SEM micrographs of electrospun PLA: 15% PCL fibres using DCM: DMF 
as a co-solvent with different PLA to low molecular weight 15% PCL blend ratios: (a) 
3:1, (b) 1:1 and (c) 1:3. 
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Figure 4-8: Solution viscosity and nanofibre diameters of PLA: low molecular weight 
15% PCL solutions dissolved in the DCM: DMF with different blend ratios. 
 
4.2.4 Effect of solvent 
The electrospun solvent is also a major determinant which affects the fibre structure. 
The selection of an appropriate solvent system is crucial for successful material 
fabrication via electrospinning (Han et al., 2010). Figure 4-9 shows that using PLA 
dissolved in chloroform: methanol co-solvent produced fibres with the average diameter 
of 510±15 nm. Increasing the amount of low molecular weight PCL to PLA with the 
blend ratio of 1:3 produced a mixed fibre-bead structure with average nanofibre 
diameters of 325±25 nm. Further increasing the PCL: PLA blend ratio to 1:1 resulted in 
non-fibrous structures, as evidenced in Figure 4-10. 
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Figure 4-9: Solution viscosity and nanofibre diameters of PLA to low molecular weight 
15% PCL solutions dissolved in chloroform: methanol and chloroform: acetone co-
solvents with different blend ratios. 
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Figure 4-10: SEM micrographs of electrospun PLA: 15% PCL fibres using chloroform: 
methanol as a co-solvent with different PLA to low molecular weight 15% PCL blend 
ratios: (a) 1:0, (b) 3:1 and (c) 1:1. 
  
Figure 4-11 demonstrates that electrospun PLA dissolved in chloroform: acetone co-
solvent led to nanofibres with an average diameter of 570±15 nm (Figure 4-10). When 
the amount of low molecular weight PCL with a PLA: PCL blend ratio of 3:1 was used, 
inhomogeneous fibre structures with a reduced average fibre diameter to 375±30 nm 
were observed. Additionally, further increasing the amount of PCL led to non-fibrous 
formations. 
 
73 
 
 
Figure 4-11: SEM micrographs of electrospun PLA: 15% PCL fibres using chloroform: 
acetone as a co-solvent with different PLA to low molecular weight 15% PCL blend 
ratios: (a) 1:0, (b) 3:1 and (c) 1:1. 
 
Considering that the solution viscosity is critical in forming fibres, Figure 4-10 
demonstrates that the viscosity was significantly reduced by the increasing amount of 
low molecular weight PCL and its effect on the electrospun fibres was almost the same 
for all solvent systems. The nanofibres produced from the DCM: DMF co-solvent 
system were uniform, with smaller fibre diameters, as compared to those obtained from 
chloroform: methanol and chloroform: acetone systems. This is because the conductivity 
of DCM: DMF solution is higher than the chloroform: methanol solution, which is, in 
turn, higher than chloroform: acetone. As a result, increasing the conductivity can 
74 
 
facilitate a uniform charge density, and thus cause higher conductivities to produce 
smaller nanofibres. 
 
On the other hand, Figure 4-5 shows that PLA with high molecular weight PCL in 
DCM: DMF produced approximately sinuous fibres especially when the PCL 
concentration was increased to 15 wt%/v, since the viscosity was significantly increased 
by the additional high molecular weight PCL (Figure 4-6). The effect on the electrospun 
fibres was the same, as can be seen with chloroform: methanol co-solvent, Figure 4-3(b). 
The electrospun fibres formed from the DCM: DMF system for all polymer blend ratios 
was relatively small as compared to those from the chloroform: methanol system, which 
can be due to the effect of the solution electrical conductivity. This finding indicates that 
the choice of a suitable solvent system is also essential in the electrospinning process. 
Furthermore, the dielectric constant of the solvent and the solubility of polymers in the 
solvent can significantly influence the structure of the resulting fibres (Abdul Rahman et 
al., 2010). DMF has a higher dielectric constant (38.3) compared to methanol (33.0), 
while DCM has a higher dielectric constant (9.1) than chloroform (4.8) (Bhardwaj and 
Kundu, 2010). Consequently, it can be concluded that enhancing the solution electrical 
conductivity promotes the first step of manufacturing uniform fibre mats due to their 
higher charge density. Secondly, at the step of fibre solidification, the volatilities of 
solvents significantly affect the drying properties and the solidification process. 
Additionally, the morphologies of electrospun nanofibres are considerably impacted by 
the rate of solvent evaporation (Qian et al., 2010). Therefore, it was found that unlike 
methanol, the low volatility of DMF could result in decreased solvent evaporation, 
leading to wet fibres being received at the collector plate. Additionally, it was found that 
fibres from the chloroform: methanol co-solvent system produced a better-aligned 
fibrous structure compared with their DCM: DMF and chloroform: acetone counterparts. 
 
4.3 Crystallinity level and thermal properties 
An XRD investigation was carried out to examine the changes in the PCL molecular 
weight, solvents, PCL concentration and PLA: PCL blend ratio on the degree of 
crystallinity (Xc). Figure 4-12 demonstrates the XRD patterns for blending PLA with 
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two concentrations of high molecular weight PCL, 15 wt%/v and 9 wt%/v, respectively. 
It can be seen that when the PLA and PCL blend had a higher PCL concentration, the 
diffraction peaks of PLA: PCL at angles of 2θ = 20.11° and 23.2° were detected, which 
are related to the crystal planes (101) and (200), respectively. They become more 
prominent as a result of the positive impact of PCL, which contributed to an increased 
degree of crystallisation for increasing PCL concentration and increasing blending ratio 
of PLA and PCL to 1:1. It is obvious from Figure 4-13 that the degree of crystallinity 
obtained from XRD patterns was improved in PLA: 15% PCL at the blend ratio of 1:1 
when dissolved in chloroform: methanol, not as has been obtained from PLA: 9% PCL 
and PLA: 15% PCL at blend ratios of 1:1 and 3:1, respectively. This phenomenon is due 
to the addition of PCL with a modest degree of crystallinity in place of amorphous phase 
PLA with low crystallinity. As observed in Figure 4-13, the key finding is that a sharp 
decline in the degree of crystallinity occurred when low molecular weight PCL was 
added compared with high molecular weight PCL at the same blend ratio (Xc = 37.95% 
and 58.84%, respectively). This arises from the dominant effect of the amorphous PLA 
phase with relatively high molecular on the degree of crystallinity when it was blended 
with low molecular weight PCL. On the other hand, it is noted that there is a moderate 
effect on the degree of crystallinity by changing the co-solvents. The use of chloroform: 
methanol co-solvent reduced the degree of crystallinity to 58.84% compared with 
61.59% when DCM: DMF solvent was added. This may be ascribed to the higher 
evaporation rate of methanol compared to DMF. During electrospinning, the fast 
evaporation leads to quick solidification, which means that the polymer molecules do 
not have enough time to be arranged into an appropriate crystal structure. 
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Figure 4-12: X-ray diffraction patterns for selected samples showing the relative position 
of the intercalation peak due to employing various solvents, PCL concentrations, 
different PLA to PCL blend ratios, and high and low molecular weights of PCL. 
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Figure 4-13: Degree of crystallization of PCL: PLA nanofibres created from a variety of 
solvents, PCL concentrations, different PLA to PCL blend ratios, and high and low 
molecular weights of PCL. 
 
The thermal behaviour of electrospun fibres was also evaluated in the present work. The 
DSC results in Figure 4-14 and Table 4-1 show that the crystallisation temperature (Tc) 
of as-received PLA was higher than that of PLA fibres because the crystallization 
process can be accelerated by the well-structured PLA molecular chains in fibre-like 
form. The glass transition temperature (Tg) of PCL within the PLA: PCL blends become 
higher when the high molecular weight PCL concentration increases from 9 to 15 
wt%/v. However, the Tg of PLA within the blends is hardly detected as it has overlapped 
the melting peak of PCL as shown in Figure 4-14. In addition, the variation of melting 
temperature (Tm) and Tg values can be attributed to the variation of fibre diameters and 
also to the electrospinning process, which influences the orientation of the polymer 
chains (Picciani et al., 2010). With respect to the impact of molecular weight, it can be 
observed that blending low molecular weight PCL with the PLA leads to the noticeable 
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increase in the value of Tc of PLA compared with high molecular weight PCL, while 
there was a significant decrease in the Tm value of PCL within the blend. Whereas with 
respect to the influence of solvent, the value of the Tc is lower in the case of using 
chloroform: methanol compared with using DCM: DMF solvent. The reason for this 
phenomenon is due to the high volatility of methanol, which leads to the preventing of 
created crystals as a result of rapid solidification. Hence there is no enough time for the 
relaxation of molecular chains. Moreover, the changes in the values of Tg, Tm and Tc in 
the case of PLA: PCL blends compared with individually electrospun PLA and PCL 
fibres, confirm a good miscibility between PLA and PCL within the blend. 
 
Table 4-1: DSC results for PLA, PCL and PLA: PCL blend dissolved in (CHCl3: 
MeOH) and (DCM: DMF) a.  
aCalculations were repeated for three sets of samples. The standard deviation for the Tg, 
Tc and Tm values was less than 0.5°C. 
 
 
 
Material sample 
 
Tg (°C)  
 PCL 
Tm (°C) 
PCL 
Tg (°C) 
PLA 
Tc (°C) 
PLA 
Tm (°C) 
PLA 
PLA (As-received) - - 65.2 120.6 152.6 
PLA (CHCl3 : MeOH) - - 64.1 87.2 155.6 
15% H. MW. PCL (CHCl3: MeOH) –58.0 63.1 - - - 
(PLA: 9% H. MW. PCL) (1:1) 
(CHCl3: MeOH) 
–56.2 62.2 - 81.1 151.6 
(PLA: 15% H. MW. PCL) (1:1) 
(CHCl3: MeOH) 
–52.2 63.8 - 84.0 152.5 
(PLA: 15% H. MW. PCL) (1:1) 
(DCM: DMF) 
–56.7 63.6 - 85.6 152.7 
(PLA: 15% H. MW. PCL) (3:1) 
(DCM: DMF) 
–57.2 62.8 - 81.9 152.4 
(PLA: 15% L. MW. PCL) (1:1) 
(DCM: DMF)   
–58.5 56.1 - 87.3 150.5 
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Figure 4-14: DSC thermograms for selected samples. 
 
4.4 FTIR examination  
Compositional changes were examined by Fourier Transform Infrared Spectroscopy 
(FTIR).  Figures 4-15(a) and (b) display the FTIR spectra of PLA: PCL blend dissolved 
in DCM: DMF and chloroform: methanol with 9 wt%/v and 15 wt%/v PCL, different 
PLA to PCL blend ratios, and high and low molecular weights of PCL. Figure 4-15(a) 
demonstrates that PLA nanofibres and PCL nanofibres without blending exhibit initially 
two carbonyl stretching (C=O) bands at 1722 cm–1 for PCL and at 1750 cm–1 for PLA, 
respectively. The bands located at 2944 and 2866 cm–1 for PCL, and at 2850 cm–1 for 
PLA are assigned to C–H stretching. The peaks at 1456 and 1367 cm–1 indicated a C–H 
deformation of PLA. In addition, many peaks represent C–C and C–O stretching among 
the range 1240 to 840 cm–1 for the PLA and PCL. 
 
 
80 
 
In the case of blending PLA with PCL it is evident that the intensity of the carbonyl 
stretching (C=O) band of PCL decreases as the PLA amount increases in the blend and 
also when the PCL molecular weight decreases, as seen in samples 1 and 5 from Figure 
4-15(b). In addition, FTIR peaks of the carbonyl stretching band have been shifted to 
higher wave numbers within the blend. This shift was higher (from 1750 to 1757 cm–1 
for PLA) in the case of using PLA: 15% PCL at a blend ratio 1:1 and dissolved in a 
chloroform: methanol system. Sample 2 from Figure 4-15(b) suggests better miscibility 
between PLA and PCL compared with other systems. 
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 Figure 4-15: FTIR spectra for selected material samples showing the relative FTIR 
peaks in different ranges: (a) large scale between 3100 and 650 cm–1, and (b) small scale 
between 1820 and 1600 cm–1. 
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4.5 Summary 
The main finding from this chapter it was that increasing the molecular weight and 
concentration of the polymeric solution has led to a remarkable improvement in the 
viscosity values, which in turn results in the formation of bead-free homogeneous 
nanofibres, especially when the blending ratio was 1:1. The nanofibres produced from 
the DCM: DMF solvent mixture, for all blend ratios of the polymers, were smaller 
compared to those created from the chloroform: methanol co-solvent. The nanofibres 
produced by using the chloroform: methanol co-solvent formed better aligned fibrous 
structures compared with those based on other co-solvents. The degree of crystallinity 
(Xc) obtained from XRD patterns increased in the PLA: 15% PCL mixture at a blend 
ratio of 1:1 when dissolved in chloroform: methanol, which was completely different 
from those for PLA: 9% PCL and PLA: 15% PCL at blend ratios of 1:1 and 3:1, 
respectively. Blending low molecular weight PCL with PLA led to a sharp decline in the 
degree of crystallinity and melting temperature (Tm) of PCL relative to high molecular 
weight PCL, while there was a noticeable increase in the crystallisation temperature (Tc) 
of PLA. Furthermore, the rapid evaporation of methanol when using the chloroform: 
methanol system caused a reasonable decrease in the degree of crystallinity and Tc 
compared with that for using DCM: DMF. Increasing the PCL concentration from 9 to 
15 wt%/v contributed to an enhanced glass transition temperature (Tg) of PCL within the 
blends. Additionally, the changes in the values of Tg, Tm and Tc in the case of polymer 
blends compared with the individual PLA and PCL fibres, as well as the shift of the 
carbonyl stretching band to higher wave numbers, give clear evidence of good 
miscibility between PLA and PCL within the blends, especially for PLA: 15% PCL at a 
blend ratio of 1:1 dissolved in chloroform: methanol. This chapter provided structural 
information on a new material system that could be potentially used as a carrier for 
nanoparticles and drugs to facilitate good drug release control as presented in the 
following chapters. 
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Chapter 5 
Biopolymer and HNT 
Nanocomposites 
5.1 PLA: PCL: HNT system 
The incorporation of nanoparticles into polymer nanocomposites is an effective 
approach for tailoring the composite properties and producing unique structures that 
could not be achieved by normal blending. The properties of fabricated nanocomposites 
are different from the properties of the poly(lactic acid) (PLA): poly(ε-caprolactone) 
(PCL) blends or halloysite nanotubes (HNT) individually. This is because of the varied 
types of PLA: PCL / HNT interactions that happen at a molecular level. Preparation of 
such nanocomposites is a new way to construct novel polymer-inorganic structures and 
may be efficiently directed by a suitable selection of synthesis conditions and initial 
materials. HNTs re-agglomerate when embedded in PLA: PCL blends due to the strong 
hydrogen bonding between HNT particles. This agglomeration influenced the properties 
and structure of the composites. HNTs without surface improvement show a much 
poorer dispersion and low interfacial interactions in the PLA: PCL blend due to their 
weak compatibility with PLA: PCL molecules in the produced nanocomposite fibres. 
Such a PLA: PCL based composite system could help to achieve a balanced level of 
crystallinity with the potential advantage of stable drug release, since PCL with its high 
level of crystallinity simply restricts the mobility of drug molecules so that they tend to 
stay around the fibre surfaces. HNT is probably suitable for the accommodation of drugs 
because of its extremely large halloysite lumen diameter and this may facilitate better 
control of the drug release process. 
In order to facilitate the steady drug release from PLA: PCL nanofibres, this chapter 
examined the effect of HNT when embedded into PLA: PCL fibres for both high and 
low molecular weight PCL. The effect of the modifier 3-aminopropyltriethoxysilane 
(ASP) on HNT was also investigated. ASP directly influences the fibre diameters, 
morphology, thermal properties, structure and degree of crystallinity, and it may help to 
delay the fast drug release normally associated with nanofibrous structures. This chapter 
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focused on blending high molecular weight PCL (9 wt%/v and 15 wt%/v) and PLA 
(fixed at 8 wt%/v) solutions with HNT at two different concentrations of 1 wt%/v and 2 
wt%/v. Both unmodified HNT and HNT modified with ASP were explored in this 
chapter. Two different PCL concentrations, namely 9 and 15 wt%/v, were chosen in 
order to evaluate how the blend viscosity affects the nanofibre diameter and degree of 
crystallinity, which are considered to be two significant factors in the control of drug 
release. The blend viscosity was a vital factor for HNT dispersion within the polymer 
blend in the electrospinning process. Additionally, this chapter also concentrated on the 
effect of using different solvents and blending ratios of PLA: low molecular weight PCL 
embedded with HNT. 
 
5.2 Morphological observations 
5.2.1 Effect polymer blend ratio and solvent on biopolymers containing 
HNT  
Figure 5-1 illustrates that electrospinning PLA and PLA: PCL blends with different 
blend ratios results in very different behaviour. For example, using PLA: PCL blend of 
1:0 in chloroform: methanol with 1 and 2 wt%/v HNT created a good-quality fibre 
structure with average diameters of 960 and 1050 nm respectively (Figure 5-2). The 
good fibrous structure is due to the high volatility of methanol, which permits sufficient 
solvent evaporation before the fibres reach the collector, leading to the creation of the 
nearly identical fibres. The addition of HNT increased the fibre diameters because HNT 
increases the solution viscosity. With the addition of HNTs, solution viscosities increase 
remarkably, especially at a blend ratio of PLA: PCL of 1:0. Increasing the amount of 
low molecular weight PCL led to heterogeneity in the nanofibrous structure with a 
configuration of large beads. Whereas, at a blend ratio of 1:1, it was difficult to 
determine fibre diameters as a result of increasing numbers of beads. Additionally, there 
was no clear effect of increasing the amount of HNT from 1 to 2 wt%/v on the nanofibre 
diameters within experimental error. This may be due to the impact of low viscosity, 
which can hinder and prevent the homogeneous distribution of HNT within polymer 
blends and also increase the possibility of HNT sedimentation over time during the 
electrospinning process. 
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Figure 5-1:  SEM micrographs of electrospun PLA: low molecular weight 15% PCL 
fibres using chloroform: methanol solvent and containing different PLA: PCL blend 
ratios: (a1) 1:0, (b1) 3:1, and (c1) 1:1 with 1 wt%/v HNT; and (a2) 1:0, (b2) 3:1, and 
(c2) 1:1 with 2 wt%/v HNT.  
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Figure 5-2: Solution viscosity and nanofibre diameters for different HNT concentrations 
and blend ratios of PLA to low molecular weight 15 wt%/v PCL solutions dissolved in 
(a) chloroform: methanol solvent and (b) DCM: DMF solvent. 
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Conversely, as shown in Figure 5-3, electrospun PLA: PCL blended in DCM: DMF with 
HNT caused beads and inhomogeneities in the structures as compared to nanofibres 
produced from chloroform: methanol. This phenomenon occurred despite an increase in 
the solution conductivity. Moreover, an increased amount of HNT from 1 to 2 wt%/v, 
when added to PLA: PCL at a blend ratio of 1:0 did not affect the fibre diameters within 
the experimental error. Nevertheless, despite increasing the amount of PCL to blend 
ratios of 3:1 and 1:1, no clear nanofibrous structure was obtained. The fibre diameter 
based on the DCM: DMF system was smaller compared to those from the chloroform: 
methanol system. In the electrospinning process, the low volatility of DMF led to 
decreased solvent evaporation, resulting in wet fibres on the collector plate. 
Consequently, the electric potential could not overcome the effect of solvent’s low 
volatility and the slightly increased number of entanglements per polymer chain by 
increasing solution viscosity, which leads to difficulty in the formation of the jet, 
causing the bead-fibre structure. 
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Figure 5-3:  SEM micrographs of electrospun PLA: low molecular weight 15% PCL 
fibres using DCM: DMF solvent and containing different PLA: PCL blend ratios: (a1) 
1:0, (b1) 3:1, and (c1) 1:1 with 1 wt%/v HNT; and (a2) 1:0, (b2) 3:1, and (c2) 1:1 with 
2 wt%/v HNT.  
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5.2.2 Effect HNT concentration and HNT type: Unmodified HNT and 
HNT modified with ASP 
To investigate the effect of HNT, the PLA: high molecular weight PCL polymer solution 
was blended with two different types of HNT, namely unmodified HNT and HNT 
modified with ASP. In addition, the solution concentration, as reflected by the viscosity 
of the polymer blends, is an important factor for fibre homogeneity and HNT dispersion 
within the polymer blend. As can be seen in Figure 5-4, the HNT tended to increase the 
solution viscosity as expected. Moreover, the embedded HNT frequently created a 
homogeneous fibrous structure with large diameters compared to those obtained from 
the corresponding PLA: PCL blends without HNT. Higher HNT amounts also led to 
larger fibre diameters regardless of the PCL concentration, Figure 5-5. Such an increase 
in fibre diameters may be ascribed to the dominant effect of solution viscosity on the 
fibrous structure. This finding is consistent with results obtained recently (Bottino et al., 
2013) However, this claim contradicts the finding by Touny et al. (2010), which 
reported that the addition of HNT was associated with the manufacture of small-
diameter fibrous structures owing to the improved electrical conductivity of the solution 
(Touny et al., 2010). 
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 Figure 5-4: Viscosity and nanofibre diameters of 1:1 v/v mixtures of solutions of PLA 
and high molecular weight PCL dissolved in chloroform: methanol solvent, and blended 
with unmodified HNT and HNT modified with ASP: (a) 15 wt%/v PCL solution, and (b) 
9 wt%/v PCL solution. 
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From Figure 5-6, it can be seen that the average fibre diameters due to the use of 
additional 1 and 2 wt%/v of HNT-ASP to form PLA: 15% high molecular weight PCL 
composites appeared to be virtually unchanged; whereas, there was a reasonable 
variation in average diameters of the 9 wt%/v PCL counterpart. The explanation for this 
behaviour could result from the nearly unchanged viscosity of 15 wt%/v PCL 
composites (538 and 540 cP for 1 and 2 wt%/v of HNT-ASP, respectively). Different 
from HNT-ASP, there was a reasonable increase in the average fibre diameter when 
embedding unmodified HNT to 9 and 15 wt%/v PCL composites, as demonstrated in 
Figure 5-4, owing to an increase of the solution viscosity. This may be also attributed to 
the increased agglomeration of unmodified HNT, which in turn may possibly lead to an 
increased solution viscosity. Further, the average fibre diameters produced from the 
additions of 1 wt%/v unmodified HNT and HNT-ASP to the PLA: 9 wt%/v PCL 
nanocomposite were unaffected regardless of the obvious variation in the solution 
viscosity, Figure 5-4(b). The low solution viscosity for 9 wt%/v PCL in comparison with 
15 wt%/v PCL may preclude the creation of an HNT suspension and perhaps also lead to 
HNT sedimentation. In addition, Figure 5-4 demonstrated the dissimilarity in the 
average fibre diameters between PLA: PCL composites embedded with unmodified and 
modified HNT-ASP. The difference in average fibre diameter increases with increasing 
HNT concentration from 1 to 2 wt%/v, which may be understood by the enhanced 
agglomeration level resulting from increasing the quantity of HNT employed. 
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 Figure 5-5: SEM micrographs of electrospun PLA: high molecular weight PCL (1:1) 
fibres using chloroform: methanol solvent and for two PCL concentrations blended with 
unmodified HNT: (a) 9 wt%/v PCL with 1 wt%/v HNT, (b) 9 wt%/v PCL with 2 wt%/v 
HNT, (c) 15 wt%/v PCL with 1 wt%/v HNT, and (d) 15 wt%/v PCL with 2 wt%/v HNT. 
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 Figure 5-6: SEM micrographs of electrospun  PLA: high molecular weight PCL (1:1) 
fibres using chloroform: methanol solvent and for two PCL concentrations blended with 
HNT modified with ASP: (a) 9 wt%/v PCL with 1 wt%/v HNT-ASP, (b) 9 wt%/v PCL 
with 2 wt%/v HNT-ASP, (c) 15 wt%/v PCL with 1 wt%/v HNT-ASP, and (d) 15 wt%/v 
PCL with 2 wt%/v HNT-ASP. 
 
Figure 5-7(a) shows TEM images of composites embedded with unmodified HNT. It can 
be seen that several HNT particles have obviously formed agglomerates. HNT 
aggregated due to strong hydrogen bonding between the filler particles (Liu et al., 2007). 
In addition, the HNT begins to re-aggregate as a result of the fast solvent evaporation 
during the electrospinning process, leading to decreased HNT dispersion in the PLA: 
PCL composites. Even though there is some degree of agglomeration, the TEM image in 
Figure 5-7(b) illustrates that HNT-ASP are individually better dispersed into the PLA: 
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PCL blend and epoxy matrices in this composite system as compared to unmodified 
HNT. As shown in Figure 5-7(a), PLA: PCL rich fibrous structures are created, which 
are segregated from the HNT and form their special individual skewed fibre clusters. 
This phenomenon is not noticeable in Figure 5-7(b) for modified HNT with ASP, which 
proposes that a better interaction could occur between PLA: PCL fibres and HNT-ASP, 
and an amount of PLA: PCL fibres simply permeate into the hollow configurations of 
HNT-ASP. It becomes evident that the ASP might facilitate the HNT dispersion to some 
extent. This is because the modifier ASP tends to react with the shell of HNT throughout 
the particle interactions, which assists to reduce the sticking problem between the 
modified surfaces of HNT. The non-homogenous distribution of HNT and PLA: PCL 
fibres, as clearly depicted in Figure 5-7, might be caused by two processes. Initially, the 
electrospinning method employed in this work possibly exerts less control on modified 
fibres, permitting them to become twisted when assembled on the collector. 
Subsequently, the polymerization of the fibre mat and epoxy resin has a slight impact on 
the fibre orientation, which is different from injection moulding as usually employed for 
manufacturing polymer-clay nanocomposites. Because of such processes the TEM 
images, Figure 5-7 could show both cross-sectional and side views of HNT, which 
appear as black round dots or cylinders, respectively. 
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 Figure 5-7: TEM images of PLA: 15% PCL composites reinforced with (a) HNT, and 
(b) HNT-ASP (Haroosh et al., 2013a). 
5.2.3 Reaction mechanism of nanocomposites 
The ethoxy groups of 3-aminopropyltriethoxysilane (ASP) can hydrolyze, resulting in 
the formation of SiOH groups, which can form hydrogen bonds with the surface 
hydroxyl groups. A hydroxyl group can react to a silica surface hydroxyl group or the 
hydroxyl group of a neighbouring silane molecule to form a siloxane bond. Therefore, 
the SiOH groups play a critical role in the formation of modified structures on the HNT 
surface, Figure 5-8. 
 
Grafting occurs between hydrolyzed ASP and the surface hydroxyl groups of HNT, 
including the aluminol groups at the internal surface of the lumen, which may enhance 
the drug loading and release delay. Levis and Deasy (2003) mentioned that coating HNT 
was particularly effective to delay the drug release (Levis and Deasy, 2003). 
Modification of the HNT external surface will be useful for increasing the interaction 
with polymers though the HNT contains siloxane and has only a few hydroxyl groups on 
its external surface, which makes improvement on the inner surface more affective 
compared to the external surface. 
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Oligomerization needs high temperatures to some extent to be the dominant process for 
treating HNT surface. Since the modified HNT-ASP had not been heated to high 
temperatures during the modification stage, the dominant mechanism will be the direct 
grafting of ASP to the HNT surface and its preferred modification to control drug 
delivery compared with oligomerization (Yuan et al., 2008). However, this does not 
prevent the occurrence of oligomerization by connecting with each other to structure a 
chain and also connecting with earlier directly grafted ASP. PCL and PLA will be cross-
linking with HNT-ASP by creating a hydrogen bond between the carboxylic group of 
the blending PLA: PCL and the hydroxyl group of the HNT-ASP, as shown in Figure 5-
8. 
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Figure 5-8: Schematic representation of the proposed mechanism of HNT surface 
modification and formation of cross-linked network between HNT-ASP and PLA: PCL 
nanofibres. 
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5.3 Crystallinity level and thermal properties 
An XRD examination was employed to investigate the variations in crystallinity owing 
to the PCL molecular weight, and HNT and HNT-ASP structures, on the electrospun 
composites formed. Figure 5-9 demonstrates the XRD patterns for blending PLA with 
high and low molecular weight PCL at 15 wt%/v. It can be observed that when the PLA 
and PCL blends used high molecular weight PCL, the diffraction peaks of PLA: PCL at 
diffraction angles of 2θ = 20.11° and 23.2°, corresponding to the crystal planes (101) 
and (200), respectively, turn out to be more prominent owing to the positive involvement 
of high molecular weight PCL on the crystallization degree of the blends. It is evident 
from Figure 5-10 that the degree of crystallinity (Xc) deduced from the XRD patterns 
also increased for the PLA: 15% high molecular weight PCL as opposed to PLA: 15% 
low molecular weight PCL, because high molecular weight PCL has reasonable 
crystallinity compared to amorphous phase  PLA with low crystallinity. 
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 Figure 5-9: X-ray diffraction patterns for selected samples showing the relative positions 
of the reflection peaks due to the addition of HNT and HNT-ASP in PLA: PCL blends 
with different molecular weights of PCL. 
 
Figure 5-9 shows the XRD pattern of as-received HNT, with the crystal planes (hkl) 
related to the major crystalline peaks and d-spacing as obtained from the DICVOL 
program in the FullProf software package (Boultif and Louer, 2004). The characteristic 
XRD peak of as-received HNT was identified at 2θ = 12.44°, in accord with the 
reflection plane of (001), with d-spacing value of 0.72 nm. This HNT basal reflection 
results from its tubular morphology and small crystal size (L) of 21.71 nm calculated 
from the Scherrer relation (Ning et al., 2007). In addition, further peaks at 2θ = 20.21° 
and 24.94°, corresponding to the (110) and (002) reflection planes with d-spacing values 
of 0.44 and 0.36 nm, respectively, are revealed in the diffraction pattern of HNT. 
Moreover, it has been pointed out that the HNT employed in this work is referred to as 
(7 Å)–halloysite with a dehydrated formation (Dong et al., 2011). It was found from the 
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database of the EVA program that the peak at 2θ = 8.76° for hydrated particles totally 
vanishes. Additionally, Figure 5-9 demonstrates the XRD patterns for PLA: 15% high 
molecular weight PCL composites embedded with 1 wt%/v HNT-ASP and HNT. The 
data showed that the XRD peaks for HNT-ASP embedded in PLA: PCL nanocomposites 
appear at 2θ = 12.21°, 19.87° and 23.26° with d-spacing values of 0.73, 0.45 and 0.39 
nm corresponding to the planes (001), (102) and (111), respectively. The (001) peaks of 
unmodified HNT and HNT-ASP based on PLA: PCL nanocomposites were smaller and 
wider compared with the peak of as-received HNT powders, which could correspond to 
the break-down of bulky HNT agglomerates into sub-micron particles. Furthermore, the 
(001) peaks were slightly shifted to lower angles of 12.35º and 12.21º for HNT and 
HNT-ASP based on PLA: PCL nanocomposites compared with that of as-received HNT 
powders at 2θ = 12.44º. This finding indicates that HNT-ASP based on PLA: PCL 
nanocomposites possess slightly enhanced dispersion than unmodified HNT based 
nanocomposites in good accordance with the TEM results in Figure 5-7. A potential 
explanation could be that the agglomeration tendency is reduced when employing ASP 
to modify HNT, which could help the HNT-ASP disperse in the PLA: PCL mat with a 
decreased occurrence of aggregates. The first peak (001) intensities have decreased for 
unmodified HNT and HNT-ASP based on PLA: PCL nanocomposites when compared 
to that of as-received HNT, further implying the less well-ordered formation of HNT 
particles. Since this is verified by the TEM findings in Figure 5-7, it can be said that 
HNT are present in a partially jumbled and randomly organized distribution. It can be 
recognized from Figure 5-10 that the embedding of 1 wt%/v HNT to blend polymers 
decreased the crystallinity of the nanocomposites as opposed to PLA: 15% high 
molecular weight PCL. Moreover, increasing the amount of HNT to 2 wt%/v led to a 
further reduction of crystallinity level. The resulting degree of crystallinity is affected by 
the restricted mobility of the polymer chains, which hinders good crystal growth. 
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Figure 5-10: Degree of crystallinity (Xc) results for PLA: PCL composites reinforced 
with HNT and HNT-ASP calculated from XRD data. 
 
The thermal behaviour of electrospun composites was determined in the current work. 
Data are reported just for the first heating scan. The data from cooling scans were 
ignored because no DSC peaks were identified due to the cold crystallization nature of 
PLA (Shibata et al., 2006). As shown in Figure 5-11 and Table 5-1, the glass transition 
temperature (Tg) and melting temperature (Tm) of PCL within the PLA: PCL/ HNT 
nanocomposites becomes lower when the PCL molecular weight decreases. However, 
the Tg of PLA within the blends is difficult to identify owing to its overlapping with the 
melting peak of PCL. In addition, the presence of 1 wt%/v HNT-ASP in the 
nanocomposites resulted in reasonable decreases in the values of Tg of high molecular 
weight PCL and crystallization temperature (Tc) of PLA. Such reductions increased with 
the addition of 2 wt%/v HNT-ASP, but displayed a more obvious decreasing trend 
relative to that with unmodified 1 wt%/v HNT. The nucleating agent role of HNT has 
been demonstrated to promote the heterogeneous nucleation of polymeric molecules, as 
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confirmed by the decreased value of Tc, particularly in the PLA: 15% high molecular 
weight PCL nanocomposites embedded with 2 wt%/v HNT-ASP as compared to the 
polymer blend without HNT. 
 
A small reduction of Tg value occurs in high molecular weight PCL of HNT-ASP based 
composites compared with unmodified HNT. This finding may result from the decreased 
crystallinity level and enhanced HNT dispersion as confirmed by the aforementioned 
XRD results. This has very good implications for the drug loading ability of the 
nanocomposites, where better dispersion of HNT would be able to accommodate a 
higher amount of drug molecules within the nanocomposite. The differences in Tm and 
Tg values might be assigned to the electrospinning processing parameters and resulting 
dispersed nanofibre diameters, which influence the orientation of polymeric chains 
(Picciani et al., 2010). 
 
Table 5-1: DSC results for PLA: PCL nanocomposites with unmodified HNT and 
modified HNT-ASPa. 
aCalculations were repeated for three sets of samples. The standard deviation for the Tg, 
Tc and Tm values was less than 0.5°C. 
 
Material sample Tg (°C)  
 PCL 
Tm (°C) 
PCL 
Tg (°C) 
PLA 
Tc (°C) 
PLA 
Tm (°C) 
PLA 
PLA: 15% H. MW. PCL –52.2 63.8 - 84.0 152.5 
PLA: 15% L. MW. PCL / (1% HNT)   –62.6 55.0 - 78.4 153.3 
PLA: 15% H. MW. PCL / (1% HNT)  –56.5 63.4 - 83.1 152.4 
PLA: 15% H. MW. PCL / (1% HNT-ASP) –58.3 62.8 - 81.1 151.1 
PLA: 15% H. MW. PCL / (2% HNT-ASP) –62.2 59.7 - 74.0 151.1 
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Figure 5-11: DSC thermograms for selected samples including PLA: 15% PCL fibres, 
PLA: 15% PCL with 1% HNT and 1% HNT-ASP. 
 
5.4 Intermolecular interactions 
Fourier transform infrared spectroscopy (FTIR) was employed to explain possible 
interactions between the HNT and the biopolymers. Figure 5-12 illustrates that PLA: 
PCL electrospun fibres exhibit two carbonyl stretching (C=O) bands at 1724 cm–1 and 
1757cm–1 for PCL and PLA, respectively. The spectrum of as-received HNT powder 
shows two intense bands at 3621 cm−1 and 3694 cm−1, which are assigned to the O–H 
group vibration. However, the peaks at 1117 cm–1, 1027 cm–1 and 1005 cm–1 are 
associated with stretching of Si–O, and the adsorption peak at 910 cm–1 is defined by 
Al–OH groups. The external surface of HNT is composed of siloxane (Si–O) groups, 
whilst the internal surface consists of aluminol (Al–OH) groups. Grafting between ASP 
and HNT occurs by connecting molecules of hydrolyzed ASP straight to the internal and 
external surface for a fraction of the HNT hydroxyl groups, as shown in the reaction 
mechanism in Figure 5-8. It comprises the aluminol and silanol groups at edges surface 
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and the aluminol groups at internal lumen surface, which may enhance the drug loading 
and delay drug release. 
 
A comparison of the spectra of PLA: PCL, PLA: PCL / HNT and PLA: PCL / HNT-ASP 
in Figure 5-12 demonstrates that some FTIR peaks have been either moved, have 
appeared or have totally disappeared. For example, when embedding HNT and HNT-
ASP into the PLA: PCL nanocompsites, the single PLA: PCL band at 1184 cm–1 has 
been broadened and moved to lower wave numbers of 1167 and 1179 cm–1, respectively. 
It is proposed that a moderate contribution of the HNT bands with wave numbers of 
1117, 1027 and 1005 cm–1 are associated with the stretching of Si–O. Moreover, the 
peak of PLA: PCL nanocomposites embedded with unmodified HNT disappeared at a 
wave number of 1130 cm–1, while for PLA: PCL nanocomposites embedded with HNT-
ASP a new peak appeared at 913 cm–1. This phenomenon might be the result of the HNT 
bond recognized at wave number 910 cm–1, which is ascribed to the Al–OH groups. 
Additionally, the involvement of the surface hydroxyl groups and the O–H group 
vibration bands at 3621 and 3694 cm–1, also confirm the effective embedding 
characteristic of HNT-ASP within the PLA: PCL nanocomposite. The infrared spectra of 
the final composites thus confirm the previous TEM and XRD results. 
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 Figure 5-12: FTIR spectra for selected samples including as-received HNT, electrospun 
PLA: 15% PCL fibres, and PLA: 15% PCL nanocomposites. 
 
5.5 Summary 
This Chapter showed that when HNTs were embedded with PLA: low molecular weight 
PCL, there was no obvious effect on the variation of nanofibre diameters due to the 
increase of HNT concentration from 1 to 2 wt%/v. This is due to the influence of low 
viscosity of PLA: low molecular weight PCL solution in reducing the homogeneous 
distribution of HNTs within the blend solution and also promoting HNT sedimentation 
during the electrospinning process. In addition, using a DCM: DMF solvent produced 
beads and inhomogeneity in the structures as compared to nanofibres generated by using 
chloroform: methanol. 
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The embedding of HNT into PLA: high molecular weight PCL blends increased the 
solution viscosity, thus resulting in the occurrence of more homogeneous fibres. The 
average fibre diameters decreased with the reduction of HNT concentration for both 
high molecular weight PCL concentrations. The average fibre diameters with HNT-ASP 
were decreased significantly in comparison to those with unmodified HNT when using 
15 wt%/v PCL. Somewhat better dispersion and less agglomeration were achieved for 
PLA: PCL composites embedded with HNT-ASP compared to unmodified HNT, which 
has benefits for drug release applications. The low solution viscosity for 9 wt%/v PCL 
compared with 15 wt%/v PCL reduced the creation of an HNT suspension and led to 
HNT sedimentation. The current chapter has promoted nanofibre quality without any 
bead defects or non-fibrous structures by controlling the crystallinity level of the PLA: 
PCL blend. Moreover, the embedding of HNT-ASP into the polymer blends led to a 
reasonable decrease in the degree of crystallinity, in addition to small decreases of glass 
transition temperature of PCL, the crystallization temperature and melting temperature 
of PLA within the composites. The infrared spectra of the composites proved the 
effective embedding of HNT-ASP into PLA: PCL nanofibres compared with unmodified 
HNT due to the modifier ASP minimizing agglomeration. 
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Chapter 6 
Biopolymer and MP 
Nanocomposites 
6.1 PLA: high molecular weight PCL: MP system 
Magnetic nanoparticles (Fe3O4) are inorganic materials with low toxicity, super-
paramagnetic properties, good biocompatibility, easy preparation and better stability in 
the atmosphere than metal nanoparticles (Zhang et al., 2009). The purpose of this 
chapter is to ultimately produce a novel electrospun hybrid composite system by mixing 
PLA: PCL blends with magnetic nanoparticles (MPs), which may be employed with a 
range of bioactive drugs for wound healing applications. This chapter also provides a 
holistic evaluation of electrospun PLA: PCL/ MP composites in a systematic manner, 
from their fabrication to structural analysis and material characterization. Furthermore, 
MPs have extremely small diameters (20–50 nm) and also have electrical and 
mechanical properties totally different from HNTs, which may significantly affect the 
properties of the PLA: PCL blends and the nanofibrous structures produced, and thus 
result in the alteration of drug release kinetics. 
 
This chapter focused on blending high molecular weight PCL (9 wt%/v and 15 wt%/v) 
and PLA (fixed at 8 wt%/v) solutions with pure and impure MPs at three different 
concentrations, 0.01, 0.1 and 1wt%/v. Both pure and impure MPs were synthesized in 
the laboratory and the chemical reaction suggested for the MP synthesis is expressed in 
equation (1). Pure and impure MPs were considered in this study because it was desired 
to assess the effect of the salts present in the impure MPs on the fibre diameter and 
morphology. It is well known that salts in polymeric solutions enhance their electrical 
conductivity, which is one of the significant factors in the electrospinning process. 
 
FeSO4(s)+2Fe(NO3)3(s)+8NaOH(aq) Fe3O4(s)+Na2SO4(aq)+6NaNO3(aq) + 4H2O(l) (1) 
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6.2 Morphological observations 
6.2.1 Effect of pure MP concentration 
To examine the impact of MPs, the PLA: PCL blend solution was mixed with three 
different concentrations of pure MPs, 0.01, 0.1 and 1 wt%/v. Figure 6-1 demonstrates 
that two main processing variables in electrospinning, namely solution viscosity and 
electrical conductivity, are both enhanced when the pure MP concentration increases 
from 0 to 1 wt%/v. As seen from Figure 6-2, the embedding of pure MPs in the PLA: 
PCL blends tends to create homogeneous composite fibrous structures with smaller 
nanofibre diameters as opposed to electrospun PLA: PCL nanofibres. The average 
nanofibre diameters are detailed in Table 6-1. It is obvious that the nanofibre diameter 
decreases sharply from 711 to 583 nm when the pure MP concentration increases from 
0.01 to 1 wt%/v, which is much lower than PLA: PCL nanofibre diameter at 814 nm. 
 
 
Figure 6-1: Effect of pure MP concentration on viscosity and electrical conductivity of 
PLA: high molecular weight PCL at a blend ratio of 1:1. 
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Table 6-1: Summary of the average fibre diametersa (nm) for hybrid composites with 
MPs. 
aThe numbers in parenthesis are the standard deviations. 
 
 
Figure 6-2: SEM micrographs of electrospun PLA: high molecular weight PCL/ pure 
MP composites: (a) 0 wt%/v MPs, (b) 0.01 wt%/v MPs, (c) 0.1 wt%/v MPs and (d) 1 
wt%/v MPs. 
 
MPs MP 0% MP 0.01% MP 0.1% MP 1% 
Pure 814 (±15) 711 (±15) 685 (±20) 583 (±25) 
Impure 814 (±15) 80 (±15) 62 (±15) 51 (±15) 
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It was previously reported that decreasing the solution viscosity resulted in a decrease of 
the fibre diameter (Ji et al., 2006), whilst a higher electrical conductivity produced 
electrospun fibres with smaller diameters. The decreased nanofibre diameters found in 
this study could be ascribed to the predominant effect of the significant increase of 
electrical conductivity relative to a modest increase of solution viscosity. In terms of the 
effect of electrical conductivity, as shown in Figure 6-1, an increase in the MP 
concentration led to an increase in the electrical conductivity, apparently due to the 
increase of the iron content. As a matter of fact, the increased electrical conductivity 
inevitably produces more electrical charges that are carried by the electrospinning jet. 
Consequently, higher repulsive forces are imposed on the jet, which elongate the jet 
materials into fibrous structures under the electrical field (Zamani et al., 2010). 
Furthermore, by increasing the electrical conductivity, the draw rate and large draw ratio 
of the jet in its bending instability area can be increased during electrospinning. Hence, 
the induced jet path becomes longer and the solution droplets undergo a stretching 
process. Both higher repulsive forces and greater bending instability could contribute to 
electrospun fibres with smaller diameters (Lee et al., 2010; Saraf et al., 2009). 
 
6.2.2 Effect of impure MP concentration 
PLA: high molecular weight PCL blend solution was mixed with 0.01, 0.1 and 1 wt%/v 
impure MPs to fabricate electrospun composite nanofibres. As shown in Figure 6-3 and 
Table 6-1, quite small nanofibre diameters, about one-tenth of those of PLA: PCL blend 
fibres with pure MPs, were produced with impure MPs. The average fibre diameters 
decline from 80 to 51 nm when the impure MP concentration increases from 0.01 to 1 
wt%/v. This phenomenon might be explained by the dual effect of a sharp decline in 
solution viscosity and a considerable increase of electrical conductivity caused by 
increasing the impure MP concentration from 0 to 1 wt%/v. Both solution viscosity and 
electrical conductivity of PLA: PCL composites with impure MPs are much more 
sensitive to MP concentration than their counterparts with pure MPs, as shown in 
Figures 6-1 and 6-4. The solution viscosity suddenly declines from 476 to 13 cP with 
impure MPs compared to a moderate increase from 476 to 522 cP with embedding pure 
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MPs. As previously indicated, a significant drop in the solution viscosity and increase in 
the electrical conductivity inevitably result in reduced nanofibre diameters. 
 
 
Figure 6-3: SEM micrographs of electrospun PLA: PCL/ impure MP composites: (a) to 
(c) 0.1 wt%/v impure MPs with micrograph scales 100, 20 and 10µm, respectively; (d) 
0.01 wt%/v impure MPs; and (e) 1 wt%/v impure MPs. 
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Figure 6-4: Effect of impure MP concentration on solution viscosity and electrical 
conductivity of the PLA: high molecular weight PCL blend solution. 
 
It is surprising to note that the fibrous structures in Figure 6-3 include nearly 3D 
spherical cells with rough nuclei diameters ranging between 1 and 10 µm. The fibres 
radiate away from a central nucleus and these cells became larger and more aggregated 
with increasing the MP concentration, particularly as revealed in Figures 6-3(c) and (e). 
Each cell is isolated from other cells by borders, which are shaped from bundles of 
overlapped fibres. The fibres line up around the nuclei, and more aligned fibres are 
visible in the central area of nucleus, Figure 6-5. The fibres were found to start to 
disappear from the nuclei when the MP concentration increased, which could be owing 
to the rapid decline in the solution viscosity, leading to the creation of tiny-diameter 
fibres and beads. These unique material structures and behaviour are reported for the 
first time in this research, and have not been indicated elsewhere in the literature. The 
nuclei seem to be aggregated MPs produced as a consequence of the low PLA: PCL 
solution viscosity. For that reason, tiny MPs tend to be easily stirred through the PLA: 
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PCL solution, which, because of their magnetization, huge surface area and high surface 
energy, allows them to attract one another and aggregate. The reorientation of MP 
positions may lead to the alignment of MPs with the applied electrical field after solvent 
removal during the electrospinning fabrication process. 
 
 
Figure 6-5: SEM micrographs showing the electrospun composite fibres lining up 
around the nuclei: (a) 0.01 wt%/v impure MPs and (b) 0.1 wt%/v impure MPs. 
 
The sharp decline in the solution viscosity is due to the impurities existing in the 
untreated magnetic nanoparticles, composed of salts such as sodium sulphate, sodium 
nitrate and sodium hydroxide. It was indicated in this work that the impurities lead to 
reduced molecular weight of the PLA: PCL blends, from 84700 g/mol in the neat 
polymer blend down to 62700, 20200 and 12600 g/mol at three impure MP 
concentrations of 0.01, 0.1 and 1 wt%/v, respectively, as seen in Figure 6-6. 
Nonetheless, there was no clear effect of embedding pure MPs on the molecular weight. 
This decline may be due to sodium sulphate, which can react with the PLA: PCL blend 
resulting in the break-down of PLA: PCL molecular chains into smaller fragments. In 
addition, when sodium nitrate loses an oxygen atom, it causes the formation of sodium 
nitrite, which reduces the polymerization rate, and in turn contributes to a decrease of 
the molecular weight for polymer blends (Detrembleur et al., 2002). Moreover, the OH 
group reacts with the ester bonds to produce intermediate degradation polymers, after 
which further break-down of the initial products into fractions with lower molecular 
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weights occur (Makino et al., 1986). It was noticed that the pure MPs did not influence 
the pH value of PLA: PCL solution. However, impure MPs increase the pH values of the 
solution to 12.11, 12.32 and 12.76, when embedding 0.01, 0.1 and 1 wt%/v impure MPs, 
respectively. These are in contrast to the pH value of 6.88 for the PLA: PCL blend 
without MPs. Such a phenomenon might be ascribed to the hydrogen bonding being 
disturbed through the depolymerisation process, which can increase the pH value, 
decrease molecular weight and improve the polymer solubility, in good agreement with 
a previous comparable finding for chitosan polymer (Mao et al., 2004). Impure MPs 
produce non-uniform fibrous structures with cell aggregation and tiny fibre diameters, 
making them unsuitable for the drug release application as opposed to pure MPs. 
 
 
Figure 6-6: Effect of impure MP concentration on molecular weight of PLA: PCL blend. 
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6.3.3 Pure and impure MP dispersion 
The impure MPs dispersed inside the electrospun PLA: PCL composite nuclei within the 
epoxy matrices were examined by TEM due to the relatively large nuclei diameters that 
hinder the identification of impure MPs by energy dispersive spectroscopy (EDS). Pure 
MP dispersion was investigated by SEM. Moreover, the elemental compositions of the 
impure and pure MPs were confirmed by EDS. Figure 6-7(a) illustrates a TEM image 
and an EDS spectrum of the morphological structures for 0.1 wt%/v impure MPs. 
Clearly, most impure MPs aggregate inside large nuclei, which is in good agreement 
with the previous SEM results. The average diameters of impure MPs are about 15–35 
nm according to image analysis based on counting 200 particles from eight TEM 
images. As shown in the EDS spectra of the nuclei, the peaks of Fe and O elements 
suggest that the hybrid nanocomposite contained Fe3O4. The presence of Na shows the 
mixture has impure MPs, resulting in the reduced molecular weight of the PLA: PCL 
blend. The peak of the C element is associated with the PLA: PCL nanofibres. Figure 6-
7(b) shows an SEM image and an EDS spectrum of the nanofibrous structures for 1 
wt%/v pure MPs. Obviously, some pure MPs aggregate inside nanofibres. As indicated 
in the EDS spectrum of the aggregated particles (specified in circuits), the peaks of Fe 
and O elements confirm that the PLA: PCL nanocomposite contained only Fe3O4 
without any impurities. 
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Figure 6-7: (a) typical TEM image and EDS spectra of epoxy/ PLA: PCL fibres 
embedded with impure MPs, and (b) SEM image and EDS spectra of PLA: PCL fibres 
embedded with pure MPs. 
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6.3 Crystallinity level and thermal properties  
The crystalline structures of MPs are reported in Figure 6-8(a), with XRD patterns 
acquired from pure and impure MPs. The peaks were labelled with the XRD reflection, 
and the crystal planes (hkl) corresponding to the main crystalline peaks were detected in 
the DICVOL program of the FullProf software (Boultif and Louer, 2004). Pure MPs 
possess the same pattern as that of crystalline magnetite, which includes six diffraction 
peaks: (220), (311), (400), (422), (511) and (440) identified at 2θ = 30.1, 34.3, 43.1, 
53.4, 57.2and 63.2°, respectively. Their corresponding d-spacing values are 0.29, 0.25, 
0.21, 0.17, 0.16 and 0.14 nm accordingly, in good accordance with those of typical 
magnetite (Fe3O4). As for impure MPs, there were other diffraction peaks (112) and 
(202) detected at 2θ = 39.2 and 41.5°, which indicates the existence of sodium carbonate 
(Na2CO3) present as an impurity. This component may have been created when impure 
MPs were synthesized. Sodium hydroxide (NaOH) is in contact with atmospheric air and 
adsorbs CO2toform Na2CO3 when added dropwise to the MP solution, as shown in 
equation (2): 
 
2NaOH(aq)+ CO2(g)   Na2CO3(aq)+ H2O(l)   (2) 
 
Additionally, it seems that the high peak labelled (220) and (002) at 2θ = 30.1º 
essentially consists of two overlapping peaks for impure MPs. The average crystal size 
(L) of MPs based on the Scherrer relation is on the order of 20±5 and 40±5 nm for pure 
and impure MPs, respectively. 
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Figure 6-8: XRD patterns for selected materials showing the relative positions of the 
diffraction peaks: (a) impure and pure MPs, and (b) PLA: PCL/ MP composites. 
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Figure 6-8(b) also shows the XRD patterns for PLA: PCL/ MP composite fibres with 1 
wt%/v impure MPs, and 0.1 and 1 wt%/v pure MPs. Generally the XRD patterns have 
two diffraction peaks (101) and (200) without any considerable difference in the peak 
position, which signifies that the addition of MPs has very minor impact on the 
alteration of the crystalline structures in the composite nanofibres. 
 
The XRD data were employed to detect the degree of crystallinity in Figure 6-9. It has 
been recognized that the degree of crystallinity of PLA: PCL/ MP composites reduces 
considerably when increasing the pure MP concentration. Such a decreasing trend might 
be explained by the abundant nucleation cores that create a proliferation of tiny 
crystallites leading to a low degree of overall crystallinity (Lee et al., 2003). The 
crystallinity decreases more remarkably when pure MPs are simultaneously embedded at 
particle concentrations from 0 to 1 wt%/v. MPs seem to greatly accelerate the nucleation 
process. Accordingly, this phenomenon results in a shorter period for the 
disentanglement of molecular chains. The associated degree of crystallinity is usually 
caused by the restricted mobility of polymer chains, which hinders good crystal growth. 
 
On the contrary, the embedding of impure MPs gives rise to an increase in the degree of 
crystallinity on account of the impurities that can decrease the molecular weight of the 
PLA: PCL blends. As a result of the low molecular weight, the short polymer chains 
could be mainly crystallized through the electrospinning process, as opposed to the 
highly entangled chains of the high molecular weight blends, leading to more amorphous 
phases. Besides, molecular rearrangements through the solidification process can be 
hindered by the longer polymer chains, resulting in lower mobility and greater 
intermolecular entanglement (Suwa et al., 1973). 
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 Figure 6-9: The degree of crystallinity Xc for PLA: PCL blends and PLA: PCL 
based composite fibres with pure and impure MPs. The Xc values were 
calculated from XRD data. 
 
Table 6-2: DSC results for PLA and PLA: PCL based composite fibres with pure and 
impure MPsa. 
Sample Tg (°C) PCL Tm (°C) PCL Tc (°C) PLA Tm (°C) PLA 
PCL (fibres) –58.0 63.1 - - 
PLA: PCL   –52.2 63.8 84.0 152.5 
PLA: PCL (0.1% pure MPs) –53.0 61.5 82.7 151.7 
PLA: PCL (1% pure MPs) –58.2 62.2 81.6 151.5 
PLA: PCL (1% impure MPs) –53.2 63.1 88.0 - 
aCalculations were repeated for three sets of samples. The standard deviation for the Tg, 
Tc and Tm values was less than 0.5°C. 
 
 
The DSC thermal properties of electrospun composite nanofibres are revealed along 
with those of neat PCL fibres and PCL: PLA blends in Figure 6-10 and Table 6-2. The 
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glass transition temperature (Tg) of PCL within the fibre composites decreases 
noticeably, and there was a slight decline in the melting temperature (Tm) of both PLA 
and PCL when increasing the MP concentration from 0 to 1wt%/v. The decrease of Tg is 
assigned to the effect of incorporation of magnetite particles having an anisotropic 
character, in good accordance with previous work (Kumar et al., 2000). Furthermore, the 
electrospinning process and resulting fibre diameters can also affect the directional 
mobility of the polymer chains, leading to a difference in Tg (Picciani et al., 2010). The 
added MPs in PCL: PLA have been found to slightly decrease the crystallisation 
temperature (Tc) of PLA. The role of MPs in promoting the heterogeneous nucleation of 
polymer molecules has not been substantially demonstrated, which could be assigned to 
the low MP concentration. The Tg of PLA within the blend is hard to detect because it 
overlaps with the melting peak of PCL. 
 
The embedding of impure MPs into the PLA: PCL blend leads to a remarkable 
enhancement in the Tc value of PLA, while there were no significant alterations to the Tg 
and Tm of PCL, which is attributed to the significant decline in the molecular weight of 
the polymer blends. This influence of impure MPs on the molecular weight was much 
greater on PLA as opposed to PCL. The major explanation is that the quantity of PCL 
was approximately double that of PLA in the blend. It also lies in the comparatively low 
crystallinity of PLA, which undergoes a more rapid process of ester hydrolysis 
compared with PCL. This can cause an increased concentration of ester groups easily 
attainable in the PLA (Pitt et al., 1981). As a result, the impurities associated with MPs 
are able to react faster with PLA, which could lead to more complexity in the Tm 
behaviour of PLA.  
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Figure 6-10: DSC thermograms for selected material samples. 
 
6.4 Intermolecular interactions 
Fourier transform infrared spectroscopy (FTIR) was utilized to explain interactions 
between the MPs and the PLA: PCL biopolymers. As displayed in Figure 6-11(a), the IR 
spectra of MPs show bands in the low frequency region between 1050 to 550 cmP–1 
Powing to the absorption band of Fe–O. For pure MPs, the band present at 1636 cmP–1 Pis 
related to water deformation, whereas the peak at 3200 cmP–1 Pis associated with the O–H 
bond, which arises from the hydroxyl group of lauric acid. For impure MPs, new bands 
occur at 1424 and 1156 cmP–1 P, which are allocated to inorganic nitrates and sulphates. 
Additionally, there are some shifts in Fe–O bands possibly due to differences in the 
particle sizes of pure and impure MPs. The surface bond force constant increases when 
the size of MPs becomes very small, resulting in the reorganization of electrons on the 
particle surface because of the destruction of many bonds between the surface atoms 
(Khan, 2008). 
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Figure 6-11(b) illustrates the FTIR spectra of PLA: PCL and MPs embedded in the PLA: 
PCL based composites. PLA: PCL nanofibres at 1757cm–1 for PLA and 1724 cm–1 for 
PCL show initially two carbonyl stretching (C=O) bands. The spectra of PLA: PCL, 
PLA: PCL/pure MP composites and PLA: PCL/impure MP composites display a range 
of different phenomena including shifting, appearance or complete disappearance of 
peaks. The single PLA: PCL band at 1184cm–1 is broadened and shifted to lower wave 
numbers of 1179 and 1175 cm–1 when incorporating pure and impure MPs, respectively, 
into the PLA: PCL blends. In addition, the existence of the Fe–O band at 583 cm−1 
confirms the successful embedding of characteristic bands of PLA: PCL and MPs in the 
infrared spectra of the final composite nanofibres. Moreover, the peaks of PLA within 
the PLA: PCL blends happen at both 1757 cm–1 and 1088 cm–1, which reflect the 
carbonyl stretching C=O  band and the C–O stretching band, respectively. These peaks 
disappeared when impure MPs were embedded. It can be established that there is a 
considerable interaction between the PLA: PCL blends and impure MPs owing to the 
impurities associated with the MPs as previously characterized. Such a result supports 
the findings from the DSC data that indicate a greater impact of impure MPs on PLA 
compared to PCL. 
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 Figure 6-11: FTIR spectra for selected material samples showing the relative FTIR 
peaks: (a) pure and impure MPs, and (b) PLA: PCL based composites with pure and 
impure MPs. 
125 
 
6.5 Summary 
The main finding from this chapter it was that increasing the pure MP concentration can 
decrease the average fibre diameter, and this trend was more significant for impure MPs. 
This effect was associated with two important properties, namely electrical conductivity 
and solution viscosity, of the PLA: PCL blends. The dispersion of pure MPs was 
enhanced in the PLA: PCL nanofibre structures relative to impure MPs. Impure MPs 
created non-uniform fibrous structures with tiny fibres, making them inappropriate for 
the drug release application. However, the configuration of these novel cell structures 
has not been observed before in the literature. The employment of pure MPs and impure 
MPs leads to completely different thermal properties. The degree of crystallinity and the 
Tg of PCL are reduced when pure MPs are embedded with the PLA: PCL blends. On the 
contrary, adding impure MPs increases the degree of crystallinity with a modest increase 
in the melting temperature of PLA. The infrared spectra of electrospun composite 
nanofibres have confirmed the successful embedding of MPs into their structure. Impure 
MPs are shown to considerably influence the C=O and C–O bonds of PLA. 
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Chapter 7  
Drug Release 
7.1 Drug delivery 
Electrospun nanofibres loaded with drugs have good structural stability and higher 
efficiency of drug encapsulation than other drug delivery systems. Adding a drug into 
the polymer solution affects solution properties. The drug release from nanofibre mats 
can be managed by the modified fibre morphology, polymer composition, dosage 
quantity, and drug loading procedure. The interaction between polymer and drug plays a 
significant role in controlled drug release. It is very challenging to understand well the 
mechanism leading to the drug release kinetics from biodegradable polymers. 
 
Based on the findings in previous chapters, fives selected nanofibres mats (PLA: 9% 
PCL), (PLA: 15% PCL), (PLA: 15% PCL/ 0.1% MPs), (PLA: 15% PCL/ 1% MPs) and 
PLA: 15% PCL/ 1% HNT-ASP) were investigated as carriers for therapeutic compounds 
tetracycline hydrochloride (TCH) and indomethacin (IMC) with potential uses in 
medical applications. These material systems infused with 1 wt% and 5 wt% of TCH 
and 5 wt% of IMC were analysed and discussed in terms of their morphological 
structure, crystallinity level, thermal properties and constituent interactions, which can 
affect drug release and nanofibre degradation. Drug release experiments were also 
performed. Moreover, the release kinetic data were fitted to five mathematical models, 
which are classified as zero order, first order, Higuchi, Ritger-Peppas and Zeng models. 
 
7.2 Morphological observations 
7.2.1 Effect of TCH concentration 
Figure 7-1 shows that using PLA: 9% PCL with blending ratio 1:1 dissolved in 
chloroform: methanol co-solvents produced uniform nanofibres with an average 
diameter of 689 nm. On the other hand, the addition of 1 and 5 wt% TCH into the 
polymer blends facilitates the reduction of fibre diameter as compared to their 
counterpart without TCH as shown in Figure 7-2. The electrical conductivity is 
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enhanced remarkably when the TCH concentration increases from 1 wt% to 5 wt%. The 
additional cationic drug TCH increases the solution conductivity as compared to the 
solution without TCH, Figure 7-2. Electrical conductivity plays a dominant role in 
determining fibre morphology. In contrast, when the TCH was added to a polymer blend 
solution, there was no impact on the viscosity. As a matter of fact, the increased 
electrical conductivity inevitably produces more electric charges that are carried by the 
electrospinning jet, which could contribute to electrospun fibres with smaller diameters 
(Lee et al., 2010; Saraf et al., 2009).  
 
 
 
Figure 7-1: SEM micrographs of electrospun PLA: 9% PCL nanofibres using 
chloroform: methanol as a solvent: (a) without TCH, (b) 1wt% TCH, and (c) 5 wt% 
TCH.  
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Figure7-2: Effect of TCH concentration on the electrical conductivity of PLA: 9% PCL 
solution and average nanofibre diameters. 
 
7.2.2 Effect of drug type (IMC and TCH) 
To investigate the effect of drug type, the PLA: PCL polymer solution was blended with 
two different drugs, namely Indomethacin (IMC) and TCH, at a 5 wt% concentration. 
Figures 7-3 and 7-4 demonstrate that IMC produced a uniform fibrous structure with 
large diameters compared to TCH. There was no remarkable change of nanofibre 
diameter with the addition of IMC compared with PLA: PCL nanofibres. The 
explanation for this phenomenon is that the addition of IMC into the PLA: PCL solution 
did not appear to significantly affect the electrical conductivity, Figure 7-4. This result 
agrees well with a previous finding (Nyström et al., 2010). Nevertheless there was a 
significant increase in the electrical conductivity when using TCH. 
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 Figure 7-3: SEM micrographs of electrospun PLA: 15% PCL: (a) without drug, (b) with 
5 wt% IMC, and (c) with 5 wt% TCH. 
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Figure 7-4: Effect of drug type (5 wt% of IMC and TCH) on average nanofibre 
diameters of PLA: 15% PCL blend solution (mix ratio: 1:1) and solution electrical 
conductivity. 
 
7.2.3 Effect of MPs and TCH 
To investigate the effect of TCH on MP nanocomposites, the addition of 5 wt% TCH 
into PLA: 15% PCL based composites with 0, 0.1 and 1 wt%/v MPs was undertaken. 
TCH facilitates the reduction of fibre diameter from 623 to 491 nm, as compared to their 
counterparts without TCH, Figures 7-5 and 7-6. In terms of the effect of electrical 
conductivity, an increase in the MP concentration led to an increase in the conductivity, 
apparently due to the addition of iron ions from the MPs, as shown in Figure 7-6. More 
prominently, the use of the drug TCH can further enhance the electrical conductivity of 
the electrospun composites especially at MP concentrations of 0.1 wt%/v. The additional 
amphoteric molecules of TCH, having several ionisable functional groups (Sassman and 
Lee, 2005), further increases the solution conductivity as compared to that without TCH. 
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This implies that electrical conductivity plays a relatively dominant role in determining 
fibre morphology though the addition of MPs increases the viscosity of the solution. 
 
 
Figure 7-5: SEM micrographs of electrospun PLA: 15% PCL/ pure MP composites: (a) 
0 wt%/v MPs and 5 wt% TCH, (b) 0.1 wt%/v MPs and 5 wt% TCH, and (c) 
1wt%/v MPs and 5 wt% TCH. 
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Figure 7-6: Effect of pure MP concentration on the average nanofibre diameters of PLA: 
15% PCL blend solution (mix ratio: 1:1) and electrical conductivity of blend solution 
with 5 wt%/v TCH. 
 
7.2.4 Effect of HNTs and TCH 
PLA: PCL/ HNT-ASP/ TCH produced a uniform fibrous structure with a small average 
diameter of 716 nm, Figure 7-7, in contrast to the corresponding PLA: PCL and PLA: 
PCL/ HNT-ASP blends. The addition of TCH is associated with enhancement of the 
solution’s electrical conductivity, which leads to the production of small nanofibre 
diameters. The use of HNT-ASP increases the average nanofibre diameter up to 905 nm 
relative to 814 nm for PLA: PCL blends. This result is ascribed to the dominant effect of 
material viscosity on the fibre morphological structure, compared with a slight increase 
in the electrical conductivity, Figure 7-8. 
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 Figure 7-7: SEM micrographs of electrospun PLA: 15%PCL: (a) without HNT-ASP, (b) 
with 1 wt%/v HNT-ASP, and (c) with 1 wt%/v HNT-ASP / 5 wt% TCH. 
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Figure 7-8: Effect of HNT-ASP and 5 wt% TCH on the average nanofibre diameters of 
PLA: 15% PCL blend solution (mix ratio: 1:1) and electrical conductivity of blend 
solution. 
 
7.3 Crystallinity level and thermal properties 
An XRD examination was carried out to investigate the changes in the TCH 
concentration and drug type on the degree of crystallinity and structure of electrospun 
nanocomposites. The peaks in the pattern were labelled for the XRD reflection and the 
crystal planes (hkl) corresponding to the main crystalline peaks were detected by the 
DICVOL program of the FullProf software. Figure 7-9 shows the XRD patterns for 
PLA: PCL blends and nanocomposite fibres with TCH and IMC. The XRD patterns 
possess two diffraction peaks at angles of 2θ = 20.11° and 23.2° corresponding to the 
planes (101) and (200), respectively. There was no significant difference in the peak 
positions for most samples, which indicates that the addition of TCH and IMC have a 
very minor effect on the crystalline structures of the composite fibres. This finding 
indicates that the TCH and IMC are most likely to be dispersed in an amorphous state in 
135 
 
the PLA: PCL nanofibre mat. In addition, the large surface area combined with small 
nanofibre diameters created through the electrospinning process can facilitate quick 
solvent evaporation, which could provide a short period for drug recrystallisation and 
formation of preferred configuration in amorphous state (Puppi et al., 2010). 
 
 
Figure 7-9: X-ray diffraction patterns for selected samples showing the relative position 
of the diffraction peaks due to the addition of the drugs TCH and IMC. 
 
Figure 7-10 demonstrates that increasing the amount of TCH from 1 to 5 wt% in the 
PLA: 9% PCL nanofibres led to a moderate decrease of the degree of crystallinity. The 
crystallinity is reduced more remarkably when 5 wt% of TCH is concurrently added as 
compared to the PLA: 15%PCL polymer blend. IMC dispersed in the PLA: 15%PCL 
blend had a more significant impact on the degree of crystallinity than TCH did. The 
presence of both TCH and IMC appears to greatly accelerate the nucleation process. 
Accordingly, this phenomenon allows a shorter period for the disentanglement of the 
molecular chains because the resulting degree of crystallinity is influenced by the 
restricted mobility of the polymer chains, which hinders good crystal growth. 
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Figure 7-10: Degree of crystallinity results for adding drugs TCH and IMC. 
 
The DSC thermal properties of electrospun composite fibres with IMC and TCH drugs 
are shown in Figure 7-11 and Table 7-1. The glass transition temperature (Tg) of PCL 
within the fibre composites decreases remarkably, and there was a slight decline in 
melting temperature (Tm) values of both PLA and PCL when increasing the MP 
concentration from 0 wt%/v to 1 wt%/v, as well as using HNT-ASP and 5% TCH. The 
decrease of Tg  is attributed to the dual effect of incorporation of magnetite particles with 
anisotropic character, in good accordance with the previous work (Kumar et al., 2000), 
and blending of the drug TCH, which has a low molecular weight. The TCH molecules 
have short chains, which results in decreased packing density of the polymer chains, and 
thus facilitates chain mobility, leading to the lower Tg. Conversely, the use of TCH 
within composite fibres shows the significant increase of Tc at over 106ºC as opposed to 
84ºC for PLA in PLA: PCL blends. This phenomenon implies that low molecular weight 
TCH can hinder the cold crystallisation process of PLA, acting as an anti-nucleating 
agent, which, however, maybe in opposition to the role of MPs. Increasing the 
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concentration of the drug TCH from 1 to 5 wt% leads to a decrease in the Tg of PCL 
with a significant increase in the Tc of PLA within the blend. On the other hand, 
changing the type of drug also had a remarkable impact on the values of Tm and Tc of 
PLA within the fibre composites. Adding IMC led to a drop in the Tm value, while there 
was a slight decrease in Tc, which could be explained by the fact that the interaction 
between the blend polymers and IMC was somewhat better compared with TCH. 
 
Table 7-1: DSC results for PLA: PCL composite fibres embedded with MPs, HNTs, 
IMC and TCHa. 
aCalculations were repeated for three sets of samples. The standard deviation for the Tg, 
Tc and Tm values was less than 0.5°C. 
Sample Tg  (°C)  
 PCL 
Tm  (°C) 
PCL 
Tc  (°C) 
PLA 
Tm  (°C) 
PLA 
PLA: 15% PCL –52.2 63.8 84.0 152.5 
PLA:  15% PCL/ 5% IMC –58.6 54.6 82.0 149.0 
PLA: 15% PCL/ 5% TCH –58.5 59.6 105.8 151.9 
PLA: 15% PCL / 1%MPs / 5% TCH –62.0 59.6 100.1 149.3 
PLA: 15% PCL/ 0.1% MPs/ 5% TCH –60.5 59.2 101.8 149.4 
PLA: 15% PCL/ 1% HNT-ASP/ 5% TCH –61.4 59.2 102.8 149.1 
PLA: 9% PCL/ 5% TCH –60.5 60.6 99.3 151.0 
PLA: 9% PCL/ 1%TCH –58.4 60.4 80.4 151.6 
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Figure 7-11: DSC thermograms for selected material samples. 
 
7.4 Intermolecular interactions 
Figure 7-12 shows the FTIR spectra of PLA: PCL/ TCH in various nanocomposites and 
the PLA: PCL/ IMC system. The spectra of 1 wt%/v and 5wt%/v TCH in PLA: PCL 
blends and nanocomposites, were difficult to interpret due to band shifting. However, 
the major distinguishable change in the infrared spectra is that the bands of TCH at 1614 
and 1581 cm−1 were observed in the nanocomposites, and these were allocated to C=O 
stretching in ring A and C=O stretching in ring C, respectively. This observation 
confirms the successful encapsulation of TCH into the nanocomposites. It was hard to 
allocate bands for the spectrum of 1 wt%/v TCH in the PLA: PCL blends. The FTIR 
spectrum of the PLA: PCL/ 5 wt%/v IMC blend demonstrated that the bonds existing at 
1560 cm–1 were associated with the ionization of carboxyl groups in the IMC, which 
shows that the IMC was intercalated in the anionic structure (Mi et al., 2001; 
Mohanambe and Vasudevan, 2005). 
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 Figure 7-12: FTIR spectra for selected material samples showing the effect of drugs on 
the relative FTIR peaks. 
 
7.5 In vitro drug release 
7.5.1 Effect of TCH concentration 
TCH release profiles from electrospun PLA: 9% PCL with 1 wt%/v and 5 wt%/v TCH 
are reported in Figure 7-13. Both samples have been found to have fast drug release 
performance. In the first 20 minutes, 44% of the drug was released for PLA: PCL/ 1% 
TCH samples compared to 56% for PLA: PCL/5% TCH samples. Within the first 2 h, 
this increased to 59% for the PLA: PCL/ 1% TCH samples and 64 % for PLA: PCL/ 5% 
TCH samples. This was followed by a steady release over the remainder of the 10 day 
release tests. The fast release is associated with the electrospinning process, which 
includes fast evaporation of the solvent and high ionic interactions leading to the drug 
being located on the surfaces of the electrospun fibres. It was found that TCH was 
released more quickly when 5 wt%/v TCH was added to the polymer blend. At higher 
concentrations of TCH, the dissolved TCH in the PLA: PCL solution has a greater 
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tendency to move to the nanofibre surface throughout the electrospinning period, which 
accelerates the drug release rate compared to that for a low TCH concentration. In 
addition, drug release took place initially from the amorphous regions (Luong-Van et al., 
2006). Accordingly, increasing the TCH concentration in PLA: PCL nanofibres led to a 
decrease of the crystallinity for the PLA: PCL blends as shown in Figure 7-10. It is also 
possible to say that TCH accumulated in the amorphous regions because there was no 
change in the structure of PLA: PCL as shown by the XRD data. Consequently, the 
higher quantity of TCH supports a faster drug release rate from these regions. 
 
 
Figure 7-13: TCH release profiles from PLA: 9%PCL with 1 and 5 wt %/v TCH. 
 
7.5.2 Effect of drug interaction 
The drug particles within polymer nanofibres have a tendency to be attached to the fibre 
surface due to quick solvent evaporation from the PLA: PCL blend solution during the 
electrospinning process and also due to the highly ionic interactions. Accordingly, a 
considerable burst release of the drug may initially take place. The burst release 
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becomes faster when the drug and the PLA: PCL solution are not compatible; that is, 
when there is weak interaction between them. 
 
A high PCL concentration in the PLA: 15% PCL fibres, as seen from Figure 7-14, leads 
to a slower drug release rate compared to low PCL concentration PLA: 9% PCL 
nanofibres. This is attributed to the lower porosity of the nanofibres produced from the 
higher concentration polymer solutions, which decreases the overall desorption of TCH 
molecules from the porous surfaces. 
 
 
Figure 7-14: TCH release profiles from PLA: 9% PCL and PLA: 15% PCL. 
 
The interaction between the drug and the PLA: PCL blend solution is an important 
factor for controlling drug release. The release kinetics of the hydrophilic drug TCH in 
the hydrophobic PLA: PCL solution were faster than for the hydrophobic drug IMC in 
the hydrophobic PLA: PCL solution. It can be seen from Figure 7-15 for the drug release 
within the first 5 h, 42% was released for PLA: PCL/ 5% TCH versus 30% for PLA: 
PCL/ 5% IMC. This could be ascribed to better interaction and compatibility between 
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IMC and the polymer blend compared with TCH. Furthermore, chemical interaction 
between drug and its carrier can impede drug crystallisation within the carrier, which 
may cause more sustained release of the drug in the crystalline state (Natu et al., 2010). 
 
 
Figure 7-15: Drug release profiles from PLA: 15% PCL for 5 wt %/v IMC and 5 wt%/v 
TCH. 
 
7.5.3 Effect of nanoparticles 
TCH release profiles from electrospun composite fibre mats with and without pure MPs 
are reported in Figure 7-16. Nanocomposite mats have been shown to offer sustained 
drug release performance though a certain degree of fast drug release was found within 
the first 5 h (62% for PLA: 15% PCL/ 1 wt%/v MPs, 46% for PLA: 15% PCL/ 0.1 
wt%/v MPs and 42% for PLA: 15% PCL samples). Whilst the addition of 1 wt% HNT-
ASP into PLA: PCL not only reduces the initial bust release to 30% after 5 h with 
reference to the initial 42% for PLA: PCL, but it also has a similar release trend over the 
duration of the steady release period from 50 h to 250 h. This implies that robust control 
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of drug release for both short and long evaluation periods can be achieved by the use of 
HNT-ASP. As explained previously, fast release is associated with the electrospinning 
process, which includes fast solvent evaporation and highly ionic interactions leading to 
the location of the drug on the surfaces of the electrospun fibres. It was found that TCH 
was released more rapidly when adding MPs to the polymer blend and the difference in 
cumulative release (%) when adding 1 wt%/v MPs becomes fairly large compared to 
those composites without MPs while for 0.1 wt%/v MPs it becomes large after 50 h. 
This finding suggests that TCH release was due to many factors, such as drug diffusion 
through the pores, biodegradation of the electrospun fibres and the interaction between 
TCH and the PLA: PCL/ MP nanofibre mats. The incorporation of MPs, due to their 
nanoscale size, leads to increased fibre porosity (Mikołajczyk and Olejnik, 2006) and the 
porosity increases with increasing MP concentration from 0.1 to 1 wt%/v, which is then 
capable of accelerating the TCH release. In addition, the small diameters of the PLA: 
PCL/ MP composite fibrous structures compared with their PLA: PCL counterparts 
certainly increase the surface area, which leads to short diffusion distances and fast TCH 
release. Moreover, the low crystallinity of the PLA: PCL/ MP composites can also assist 
in the enhancement of fibre degradability, which affects long term TCH release. The 
release of TCH from PLA: PCL/ HNT-ASP nanocomposites is much slower than for 
PLA: PCL and PLA: PCL/ MP nanocomposites. HNTs are negatively charged on their 
outer surface and positively charged on their inner surface (Vergaro et al., 2010). Such 
charges on the HNT-ASP may permit electrostatic interaction between TCH and the 
surface and lumen of HNT-ASP, resulting in reduced TCH drug release from PLA: 
PCL/ HNT-ASP nanocomposites. 
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Figure 7-16: TCH release profiles from PLA: 15% PCL and its nanocomposites 
containing MPs and HNT-ASP for 5%TCH. 
 
7.6 In vitro biodegradation studies 
The biodegradation behaviour of the nanofibres mats is shown in Figure 7-17. After the 
degradation in PBS for the first 3 to 12 hours, the weight of all nanofibres mats remained 
approximately unchanged within a standard error, especially for PLA: 15% PCL, PLA: 
15% PCL/ 0.1% MPs and PLA: 15% PCL/ HNT-ASP nanofibres as detected in the 
Figure 7-17. There was a high initial mass loss at 24 h for some nanofibre mats (1.13% 
for PLA: 15% PCL/ 1% MPs and 1.37% for PLA: 9% PCL), while the other nanofibres 
mats demonstrated very little mass loss (0.36% for PLA: 15% PCL). Mass loss for PLA: 
15% PCL started after 72 h, and the mass loss increased over the degradation time of 
336 h to reach 2.91% for PLA: 15% PCL, 3.44% for PLA: 15% PCL/ 1% HNT-ASP, 
4.73% for PLA: 15% PCL/ 0.1% MPs, 6.10% for PLA: 15% PCL/ 1% MPs and 6.26% 
for PLA: 9% PCL. The possible explanation for this behaviour is that increasing the 
PCL concentration within the blends may hinder water penetration inside the nanofibres 
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and the absorption of water occurs slowly due to PCL being hydrophobic and semi-
crystalline. That means the samples with 15% PCL had a higher degree of crystallinity 
than those with 9% PCL. The amorphous regions are easily degraded when compared 
with the crystalline regions due to the random and less tightly packed arrangement of the 
molecular chains. In addition, when a hydrophilic drug is released from the nanofibre 
mat, it may accelerate the degradation of the hydrophobic nanofibres due to its increased 
wettability (Huang et al., 2006). 
 
The biodegradation rate of the PLA: 15% PCL/ MP nanocomposites are considerably 
accelerated in comparison with the PLA: 15%PCL blend. The difference in terms of the 
mass loss increases with increasing MP concentration. This may be due to the decrease 
in nanofibre diameter and also the increase of the porosity at the nanofibre surface when 
MPs are added. Moreover, it is noted that adding HNT-ASP to the nanofibres does not 
significantly affect the biodegradation rate and mass loss compared with adding MPs. 
This is related to the surface area exposed to the PBS being larger in the case of 
embedding MPs due to the creation of small diameter nanofibres. 
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Figure 7-17: Mass loss of electrospun nanofibre mats during the degradation time. 
 
Figure 7-18 shows the morphological changes in the fibres after immersion in PBS over 
a two week period. It was found that different morphologies appeared for nanofibre mats 
with different nanocomposite contents and PCL concentrations. The nanofibre diameters 
increased and the space between the nanofibres decreased after seven days, especially 
for PLA: 15% PCL/ 1% MP and PLA: 15% PCL/ 1% HNT-ASP nanocomposites. The 
nanofibres showed more wrinkled structures after 7 days compared with those for the 3 
h degradation. The degradation initially took place in the amorphous area of the blend 
nanofibres, and then occurred in the crystalline area (Huang et al., 2004; Stefani et al., 
2006). The degradation of the nanofibres in the solution is heterogeneous and the 
degradation at the nanofibre surface could be slower than in the nanofibre core due to 
the carboxylic acid groups existing in the fibre core areas by ester hydrolysis (Maquet et 
al., 2004). Moreover, the large diameters and swelling behaviour of the degraded 
nanofibres for PLA: 15% PCL/ 1% MP and PLA: 15% PCL/ 1% HNT-ASP 
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nanocomposite mats were more evident than for the PLA: 15% PCL nanofibre mats, 
indicating that the nanoparticles increased PBS absorption. 
 
 
Figure 7-18: SEM micrographs of in vitro degradation of nanofibre mats: (a) to (d) PLA: 
15%PCL/ TCH, (e) to (h) PLA: 15%PCL/ 0.1% MPs/ TCH, (i) to (l) PLA: 15%PCL/ 
1% MPs/ TCH, (m) to (p) PLA: 15%PCL/ 1% HNT-ASP/  TCH, and (q) to (t) PLA: 
9%PCL/ TCH, for periods of 3 h, 24 h, 7 days and 14 days, respectively. 
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7.7 Release kinetics and mechanistic interpretation 
The release kinetics were examined by fitting five mathematical models, which are 
categorized as zero order, first order, Higuchi, Ritger-Peppas (Cai et al., 2011) and Zeng 
(Zeng et al., 2011) models, to the drug release data using a least squares objective 
function. Comparisons between the release data and the best-fit predictions for these five 
models are shown in Appendix I. The equations of each model and their reported best-fit 
parameters are listed in Table 7-2. The R2 value was highest when fitting the 
experimental data to the first order, Ritger-Peppas and Zeng models compared to the 
other models. The first order model illustrates that drug release rate mainly depends on 
drug concentration and its carrier. According to the n values of the Ritger-Peppas model, 
the drug release mechanism follows Fickian transport phenomenon (Cai et al., 2011) 
with a dominant diffusion process. On the other hand, according to Zeng's model, the 
diffusion process and interaction between PLA: PCL and TCH has significant impact on 
the drug release. In the Zeng model, ΔG is the difference in the free energies of the free 
and bound states of the drug in the nanofibres. The addition of 0.1 wt%/v MPs to PLA: 
PCL led to a little decrease in ΔG values from –2.0×10-22 J to –2.6×10-22 J, which means 
that there is slightly improvement in the interaction between the drug carrier and TCH. 
Nevertheless, such improvement did not adjust the TCH release, and the fast release 
from PLA: PCL/ 0.1% MPs was higher than PLA: PCL/ TCH release. This observation 
could be due to the creation of small fibre diameters by adding MPs, which leads to the 
acceleration of TCH release. The fast release is also due to increasing the fibre pore size 
with the addition of MPs, which is reflected in increased values of Ks. On the other 
hand, incorporating 1wt%/v MPs suggests a weaker interaction while the number and 
size of fibre pores are suggested to grow. The TCH release kinetics are not completely 
described by these models because they do not take into account the 
erosion/biodegradation and dimensional alteration of the drug carrier. The big difference 
in ΔG, 1.47×10-21 J versus –2.2×10-21 J for PLA: 15% PCL/ 1% MPs and PLA: 15% 
PCL/ 1% HNT-ASP, respectively, suggests a better interaction between TCH and the 
larger HNT-ASP particles than the smaller MPs. The Zeng model suggests that due to 
embedding HNT-ASP into the nanofibres there was a small change in KS. However, ΔG 
decreased from –2.0×10-22 J to–2.2×10-21 J. Such a result indicates that embedding HNT-
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ASP enhances steady drug release and overcomes the fast release due to interaction 
between the TCH molecules and HNT-ASP from hydrogen bonding with the silanol 
groups on the HNT-ASP. 
 
The Zeng model demonstrates the effect of drug concentration on drug release. When 
the drug concentration increases from 1 wt% to 5 wt%, ΔG also increases from 
1.47×10-21 J to 2.49×10-21 J, which reveals to increase TCH release and diffusivity due to 
increase amount of free TCH on the PLA: 9% PCL nanofibre surface. Furthermore, KS 
increased from 5.127 to 8.343 h–1, indicating the pore size increases when the TCH 
concentration increases. 
 
The Zeng model detected the effect of interaction between both drugs (TCH and IMC) 
and the carrier (PLA: 15% PCL nanofibres) on the release rate. IMC exhibits a much 
lower ΔG than TCH (−2.1×10-21 J for IMC against –2.0×10-22 J for TCH), suggesting 
that PLA: 15% PCL can decrease the release of hydrophobic IMC, but not hydrophilic 
TCH, due to the interaction enhancement between the drug and polymer. Furthermore, 
the decrease in Koff  values of TCH (0.0033 h–1) and IMC (0.0025 h–1) implies a stronger 
interaction between IMC and carrier. 
 
In addition, the Zeng model shows the effect polymer concentration on drug release. 
When the PCL concentration within a blend decreased from 15 to 9 wt%/v, the release 
rates of TCH from the nanofibre mat increased significantly. The Zeng model shows an 
increase in ΔG, from –2.0×10-22 J to 2.49×10-21 J, on account of a reduction of PCL 
concentration for the same amount of drug. Moreover, big pores increase diffusivity and 
TCH release from the nanofibres, and correspondingly KS increased from 1.160 to 
8.343 h–1, which reflects increased pore size. The variations in the fitted model 
parameters, especially ΔG and KS, are consistent with the previous interpretations of the 
experimental results. 
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Table 7-2: Parameters obtained by fitting five different models for drug release kinetics 
to the drug release data. 
Model Zero order First order Higuchi Ritger-Peppas Zeng 
Equation Mt/M∞= K0t 
Mt/M∞= 1–e–
K1t Mt/M∞= KHt
1/2 Mt/M∞= KRtn ** 
PLA:15%PCL/ 
5%IMC 
K0=0.002 h–1 
R2=0.564 
 
 
K1=0.436 h–1 
R2=0.822 
 
 
KH=0.037 h-1/2 
R2= 0.801 
 
 
KR=1.618 h-n 
n=0.251 
R2=0.938 
 
 
Kon=0.0049 h–1 
Koff=0.0025 h–1 
Ks=1.006 h–1 
*ΔG=–2.1×10–21J 
R2= 0.945 
PLA:15%PCL/ 
5%TCH 
K0=0.002 h–1 
R2=0.434 
 
K1=0.582 h–1 
R2=0.839 
 
KH=0.038 h-1/2 
R2= 0.691 
 
KR=1.262 h-n 
n=0.204 
R2=0.927 
 
Kon=0.0034 h–1 
Koff=0.0033 h–1 
Ks=1.160 h–1 
*ΔG=–2.0×10–22J 
R2=0.920 
PLA:15%PCL/ 
0.1%MPs/ 
5%TCH 
K0=0.0022 h–1 
R2=0.451 
 
K1=0.625 h–1 
R2= 0.808 
 
KH=0.042 h-1/2 
R2=0.705 
 
KR=1.127 h-n 
n=0.193 
R2=0.950 
 
Kon=0.0069 h–1 
Koff=0.0065 h–1 
Ks=1.864 h–1 
*ΔG= –2.6×10-22J 
R2=0.923 
PLA:15%PCL/ 
1%MPs / 
5%TCH 
K0=0.0019 h–1 
R2=0.348 
 
K1=2.097 h–1 
R2=0.856 
 
KH=0.037 h-1/2 
R2=0.560 
 
KR=0.806 h-n 
n=0.138 
R2=0.938 
 
Kon=0.0041 h–1 
Koff=0.0059 h–1 
Ks=3.764 h–1 
*ΔG=1.47×10–21J 
R2=0.956 
PLA:15%PCL/ 
1%HNT-ASP 
/5%TCH 
K0=0.0012 h–1 
R2=0.314 
K1=0.857 h–1 
R2=0.961 
 
KH=0.024 h-1/2 
R2=0.534 
KR=2.025 h-n 
n=0.323 
R2=0.684 
 
 
Kon=0.0012 h–1 
Koff=0.00068 h–1 
Ks=1.025 h–1 
*ΔG= –2.2×10–
21J 
R2=0.986 
PLA:9%PCL/ 
1%TCH 
K0=0.0017 h–1 
R2=0.291 
 
K1=3.372 h–1 
R2=0.889 
 
 
KH=0.035 h-1/2 
R2=0.489 
 
KR=0.912 h-n 
n=0.167 
R2=0.779 
 
 
Kon=0.0025 h–1 
Koff=0.0036 h–1 
Ks=5.127 h–1 
*ΔG=1.47×10–21J 
R2=0.948 
PLA:9%PCL/ 
5%TCH 
K0=0.0015 h–1 
R2=0.224 
 
 
K1=6.899 h–1 
R2=0.930 
 
 
KH=0.030 h-1/2 
R2=0.387 
 
 
KR=0.692 h-n 
n=0.117 
R2=0.828 
 
Kon=0.0017 h–1 
Koff=0.0031 h–1 
Ks=8.343 h–1 
*ΔG=2.49×10–21J 
R2=0.975 
**Mt/M∞= (Koff/(Kon + Koff))(1 − e−KSt) + (Kon/(Kon + Koff))(1 − e−Kofft). 
*ΔG= −kB T ln(Kon/Koff) where kB is Boltzmann’s constant and T is absolute temperature (300 K). 
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7.8 Summary 
This Chapter demonstrated that increasing the concentration of TCH appears to increase 
the electrical conductivity of solution thus considerably decreasing the average 
nanofibre diameters. However, when adding IMC, there was no noticeable change in the 
nanofibre diameters. TCH and IMC loading can contribute to decreased crystallinity 
levels, and decreased Tg and Tm values for PCL within the blend. The biodegradation 
rate was accelerated when blending 9% PCL with PLA and adding MPs to the solution 
in comparison with blending 15% PCL and loading HNT-ASP. The TCH release was 
found to be accelerated by adding pure MPs to PLA: PCL blended polymers. Loading a 
hydrophilic drug (TCH) into HNT-ASP and hydrophobic polymers (PLA: PCL) was 
shown to decrease drug release and overcome the weakness of the interaction between 
the polymer and drug. This typical characteristic was clearly revealed with excellent 
agreements obtained between the experimental data and the Ritger-Peppas and Zeng 
models for drug release kinetics. 
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Chapter 8 
Conclusions and  
Future Work 
8.1 Conclusions 
This work has created several novel electrospun hybrid nanocomposite systems (PLA: 
PCL, PLA: PCL/ HNT-ASP and PLA: PCL/ MPs) with the aim of achieving sustained 
release of a hydrophilic drug (TCH) from the hydrophobic PLA: PCL composite system. 
This thesis examined the effects of the solvent system, solution electrical conductivity, 
solution viscosity, PCL concentration and PCL molecular weight on the nanofibre 
diameters, porosity and degree of crystallinity, which are considered to be significant 
parameters in the control of drug release. Furthermore, the work studied the effect of the 
embedded HNT and MPs on nanofibre morphology, crystallinity, thermal properties, 
connecting bonds and drug release kinetics of these hybrid nanocomposites. The impact 
of interactions between the drugs (TCH and IMC) and the PLA: PCL polymer blend on 
the drug release rate was examined. The study also investigated the drug release kinetics 
by fitting the release data to five mathematical models, including the zero order, first 
order, Higuchi, Ritger-Peppas and more recent Zeng models to help understand the 
mechanism of drug release. The following main conclusions were drawn from this work. 
 
• Blending PLA with PCL alleviated the negative individual aspects of each 
polymer in terms of its crystallinity or formation of an acidic environment. There 
was a noticeable increase in the solution viscosity when the molecular weight 
and concentration of the PCL were increased. That improvement in viscosity 
leads to well-structured and bead-free nanofibrous networks, particularly at a 
PLA: PCL blending ratio of 1:1. The nanofibres created from co-solvents 
chloroform: methanol for all blend ratios of PLA: PCL had larger fibre diameters 
as compared to those based on DCM: DMF co-solvents. Chloroform: methanol 
was also found to facilitate better aligned fibrous structures than DCM: DMF or 
chloroform: acetone co-solvents. 
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• PLA: 15% high molecular weight PCL solution at blend ratio of 1:1 produced a 
higher degree of crystallinity (Xc) compared to PLA: 9% PCL at a blend ratio of 
1:1 or PLA: 15% PCL at a blend ratio of 3:1. There was a sharp decline in Xc and 
melting temperature (Tm) of PCL within the blends when PLA was mixed with 
low molecular weight PCL compared to high molecular weight PCL. However, 
there was a noticeable increase in the crystallization temperature (Tc) of PLA due 
to the low molecular weight PCL. In addition, the fast evaporation of methanol in 
the chloroform: methanol solvent system led to moderate decreases in Xc and Tc 
relative to the DCM: DMF co-solvent system. Increasing the PCL concentration 
from 9 to 15 wt%/v increased the glass transition temperature (Tg) of PCL within 
the blends. Additionally, the shift of the carbonyl stretching band to higher wave 
numbers and the variations in Tg, Tm and Tc for nanofibres produced from 
blending, compared to pure PLA or PCL nanofibres, demonstrate the good 
miscibility of PLA and PCL within the blends. The miscibility was quite high for 
PLA: 15%PCL at a blend ratio of 1:1 dissolved in the chloroform: methanol 
system. 
 
• When HNTs were incorporated into a PLA: low molecular weight PCL blend the 
non-uniform dispersion of HNT resulted and also HNT sedimentation increased 
during the electrospinning process. Furthermore, an increase of HNT 
concentration from 1 to 2 wt%/v did not substantially influence the nanofibre 
diameters due to the low viscosity of the blend solution. On the other hand, the 
embedding of HNT into PLA: high molecular weight PCL blends produced 
homogeneous fibres owing to the increase of the solution viscosity. For both 
concentrations of high molecular weight PCL within the blend, the average fibre 
diameters decreased with reduction in the HNT concentration. For 15 wt%/v 
PCL embedded with HNT, the average fibre diameters were found to be 
considerably smaller for HNT-ASP compared with unmodified HNT. Moreover, 
the PLA: PCL composites embedded with HNT-ASP showed slightly better 
HNT dispersion and less agglomeration compared to unmodified HNT. The high 
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solution viscosity for 15 wt%/v PCL compared with 9 wt%/v PCL promoted the 
formation of a HNT suspension and led to decreased sedimentation of HNT.  
 
• There was a small decrease in the value of Tg of PCL, the Tc and Tm values of 
PLA when embedding HNT-ASP into the polymer blends, while there was a 
moderate decline in the degree of crystallinity. The addition of HNT-ASP into 
PLA: PCL nanofibres reduced HNT agglomeration compared to unmodified 
HNT as evidenced by the infrared spectra of the samples. 
 
• The addition of pure MPs appears to increase the solution viscosity and thus 
facilitates better MP dispersion inside the electrospun composite fibrous 
networks, as compared to impure MPs, which result in a significant viscosity 
reduction. However, considerably decreased average fibre diameters were shown 
to result from impure MPs. The addition of impure MPs creates unique cell 
structures that are reported for the first time in this study.  
 
• The incorporation of pure and impure MPs also led to quite different thermal 
properties. The former led to a decreasing crystallinity level and Tg of PCL, as 
well as decreasing Tc of PLA. In contrast, the latter caused overall increases of 
the aforementioned thermal parameters, except for the unidentified Tm of PLA. 
The infrared spectra of the electrospun composite nanofibres confirmed the 
successful embedding of MPs into the structure. In particular, impure MPs 
significantly affect the carbonyl stretching C=O and C–O stretch bonds.  
 
• The average nanofibre diameters were significantly reduced when increasing the 
TCH concentration due to the increase of the solution electrical conductivity in 
contrast to the addition of IMC, there was no noticeable change in the nanofibre 
diameters. The addition of both TCH and IMC drugs to the PLA: PCL blends 
reduced the crystallinity level, Tg and Tm values of PCL within the blend. 
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• The nanofibre biodegradation rate was found to be greater for low concentration 
(9%) PCL blends and for embedding MPs compared to high concentration (15%) 
PCL blends and for embedding HNT-ASP. Embedding pure MPs into the PLA: 
PCL blend solution was found to increase the TCH release rate. Loading a 
hydrophilic drug (TCH) into HNT-ASP and then to hydrophobic polymer blends 
(PLA: PCL) was detected to decrease drug release and overcome the weak 
interaction between the PLA: PCL blends and TCH drug.  Excellent agreement 
was obtained between the experimental data and the Ritger-Peppasand Zeng 
models for drug release kinetics. 
 
8.2 Future work 
Based on the outcomes of the work contained within this thesis, several possibilities for 
further studies concerning the improvement of the performance for hybrid composite 
nanofibre mats and drug release were identified as follows. 
 
• Tailoring the mechanical properties of electrospun nanofibres may perhaps be 
achieved by embedding MPs and HNTs. It is important to study the possibility of 
using the nanofibre mats created by the current research for tissue engineering 
applications; that is, to further investigate their mechanical properties, 
dimensional shrinkage and surface erosion. Nanofibre mats must have very 
controllable mechanical properties related to physical handling, facilitating the 
process of tissue regeneration and their degradation. 
 
• Depending on the best conditions and mix ratios obtained from this study, it can 
attain the benefit from the core-shell structure based electrospinning method to 
control or reduce the fast drug release. TCH could be mixed with a hydrophilic 
polymer and embedded HNTs, and this mixture could be made into the core of a 
fibre, while the shell of the fibre could be made from a PLA: PCL blend. The 
effect of drug release could then be studied. 
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• Develop a model to predict nanofibre diameter and beads formation as a function 
of solution composition. 
 
• As the porosity affects the drug release, so it is substantial to study the 
relationship between nanofibre diameters and the porosity that exist on the 
nanofibres surface as well as that formed from nanofibers entanglement with 
each other. 
 
• Develop a new mathematical model, or modify the Zeng model, to better 
describe the most important behaviour of the TCH and IMC release kinetics by 
taking into account the change in the nanofibre diameters and the mat’s 
erosion/biodegradation. 
 
• Intermolecular interactions are vital to the material morphology and the 
performance in drug delivery. It is important to understand the potential drug–
polymer interactions that rely on the actual drug–polymer miscibility. In 
addition, it can further assist in developing a new molecular modelling study to 
indicate intermolecular interactions between drug and polymer molecules. 
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Appendix I  
Model fitting to drug release data 
 
 
Figure I-1: Model fittings to the drug release data for PLA: 15% PCL/ 5 wt%/v IMC 
nanofibres. 
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Figure I-2: Models fittings to the drug release data for PLA: 15% PCL/ 5 wt%/v TCH 
nanofibres. 
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Figure I-3: Model fittings to the drug release data for PLA: 15% PCL/ 0.1 wt%/v MPs/ 
5wt/v % TCH nanofibres. 
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Figure I-4: Model fittings to the drug release data for PLA: 15% PCL/ 1% MPs/ 5 wt%/v 
TCH nanofibres. 
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Figure I-5: Model fittings to drug release data for PLA: 15% PCL/ 1% HNT-ASP/ 
5 wt%/v TCH nanofibres. 
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Figure I-6: Model fittings to drug release data for PLA: 9% PCL/ 1wt%/v TCH 
nanofibres. 
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Figure I-7: Model fittings to drug release data for PLA: 9% PCL/ 5wt%v TCH 
nanofibres. 
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